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ABSTRACT 
Feed ingredient economics are pushing pork producers to increase the use of 
higher-fiber coproducts while maintaining high production and efficiency goals. To do 
this, nutritionists utilize -mannanase and xylanase enzymes. It is important to evaluate 
the metabolic impacts of -mannan and xylose to accurately estimate enzyme effects on 
dietary energy availability. Therefore, the overall objective of the work presented in this 
dissertation was to evaluate the influence of -mannan and xylose on energy metabolism 
in the pig. -Mannanase is added to swine diets with the objective of inhibiting an 
energetically-expensive -mannan-induced immune response; however, this rationale 
was not supported by the experiments presented in Chapters 2 and 3. Research presented 
in Chapter 2 showed that -mannanase did not affect immune status, nutrient 
digestibility, growth performance, energy balance, or maintenance energy requirements 
(MEm) of young pigs. These conclusions were further supported by a nursery growth trial 
that tested the interactions of dietary -mannan concentration and -mannanase 
inclusion, presented in Chapter 3. In Chapter 2 it was also found that a 
lipopolysaccharide-induced innate immune challenge elevated pigs’ MEm by 23.3% 
which lipid deposition by 30.2% and lead to an 18.3% decrease in ADG during the 
immune challenge. These novel data directly related decreased ADG to increased MEm 
independent of changes in feed intake in immune challenged pigs. Xylose metabolism in 
the pig was also evaluated and presented in Chapter 4. An improved understanding of 
xylose metabolism in the pig and its energetic value is essential for effective xylanase 
utilization. Our data showed that the pig can utilize xylose but does so less efficiently as 
more xylose is consumed; and only 40 – 60% of xylose was retained. Furthermore, pigs 
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can adapt over time to improve xylose utilization. By applying metabolomic approaches, 
urinary metabolites of xylose were identified and quantified. This information facilitated 
construction of a comprehensive pathway for xylose metabolism in the pig. Overall, 
research presented in this dissertation improved our understanding of how -mannanase 
and xylanase impact pig energy metabolism. This research also furthered the 
understanding of how immune activation repartitions energy and increases maintenance 
energy requirements.  
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CHAPTER I 
 LITERATURE REVIEW: THE INFLUENCE OF CARBOHYDRATES ON 
ENERGY METABOLISM IN THE PIG 
 
Introduction 
Plant carbohydrates represent the largest energy source in commercial pig diets, 
comprising 60 – 75% of total energy intake. A portion of the carbohydrates (dietary 
fiber) cannot be digested by endogenous enzymes in the small intestine and are partially 
fermented in the hindgut. Dietary fiber is a chemically complicated classification of 
carbohydrates possessing a wide range of physiological properties. These properties 
profoundly influence digestive physiology and overall energetics and must be considered 
to fully understand the value of high-fiber ingredients in pig diets. As industry 
economics continues to favor increasing inclusion of low-cost, high-fiber ingredients, the 
complexity of dietary carbohydrate components increases and the swine nutritionists’ 
role of assigning accurate energy values to these ingredients is a challenge.  
Swine nutritionists are beginning to understand the influence of different fiber 
types on diet digestibility and intestinal physiology and have developed and 
implemented technologies such as exogenous enzymes to improve the utilization of 
high-fiber ingredients. However, the systemic effects of fiber components on energy 
balance are still poorly understood. Xylose and mannose are two of the primary 
monosaccharide building blocks of grain and legume polysaccharides and their 
influences on swine energy metabolism are poorly understood. Therefore, the objectives 
of this review are to provide an overview of mannose and xylose relevance in current 
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swine diets, their specific metabolic impacts as well as more comprehensive influences 
on overall physiology, and to outline the need to understand how dietary xylose and 
mannose impact energy metabolism in pigs.    
 
Arabinoxylans and -mannans - fiber in swine diets 
Dietary fiber is the fraction of carbohydrates not digested by endogenous enzymes 
secreted into or present in the small intestine. These includes non-starch polysaccharides 
(NSP), resistant starch, oligosaccharides, and the non-carbohydrate polyphenolic lignin 
[1]. Non-starch polysaccharides are the largest component of dietary fiber in swine diets 
and so for the purposes of this review, discussion will focus on dietary NSP and its 
components. The main NSP in cereals are arabinoxylans, mixed linkage -(1,3 and 1,4)-
glucans (-glucans), and cellulose. Cellulose consists of long, highly structured chains of 
-1,4-linked glucose molecules. Unlike cellulose, hemicellulose is chemically complex. 
Hemicellulose is comprised of D-xylose, D-mannose, D-galactose, D-glucose, L-
arabinose, 4-O-methylglucuonic acid, D-galacturonic acid, and glucuronic acid [2]. These 
sugars are linked together in a wide variety of combinations, branch types, and degrees of 
polymerization to form hemicellulose.  
Arabinoxylans 
Arabinoxylans are the main NSP component in cereal grains (Table 1.1), followed 
by cellulose and -glucan [1], and are composed of a linear backbone of -1,4-linked-D-
xylopyranosyl residues mainly substituted with -L-arabinofuranosyl residues to varying 
degrees at the O-2 position, the O-3 position, or both [3,4] (Fig. 1). 
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-Mannans 
β-Mannans are components of hemicellulose in the plant cell wall and are linear 
polysaccharides comprised of repeating β-1,4-linked D-mannose units with galactose 
and/or glucose substitutions [5]. Plant mannan polysaccharides are divided into three 
structural subgroups; the glucomannans, galactomannans, and galactoglucomannans (Fig. 
2). Galactomannans are the most common type found in swine and poultry diets. In 
galactomannans, single α-1,6-linked D-galactose residues are attached to some of the 
mannose residues within the β-1,4-mannan backbone [6].  
Galactomannans are mainly found in the endosperm of legume plant seeds such as 
soybeans [5] where they function in water retention and are the main storage 
carbohydrate [6,7]. In North American swine diets, -mannans are primarily found as 
galactomannans in soybean meal; but around the world, other sources include palm 
kernel meal, copra meal, and guar meal (Table 2). 
Fiber effects on diet digestibility and pig growth performance 
The pig industry is known for its ability to evolve and improve throughout ever-
changing economic and social environments. Currently, feed ingredient economics are 
pushing producers to increase the use of higher-fiber coproducts while maintaining high 
production and efficiency goals. To do this, nutritionists must have a comprehensive 
understanding of fiber utilization in the pig as well as how fiber inclusion may affect 
digestion and absorption of other nutrients. Unlike starch and amino acids, dietary fiber is 
indigestible by mammalian endogenous enzymes and its contents are highly variable 
among sources. Fiber’s digestive fate and impact on gut physiology depend on 
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physicochemical properties such as solubility, viscosity, physical structure, and 
fermentability [8,9]. 
In general, increased fiber in diets decreases diet energy density and digestibility, 
resulting in impaired feed efficiency and potentially growth performance if pigs are not 
able to increase feed intake to maintain energy intake. Increasing dietary fiber decreases 
dry matter (DM) and energy digestibility and potentially amino acid and lipid 
digestibility, with varying magnitude according to the level and type, or source, of fiber 
[9,10]. Cellulose, lignin, and insoluble arabinoxylans, such as that from corn and its 
coproducts, have limited fermentability resulting in increased fecal bulk and decreased 
DM digestibility due to the trapping of starch and protein within the fiber matrix [11,12]. 
Soluble dietary fiber, such as in soybean hulls and oats, increases small intestine digesta 
viscosity which delays gastric emptying and reduces mixing of dietary components with 
endogenous digestive enzymes [13]. Both soluble and insoluble fiber sources may reduce 
intestinal transit time [14,15] and increase epithelial cell proliferation rate [16]. 
Fiber inclusion in swine diets dilutes dietary energy concentration; thus, greater 
intake is required to achieve similar growth rates and feed efficiency is decreased [17,18]. 
Based on analysis of 78 diets with varied fiber inclusion, Bach Knudsen et al. [19] 
concluded fiber has the largest impact on organic matter digestibility and the smallest 
impact on lipid and starch digestibility throughout the small and large intestines. Energy 
digestibility declines linearly with fiber content and the decline extent is due to the 
specific fiber source fermentability [18,20].   
Fiber fermentation is substantially more variable than starch digestion, crude 
protein, and fat (generally greater than 80%) [19]. In growing pigs, fiber digestibility 
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ranges from 15% for wheat straw, 44% for wheat bran, 47% for corn distillers’ dried 
grains with solubles (DDGS), to 79% for soybean hulls [21,22] and depends on viscosity 
and solubility properties [11,14]. Furthermore, fiber digestibility may be influenced by 
other nutrient concentrations, such as lipids. Gutierrez et al. [23] reported an interaction 
between soybean oil and reduced-oil DDGS inclusion on apparent ileal and total tract 
digestibility of neutral detergent fiber (NDF). It was hypothesized that increased dietary 
ether extract (EE) concentration increased digesta retention time [23], which may 
increase fiber fermentability due to longer exposure of substrates to the intestinal 
microbiota at the terminal ileum or in the hindgut [20,22,24]. Future research may 
provide insight into similar interactions with other nutrients.  
Fiber decreases dietary energy concentration regardless of the physiological stage 
of the pig; however, the pig’s ability to utilize energy from fiber improves with increased 
physiological maturity [25]. Fiber digestibility increased with physiological maturity and 
the digestible energy (DE) value of fiber was on average 0.14 Mcal/kg DM higher in 
adult sows than in growing pigs [18]. This difference between sows and growing pigs is 
not constant but increases with fiber content (0.8 kcal for each gram of dietary NDF 
increase) due to larger volume hindguts and longer retention times [18,25]. The notion of 
increasing DE and net energy (NE) value of fibrous ingredients when fed to higher 
bodyweight pigs and sows is supported by numerous studies [26–30]. 
Crude protein (CP) digestibility is also negatively associated with fiber inclusion 
[19,23,31]. This effect is more pronounced with soluble fiber compared to insoluble fiber 
[32]. Fiber may increase endogenous nitrogen losses depending on concentration [33], 
type [34], and physicochemical properties such as water-holding capacity [35]. High 
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digesta viscosity may increase epithelial cell proliferation leading to lower apparent ileal 
amino acid digestibility [20,35]. Much of fiber’s negative effect on total tract CP 
digestibility derives from increased hindgut fermentation and nitrogen sequestration in 
microbial protein [36,37]. The inclusion of fermentable fiber shifts nitrogen excretions 
from urea in urine to bacterial protein in feces without affecting total nitrogen excretion 
or retention [24,37].  
A similar effect on microbial lipid synthesis may influence observed fiber effects 
on lipid digestibility [30,38]. Increased dietary fiber concentration has been associated 
with decreased fecal digestibility of EE [24,39]; however, in an analysis of 78 diets [19] 
it was concluded that fiber had a small impact on lipid digestibility throughout the small 
and large intestine. Gutiérrez et al. [23] found that at low dietary EE levels (2% soybean 
oil) increased DDGS inclusion deceased EE apparent ileal and total tract digestibility, but 
the same effect was not observed at higher dietary EE levels (6% soybean oil). Fiber’s 
negative influence on lipid digestibility may be related to solubility characteristics. When 
insoluble fiber is provided in diets, little to no effect on ether extract digestibility is 
observed [40,41].   
While much variation exists in dietary fiber literature, it can be concluded that 
increasing fiber concentrations reduces diet energy density and DM digestibility resulting 
in impaired feed efficiency and potentially growth performance. Continued research will 
provide a more comprehensive understanding of fiber utilization in the pig, its 
interactions with other nutrients, and improvement in feeding strategies and technologies 
to achieve pork production goals.   
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Carbohydrases in swine diets 
Because animals do not possess the endogenous enzymatic capability to digest -
linked polysaccharides (dietary fiber), exogenous carbohydrase enzymes, such as 
xylanase and -mannanase, have been developed and employed to mitigate the negative 
effects of dietary fiber on feed efficiency.  
The most commonly discussed benefits of NSP hydrolysis due to carbohydrase 
supplementation are the release of cell wall-bound nutrients for absorption and a reduced 
ability of the polysaccharides to form viscous solutions which inhibit nutrient diffusion 
and absorption [42–44]. An often overlooked benefit is the potential to utilize enzyme 
hydrolysis products, the oligosaccharides and monosaccharides [45]. While some studies 
in growing pigs supplemented with NSP-hydrolases show improved nutrient 
digestibility, this is not always reflected in enhanced growth performance. Responses 
depend on the nutrient composition of the diet [46], age of the pig [47], health status, and 
other factors. 
 Although the use of carbohydrase enzymes has not yet been fully refined or 
applied in a targeted manner, the potential value of this technology is substantial. 
Carbohydrases have the potential to improve feed efficiency and nutrient digestibility, 
allow greater flexibility in types of ingredients available to feed, decrease the negative 
impact of swine production on the environment thus, improve the profitability and 
sustainability of swine operations by decreasing excretion of undigested nitrogen and 
phosphorus in manure, and to improve gut health through production of prebiotic 
oligosaccharides [8,44,48,49]. 
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-Mannanase 
Endo-β-mannanases are hydrolase enzymes that cleave internal glycosidic bonds 
of the mannan backbone, producing β-1,4-manno-oligosaccharides [6,50]. β-Mannanase 
is supplemented into swine diets that have high inclusion of β-mannan containing 
ingredients such as soybean meal, palm kernel meal, or copra meal. This enzyme was 
developed based on the hypothesis that dietary -mannans resemble carbohydrate 
structures found on the surface of pathogenic bacteria and therefore might induce an 
innate immune response.  
This “feed-induced immune response” hypothesis will be discussed in detail in a 
later section of this review; for now, it is sufficient to understand that stimulating the 
immune system is an energetically expensive process. It is hypothesized that after -
mannanase supplementation, the hydrolyzed manno-oligosaccharides no longer retain the 
degree of polymerization necessary to stimulate and cross-link multiple mannose 
receptors, thus reducing innate immune stimulation. However, this phenomenon has yet 
to be demonstrated in pigs.  
Xylanase 
Xylanase catalyzes the hydrolysis of β-1,4-D-xylosidic linkages in the 
indigestible arabinoxylan constituents of hemicellulose. Xylanase is supplemented into 
swine diets containing wheat and barley which have more soluble and viscous 
arabinoxylans [51]. Xylanase is also used in diets including higher concentrations of 
grain coproducts, such as wheat middlings and corn DDGS, which contain the residual 
seed coats or bran of the parent grain and therefore have 2 to 3 times greater NSP 
concentrations [11,52].  
  
 
 
 
9 
Due to the heterogeneity of arabinoxylan, its complete hydrolysis requires the 
action of a complex enzyme system including the interaction of main chain- and side 
chain-cleaving enzymes (Fig. 3) [2]. The enzymes which cleave the main chain, or xylan 
backbone, are endo--1,4-xylanases (GH10 and 11 families, EC 3.2.1.8; what is referred 
to by “xylanase”) and -1,4-xylosidases (GH3 family, EC 3.2.1.37) [53]. The primary 
side chain-cleaving enzymes include -L-arabinofuranosidases and -D-glucuronidases 
[2]. Endoxylanases release a range of products after hydrolysis of xylan such as xylose, 
xylobiose, xylotriose, and further polymerized xylo-oligosaccharides [2,54,55]. Beta-1,4-
xylosidases cleave chain-ending xylose monomers preferentially from the non-reducing 
end of the substrates, with some xylosidases able to hydrolyze xylobiose [2].  
Carbohydrase mechanisms of action 
Viscosity 
In the intestinal lumen, soluble NSP can create viscous solutions by aggregating 
into large networks. So, if exogenous carbohydrases degrade the highly polymerized 
structures into shorter oligosaccharides, they can no longer associate in large 
entanglements and the viscosity of the digesta is decreased [56]. Viscosity affects nutrient 
digestibility in poultry; however, few data are available to support this claim for swine. 
Few studies have reported results of enzyme supplementation on intestinal viscosity. Of 
those that have, some reported reduced intestinal viscosity with xylanase supplementation 
[57,58] while others reported increased viscosity [59,60]; yet, all resulted in improved 
nutrient digestibility. Other studies found no effect of enzyme supplementation on 
intestinal viscosity [60,61]. From the available data, intestinal viscosity is not likely to be 
a significant mode of action of carbohydrases in pigs. 
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Entrapped nutrient release 
Plant cell wall structures (i.e. fiber) are a matrix of NSP, lignin, and other soluble 
nutrients such as starch and amino acids. The idea behind this mode of action is that these 
soluble nutrients are “trapped” within the fiber matrix which impedes digestive enzyme 
access and limits their availability for absorption. As carbohydrases hydrolyze and 
depolymerize the NSP structures, the entrapped nutrients are released and become 
available for absorption. This is a plausible mode of action supported by data showing 
increased apparent ileal digestibility (AID) of nutrients other than NSP [62–67]. 
However, improvements in AID are not consistent and do not always translate into 
improved growth performance [59,63,68]. 
Impact on intestinal microbial populations 
 As carbohydrases hydrolyze the highly polymerized NSP, oligosaccharides are 
produced which may have a prebiotic effect in the distal ileum, cecum, and colon and 
thus influence hindgut microbial populations [53,69,70]. Carbohydrase supplementation 
alters hindgut microbial population abundance and composition with increases in 
Lactobacillus sp. and decreases in Escherichia coli [71]. Often, the implication of these 
changes are difficult to interpret or no effect of enzyme supplementation is reported 
[72,73]. Performance benefits may derive from the provision of any of the manno-, 
gluco-, or xylo-oligosaccharides, but consistency of the response may be more reliant on 
delivery of the correct quantity of a specific oligosaccharide rather than the variable 
delivery of multiple oligosaccharides [74].  
 In the same way, carbohydrase supplementation likely changes the composition of 
substrates reaching the hindgut which may influence hindgut environment. In addition to 
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oligosaccharide production, carbohydrases may be increasing fermentability of the fiber; 
thus, increasing the amount of energy obtained from short chain fatty acids (SCFA). This 
hypothesis is supported by improvements in total tract fiber digestibility, with increases 
cecal and colonic SCFA concentrations and decreases in luminal pH [43,60]. However, 
this response is variable and depends on the enzyme and fiber composition, solubility, 
and fermentability [60,69,75,76]. 
 Together, carbohydrases’ influences on microbial populations, decreases in 
luminal pH, and increases in butyrate production may improve gut health. This idea is 
primarily based on the theoretical understanding that decreased luminal pH may inhibit 
pathogen colonization and that butyrate may improve colonocyte health [77,78]. Few 
data are available which directly evaluate this carbohydrase mode of action. Preliminary 
data in our laboratory showed that supplementation of an enzyme blend decreased 
intestinal permeability in nursery pigs, demonstrated by a decrease in the ratio of 
lactulose: mannitol absorption and increases in mRNA abundance of tight junction 
proteins [76].  
Energy sparing effect 
As previously discussed in the -mannanase section, this enzyme was developed 
to break down dietary -mannans which are hypothesized to stimulate the immune 
system. The energy once necessary for induction and maintenance of the immune 
response can then theoretically be repartitioned toward other biological functions such as 
growth. There is evidence in poultry to suggest that diets high in -mannan content may 
induce immune stress [79]. Poultry fed high -mannan diets had elevated serum acute 
phase protein concentrations and this effect was ameliorated by -mannanase 
  
 
 
 
12 
supplementation [79]. However, in pigs, growth and efficiency responses due to -
mannanase supplementation are much more variable than they are in poultry and data 
regarding its effects on immune stimulation in pigs are scarce. In North American swine 
diets, -mannans are primarily found in soybean meal. Due to the ubiquitous inclusion of 
soybean meal in the diets for all stages of pig production, it is imperative to understand -
mannans’ impact on the immune system and energy metabolism in pigs and how -
mannanase affects these responses.  
Monosaccharide release 
As NSPs are hydrolyzed by exogenous carbohydrases, the degree of 
polymerization is decreased. The types of products released from NSP hydrolysis depend 
on the polysaccharide’s chemical composition and structure (i.e. branching and degree of 
polymerization) and the type of exogenous enzyme(s) supplemented [53,54,80]. Initial 
arabinoxylan hydrolysis by endo-xylanase enzymes releases arabino- and xylo-
oligosaccharides, with continued hydrolysis and additional enzyme activity required for 
the release of monosaccharides [56]. There is a paucity of data on the quantification of 
xylose release from arabinoxylans with xylanase supplementation. In vitro data suggest 
that it is possible, but not highly effective, with the combined action of endo-xylanases 
and xylosidases [80]. Therefore, as carbohydrase efficacy improves, small but impactful 
quantities of xylose, arabinose, and glucose monosaccharides will be released and 
absorbed in the small intestine.  
Glucose and other hexose sugars contribute energy to the pig with much greater 
efficiency when absorbed in the small intestine than through fermentation in the large 
intestine, but this may not be the case for pentose sugars such as xylose and arabinose. It 
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is commonly assumed that these sugars are poorly metabolized in the pig and contribute 
little metabolizable energy (ME) if absorbed in the small intestine [81,82]. As interest in 
xylanase supplementation continues to increase, an improved understanding of xylose 
metabolism in the pig and its energetic value is essential for effective xylanase utilization. 
Therefore, an objective of this dissertation research was to evaluate how xylose, if 
enzymatically released from arabinoxylan in the small intestine, would impact pig energy 
metabolism. A review of previously available literature on xylose metabolism will be 
presented later in this review. 
 
Impact of mannose and xylose on energy metabolism in the pig  
 The energy value of dietary carbohydrates depends on the location of digestion in 
the gastrointestinal tract. In the small intestine, starch is efficiently digested by 
endogenous pancreatic and brush border enzymes and is absorbed into the portal vein for 
utilization throughout the body. Carbohydrates not digested and absorbed in the small 
intestine enter the cecum and large intestine where they can be fermented by the 
microbial populations and SCFA are produced. The SCFA are absorbed and can be 
utilized for energy by the intestinal epithelium, liver, and other tissues. Compared to 
enzymatic digestion in the small intestine, a smaller portion of the carbohydrate’s 
potential energy is available to the pig as SCFA due to losses of efficiency through the 
fermentation process [83]. 
 It is important to remember that fiber fermentation does not occur solely in the 
hindgut. Forty to ninety-five percent of the non-digestible oligosaccharides and 20 to 
25% of the NSP are degraded before the end of the small intestine [84]. In addition, 
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microbes in the small intestine also modify the size and structure of NSP [85–87]. 
Through this initial modification in the small intestine, the NSP are then provided to the 
cecum and large intestine in a form that is more readily available for fermentation [84].  
With arabinoxylans, the section of the intestinal tract in which they are fermented 
depends upon their solubility and degree of substitution. The greater the degree of 
arabinose substitution of the xylan backbone and the lower the solubility of the polymer, 
the slower the rate of fermentation. The same NSP could have significant and varied 
effects throughout the intestinal tract depending on where it is fermented. This means that 
exogenous carbohydrase supplementation likely plays a similar role, shifting the site of 
the majority of NSP degradation more proximally into the small intestine, perhaps 
liberating some monosaccharides to be available for absorption before they are 
fermented. Therefore, to accurately determine the NE value of mannose and xylose to the 
pig, knowing the site of absorption and the form in which it provides energy 
(monosaccharide vs. SCFA) is key.  
Energy efficiency of NSP fermentation 
The energy available to the pig due to fermentation is not inconsequential. 
Depending on the diet and age of the animal, SCFA arising from fiber fermentation can 
account for 7 to 25% of the pig’s available NE for maintenance [88–91]. Through 
fermentation, only about 60 – 75% of the potential energy of NSP is captured as SCFA 
with the remaining energy lost as the heat of fermentation, microbial mass, methane, and 
CO2 [88,92,93]. 
Short chain fatty acids are efficiently absorbed across the intestinal epithelium 
[88,94] and the absorption mechanism depends on the SCFA ionization form. Generally, 
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SCFA are thought to be absorbed through passive diffusion across the epithelium, but this 
only occurs for the undissociated form of SCFA (ex. acetic acid). With a pKa of about 
4.8 and a luminal pH of approximately 6, only a very small proportion of the SCFA exist 
in the undissociated form [94]. So, it is more probable that active transport of the ionized 
SCFA (ex. acetate) is the primary absorption mechanism [95]. Short chain fatty acid 
anion transport can be coupled to bicarbonate secretion into the lumen or can occur 
through members of the monocarboxylate transporter family [94]. 
Short chain fatty acids are partially metabolized by epithelial cells during the 
process of absorption and transportation to the bloodstream. Little butyrate ever makes it 
to portal vein circulation as it is a preferred energy substrate for colonic epithelial cells 
[88,95]. Propionate is largely metabolized by the liver, entering the TCA cycle through 
oxaloacetate and acetate is mostly metabolized in peripheral tissues for fatty acid 
synthesis [88]. Once absorbed, the energy utilization efficiency of SCFA for maintenance 
or gain ranges between 0.60 – 0.70, which is about 5 – 10% lower than energy supplied 
as starch digested and absorbed in the small intestine [18,88].  
Taking into account efficiencies of digestion, conversion to SCFA, and SCFA 
metabolic utilization, the overall ME utilization efficiency of NSP averages 0.50 in 
growing pigs – 0.60 in sows [18]. In general, utilization of fermented NSP energy is 
equivalent to about 0.70 of enzymatically digested carbohydrates because of the 
additional energy costs for ingestion, digestion, fermentation, and metabolism of the 
intestines which are greater in high fiber diets [18]. It is important to consider these 
energetic efficiencies when determining NSP energy values. 
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Impact of mannose and -mannan on energy metabolism 
If released as a monosaccharide in the small intestine, mannose (a 6-carbon sugar) 
can be absorbed through similar mechanisms as glucose and efficiently metabolized [96]. 
Within the cell, mannose is phosphorylated by hexokinase and can then be efficiently 
converted by phosphomannose isomerase to glucose for catabolism. A small proportion 
of mannose is used for N-glycosylation [96]. 
More commonly, -mannan remains mostly intact throughout the gastrointestinal 
tract but still has the potential to indirectly impact energy metabolism. As previously 
discussed, intact β-mannans are available to bind carbohydrate recognition domains 
(CRD) of pattern recognition receptors (PRR) on innate immune cells surveying the 
intestinal epithelium for potential pathogens [97–99]. In this way, β-mannan is 
theoretically capable of stimulating innate immune cells resulting in a nonproductive, 
energy-draining, inflammatory immune response [79,100,101]. This effect has been 
termed a feed-induced immune response (FIIR) and is one of the cited reasons for 
supplementing swine diets with -mannanase.  
The initial FIIR descriptions were in poultry and reported increased macrophage 
and lymphocyte proliferation [102] and plasma acute phase protein concentrations [79] 
due to increasing dietary soybean meal inclusion. This response was then attenuated by 
-mannanase addition and was supported by improvements in feed efficiency [79,102]. 
This research has been interpreted to support the hypothesis that improvements in 
energetic efficiency due to β-mannanase supplementation are due, in part, to amelioration 
of a β-mannan-induced innate immune response. It was hypothesized that the hydrolyzed 
manno-oligosaccharides no longer retain the degree of polymerization necessary to 
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stimulate and cross-link multiple mannose receptors, thus reducing innate immune 
stimulation. However, there is a paucity of data regarding immune responses of pigs to 
dietary -mannan and -mannanase supplementation; and a -mannan-derived FIIR has 
yet to be demonstrated.  
Potential mechanisms for -mannan stimulation of innate immunity 
Dietary -mannans are proposed to stimulate the innate immune system through 
direct interactions with the carbohydrate-binding domains of mannose recognition 
receptors such as the membrane-bound mannose receptor and secreted mannose binding 
lectin. C-type lectin receptors (CLR) are a type of PRR with a central role in innate 
immunity through recognition of highly conserved pathogen-associated molecular 
patterns. This type of receptor, specifically the mannose receptor, could be responsible 
for inducing innate immune responses to dietary β-mannans. Mannose is frequently 
found on pathogen surfaces but is not commonly found in terminal positions of 
endogenous mammalian oligosaccharides [103].  
The mannose receptor mediates responses including pathogen binding, 
phagocytosis, and cytokine production [98]. Downstream signaling due to mannose 
binding has been described [99] and seems to require coordination with other PRR 
molecules such as TLR2 and 4. In vitro studies have demonstrated mannan stimulation of 
macrophages and dendritic cells resulting in increased pro-inflammatory cytokine 
production [100,101,104]. 
Another potential mannose-detecting receptor is called the mannose binding lectin 
(MBL, also called mannose binding protein; Fig. 4) which is a soluble CLR synthesized 
in the liver as part of the acute phase response [105,106]. Unlike typical acute phase 
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proteins that increase 10-1000 fold in serum concentration in response to inflammation, 
MBL levels fluctuate only 2-3 fold [105,106]. Pathogens recognized by MBP include 
gram-negative bacteria such as Escherichia coli and fungi in the Candida and 
Cyptococcus groups [103]. 
Mannose ligand binding by several types of C-type lectins, including MBL, is 
dependent upon formation of multimer complexes [107]. Individually, CRD demonstrate 
low carbohydrate affinity but confer broad specificity when they are complexed [103]. 
Thus, repeating sugar arrays decorating pathogen surfaces, or located within dietary 
plant-based -mannan polymers, provide potential targets for MBL binding [106]. As 
part of the lectin complement system of innate immunity, mannose-bound MBL can 
induce the complement protease cascade resulting in pathogen lysis, stimulation of 
phagocytosis through direct opsonization, and inflammation induction. 
Impact of -mannans and -mannanase in pigs 
 Although β-mannan’s influence on the immune system is of great interest, 
commonly, only growth and energy efficiency responses to β-mannan intake are reported 
in swine nutrition literature. Reduced feed efficiency [108–111] and decreased growth 
performance [111,112] are frequently reported due to increasing dietary β-mannan 
concentrations. Negative growth performance effects may be explained by several 
factors: increased intestinal digesta viscosity [111,113,114]; exclusion of endogenous 
digestive enzymes from dietary substrates [6], or potentially, the FIIR [79]. For the 
purposes of this review, we will highlight the scarce research regarding β-mannan or -
mannanase effects on immune parameters.  
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Dietary supplementation with galactomannan oligosaccharides in piglets was 
reported to increase interleukin (IL)-1 mRNA expression in peripheral blood 
mononuclear cells, the jejunal mucosa, and mesenteric lymph nodes [115]. Furthermore, 
serum IL-1 and IL-6 concentrations were increased with galactomannan oligosaccharide 
supplementation [115]. A prebiotic of -galactomannan was developed from carob bean 
and was reported to inhibit Salmonella association with intestinal epithelial cells due to 
attachment of salmonellae to the surface of the -galactomannan oligosaccharide [116]. 
In this study, -galactomannan did not induce pro-inflammatory effects; rather, the data 
suggested anti-inflammatory effects due to prevention of pathogen adhesion and invasion 
[116]. 
Contrary to the immune stimulation hypothesis, dietary -mannans have also been 
reported to be beneficial during infection. In a Salmonella enterica in vitro infection 
model, β-galactomannan actually inhibited Salmonella-induced proinflammatory 
cytokine and chemokine expression in porcine intestinal epithelial and dendritic cell 
cultures [117]. Similarly, in vivo E. coli challenges have demonstrated an inhibitory 
effect of dietary β-mannan [118]. The authors hypothesized that the pathogens bind to the 
mannose residues on the dietary polysaccharides instead of onto epithelial cells, thus 
reducing pathogen internalization and infection [118].  
Clearly, a more direct evaluation of dietary β-mannan in swine diets and its 
effects on immune parameters is required to truly address the FIIR hypothesis in pigs. A 
better understanding of β-mannan effects on the innate immune system and maintenance 
energy requirements of pigs will allow more appropriate and efficient use of β-
mannanase to improve feed utilization in growing pigs. In addition to evaluating if, and 
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how, dietary -mannans impact the immune system in pigs, it is important to understand 
the energetic cost of inducing and maintaining an innate immune response. 
The energetic cost of an immune response 
Significant interplay exists between an animal’s nutritional status and immune 
system function. While much research has been conducted on the impact of certain 
nutrients or feeding strategies on an animal’s ability to respond to a pathogenic challenge, 
in this review we will focus on energy partitioning during an immune challenge. In 
immune-challenged animals, energy is diverted away from growth and toward initiating 
and maintaining an appropriate and efficient response to clear infection or the perceived 
pathogen from the body [119–121].  
During the innate immune response, proinflammatory cytokines orchestrate a 
response resulting in fever, acute phase protein production, and neutrophil and 
lymphocyte proliferation, each of which increases amino acid and energy requirements 
[122]. For example, IL-6 infusions in healthy human volunteers increased resting 
metabolic rates by 25% [123], and a core body temperature increase of 1°C has been 
reported to increase basal caloric requirements between 15 - 30% [124,125]. 
Furthermore, cytokines invoke other growth modulators such as glucocorticoids, 
prostaglandins, and catecholamines [121]. Together these responses generally suppress 
feed intake and accelerate protein degradation rates resulting in an economically costly 
decrease in feed efficiency [126]. 
Decreases in growth and feed efficiency have been well documented during 
disease challenges, yet data quantifying the energy requirements of an immune response 
are scarce. Few studies have evaluated the magnitude of change in energy balance during 
  
 
 
 
21 
an immune challenge to inform more effective dietary intervention strategies. Previous 
studies have evaluated increased caloric requirements with fever [127,128], but few have 
directly related a chronic immune challenge with increased maintenance energy 
requirements. In vitro studies with isolated mitochondria from rats stimulated with TNF 
or IL-1 showed up to 30% increases in respiration rate [129]. Demas et al. [128] showed 
that mice injected with a mild antigen caused limited immune activation resulting in 
significantly more O2 consumption that control mice injected with saline and a study in 
humans found that IL-6 infusions increased resting metabolic rates by 25% [123].  
In pigs, however, the direct relationship between immune stimulation and 
increased energy requirements has not previously been demonstrated. Immune system 
stimulation did not impact rate or efficiency of gain, or energy balance measurements in 
studies by Moon et al. [130] and Williams et al. [131]. However, Moon et al. [130] 
reported fibroblast formation at the injection site which encapsulated the immunogen and 
prevented systemic delivery. Williams et al. [131] used the comparative slaughter 
technique and found no differences in the energetic costs of maintenance and protein and 
lipid deposition between pigs raised in environments encouraging high or low chronic 
immune activation. 
Conversely, Labussière et al. [132] and Campos et al. [133] reported decreased 
heat production (HP) in pigs during inflammatory challenges. A single injection of 
complete Freund’s adjuvant in nursery pigs decreased resting and total HP in the residual 
feed intake (RFI) positive genetic lines, but not the RFI negative lines. However, it is 
important to note that the pigs were not measured for HP until the day after injection and 
only re-entered the calorimetry chamber after visual recovery which likely biased the 
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response [132]. Campos et al. [133] reported a 14% decrease in total HP in response to a 
chronic lipopolysaccharide (LPS) inflammatory challenge in growing pigs even though 
typical inflammatory-type and febrile response were observed. Decreased HP was mainly 
attributed to feed intake depression. In addition to evaluating the energetic costs of 
dietary -mannans and potential -mannanase energy sparing effects, it was clear that a 
better understanding of the energetic cost of pathogen innate immune stimulation was 
also needed.  
Impact of xylose on energy metabolism 
While studying the xylose literature to prepare for this dissertation work it was 
apparent that there was a glaring paucity of information and research available on xylose 
metabolism in all vertebrate species. No comprehensive review of the available literature 
had been published. Therefore, the following review is part of the manuscript published 
in the Journal of Animal Science and Biotechnology (2018, vol. 9(1): 4; doi: 
10.1186/s40104-017-0226-9) 
Xylose, as a major constituent of plant xylan polymers, is one of the most 
abundant carbohydrates on Earth, second only to glucose [134,135]. This abundant 
pentose sugar, along with arabinose, makes up a majority of the hemicellulose backbone 
as arabinoxylan in the cell walls of cereal grains fed to pigs [12]. In contrast to α-linked 
starch, which is hydrolyzed to glucose by endogenous enzymes, β-linkages in 
arabinoxylan and other NSP must be degraded by microbial enzymes. Thus, pigs cannot 
derive energy directly from arabinoxylans. The large proportion of arabinoxylan in the 
hemicellulose fraction of cereal grains and coproducts makes xylanase supplementation 
of great interest in swine nutrition [136,137]. While greater progress is needed to achieve 
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consistent enzyme efficacy, it is yet to be determined how the products of xylanase 
hydrolysis will be utilized by the pig and to what extent these products may contribute to 
overall energy balance.  
Xylanase hydrolysis products have not been well studied in vivo, but an 
understanding of enzyme function indicates that a mix of oligosaccharides, disaccharides, 
and monomeric pentose sugars, such as xylose (Fig. 5), may be released through the 
combined actions of xylanases with various activities [53,54,138]. Typical growing pig 
diets will contain 3 - 5% polymeric xylose that may significantly impact the nutrition of 
growing pigs if released as free xylose. Yet, the current understanding of xylose 
metabolism and potential contribution to dietary energy is vague at best. This review 
examines published, peer-reviewed research on xylose absorption and metabolism in the 
pig and identifies gaps in this knowledge that are essential to understanding the value of 
carbohydrase hydrolysis products for swine nutrition. Xylose research in pigs began with 
initial observations by Wise et al. [139] in 1954; however, little research hass been 
conducted since. Therefore, this review will also discuss relevant xylose absorption, 
metabolism, and fermentation research in other monogastric species, including humans. 
Furthermore, xylose effects on glucose and energy balance in monogastric animals are 
considered.  
Effects of xylose on animal performance 
In both pigs and poultry, increasing the dietary inclusion of D-xylose generally 
results in a linear decrease in ADG, feed intake, feed efficiency, and excreta DM content 
[45,139–142]. Linear decreases in the apparent total tract digestibility of DM, energy, and 
nitrogen were reported in broilers consuming dietary D-xylose concentrations of 0, 5, and 
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15% [142]. Exceptions exist in poultry; Longstaff et al. [143] reported no significant 
differences at 5 or 20% dietary D-xylose inclusion and in pigs where ADG was not 
reduced when a basal diet was supplemented with 10% D-xylose compared to 5% D-
glucose [81]. However, xylose generally imparts negative performance responses that, in 
some cases, have been severe. Two-week-old pigs fed purified diets containing 18.7 or 
37.4% D-xylose had drastically decreased feed intake and ADG compared to pigs fed 
37.4% D-glucose [139]. The authors also noted decreased physical activity in xylose-fed 
pigs along with vomiting, diarrhea, cataract formation, and nephritis in pigs fed the 
highest xylose diet [139].  
Importantly, these drastic xylose effects on animal performance are only observed 
when purified D-xylose is supplemented, not with xylanase supplementation [43,62,144]. 
This distinction could be explained if exogenous xylanase releases only small quantities 
of monomeric xylose in vivo, as compared to the levels fed in the above-mentioned 
studies. Based on the NSP composition of fibrous ingredients fed to growing pigs, most 
diets rarely contain more than 5% xylose [12,136,137,145], regardless of the degree of 
polymerization. Furthermore, only a small proportion of the polymeric xylose would 
likely be hydrolyzed to its monomeric components [57]. Even if 100% of the xylose 
molecules are liberated through exogenous enzyme supplementation, this level is unlikely 
to compromise pig health. However, the minimum level of xylose required to impact pig 
health has not yet been defined empirically.  
Xylose absorption and disappearance 
In pigs, xylose has a high disappearance rate in the small intestine, ranging from 
96 – 99% when supplemented as purified D-xylose [81,82,140,146]. Similarly, xylose 
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disappearance in poultry is very high (93.5 – 97.8%) when supplemented at 5% of diet 
DM; the rate of disappearance from the gut declined as the quantity of xylose in the diet 
increased: 91.9% at 20% and 87.3% at 40% dietary D-xylose [140,143]. Although it is 
possible that a portion of the xylose disappearance is due to microbial fermentation in the 
small intestine, there is empirical evidence that xylose is also readily absorbed in the 
duodenum and proximal jejunum in rats [147,148]. This is assumed to be similar in pigs 
and poultry based on disappearance prior to the cecum [82,146,149,150]. However, 
xylose mucosal transport throughout the entire digestive tract, including the colon, has 
been described [149]. Providing purified D-xylose in the diet at high levels (> 20%), also 
decreases ileal digestibility of DM, organic matter, gross energy and nitrogen in pigs 
[81,82]. 
Mechanisms of xylose absorption have yet to be fully characterized in pigs and 
poultry. Passive diffusion was initially reported [151], but most research indicates the 
existence of a sodium-dependent active transport system similar to that described for 
glucose and amino acids [82,149,150,152]. D-Xylose in rat diets induced expression of 
sodium-linked glucose transporter mRNA [153] suggesting at least some xylose is carried 
by this transporter and that competitive binding with glucose may occur. [152]. Xylose 
did not affect mRNA abundance of either GLUT2 or GLUT5 [153]. An active transport 
mechanism is further supported by data from equine and rabbit jejunal tissue which 
accumulated xylose against a concentration gradient when incubated in a 1 mmol/L D-
xylose solution [154]. However, when the tissues were incubated in a 5 mmol/L D-xylose 
solution, no accumulation was reported.  
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Freeman’s data in horses and rabbits [154] suggest that an active transport system 
may exist for xylose although it has a low affinity and is easily saturated. If this system 
does exist in swine, the proportion of xylose that is actively transported is likely very 
low. This hypothesis may relate to the considerably slower rate of xylose absorption 
compared to glucose [148]. Furthermore, because the transportation system becomes 
saturated at low xylose concentrations, absorption would be expected to continue to occur 
through diffusion given the high xylose disappearance rate in the small intestine [154]. In 
humans, however, xylose is absorbed by sodium-independent passive diffusion [155,156] 
and no inhibitory effects of glucose have been observed [156].  
Although precise mechanisms of xylose absorption and retention have not been 
reported for pigs and poultry, based on data in other species, it is clear that xylose is 
readily absorbed but at a slower rate than galactose and glucose and faster than arabinose 
[45,148,157]. Like most other water-soluble monosaccharides, xylose is then probably 
transported from the serosal side of the enterocyte to systemic circulation via the portal 
vein to the liver [158]. However, transporters potentially involved in this transfer have 
not been described. Once xylose is absorbed into the enterocyte it must be retained. 
Unlike glucose, reports on xylose phosphorylation are variable and the retention 
mechanism is unclear. Mucosal homogenates from rats did not demonstrate the ability to 
phosphorylate xylose [159]. In contrast, 13 and 36% of the xylose accumulated in jejunal 
tissues during D-xylose incubation was phosphorylated in the equine and rabbit tissues, 
respectively [154]; xylose phosphorylation following active absorption has also been 
reported [160]. 
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While absorption mechanisms of xylose may not be fully revealed, its ability to 
decrease glucose absorption has been more clearly demonstrated. Currently, xylose is of 
interest in human nutrition as a supplement to suppress postprandial glucose and insulin 
surges. Xylose has been reported to selectively inhibit sucrase activity in a non-
competitive manner [161]. When consumed with a glucose solution or high carbohydrate 
meal, xylose decreased serum glucose levels up to 30 min post-consumption in one study 
in humans [162] and up to 120 min in another [163]. Additionally, xylose 
supplementation decreased insulin area under the curve for up to 90 min compared to a 
pure glucose solution or high carbohydrate meal. [162,163].  
Suppression of the glycemic effect may occur in part through sucrase inhibition as 
well as through stimulation of glucagon like peptide-1 (GLP-1) secretion. In humans 
with type 2 diabetes consumption of a 50-g D-xylose solution 40 min prior to a high 
carbohydrate meal attenuated the postprandial glycemic and insulin responses associated 
with GLP-1 secretion before the meal [164]. The authors initially postulated that GLP-1 
secretion was stimulated in response to SCFA produced through bacterial fermentation of 
xylose, confirmed by an increase in hydrogen production in breath samples [164]. 
However, GLP-1 concentrations began to increase within 20 min of xylose ingestion, 
suggesting that more direct metabolism of the pentose was also involved [164].  
Some researchers have speculated that xylose supplementation would not exert 
similar effects in a high-fat meal due to the typically lower glycemic response [163], yet 
positive responses have been demonstrated. In obese mice fed high-fat diets, 5 and 10% 
D-xylose supplementation attenuated fasting blood glucose concentration back to healthy 
control levels, compared to mice fed a high-fat diet without xylose [165]. However, in 
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poultry, no effect of xylose supplementation on serum glucose concentration was 
reported and the responses to increasing dietary xylose concentration on serum insulin 
were highly variable [142]. This discrepancy may be related to the tight regulation of 
circulating glucose concentrations in birds [166]. Xylose effects on glucose absorption 
and regulation must be considered when determining how xylanase hydrolyzed 
monomers impact overall energy balance in pigs.  
Xylose fermentation 
Results of most experiments with monomeric xylose report almost complete 
disappearance prior to the terminal ileum; furthermore, increasing dietary xylose 
inclusion has been reported to increase ileal SCFA flow [82], cecal SCFA concentration 
[167], and cecal weight [45], indicating some degree of microbial fermentation of xylose 
in the small intestine. In humans, consumption of a 50-g D-xylose solution was reported 
to increase breath hydrogen production, a measure of bacterial fermentation, within 40 
min of consumption, and continued increasing through at least 280 min post consumption 
(the last time point sampled) compared to a placebo control [164].  
The importance of the microbiota to D-xylose disappearance is verified by studies 
with germ-free or antibiotic-treated mice and rats [168–171]. Conventional rats had 
87.8% total tract D-xylose disappearance compared to 74.3% in germ-free rats, with all 
differences occurring in the cecum and colon [169]. Studies with wild-caught rock mice 
(Aethomys namaquensis) who consume xylose containing nectar showed a 43% reduction 
in xylose metabolism following a heavy antibiotic regimen to drastically reduce gut 
microbial populations [170,171]. The xylose-metabolizing gut bacteria were identified as 
an inducible population with higher numbers present when xylose is present in the diet 
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[170]. If a xylose-metabolizing hindgut population is inducible in pigs, it is possible that 
the extent to which xylose is fermented may increase as pigs are adapted to diets with 
higher free xylose concentrations.    
Xylose oligomers hydrolyzed from arabinoxylans in the small intestine by 
xylanase can be readily fermented by microbial populations in the distal ileum, cecum, 
and colon [82,167,172]. Xylose utilization was demonstrated by pig cecal cultures which 
fermented xylose at the same rate and curve of gas production as glucose fermentation 
[167]. Xylose fermentation generally results in greater acetate and butyrate proportions 
compared to glucose fermentation [167,172,173]. These data indicate that the ability of 
pig microbiota to utilize xylose is not limited. 
Xylose metabolism 
 Distinguishing the mechanism by which xylose disappears from the small 
intestine, either by absorption of the intact sugar or by microbial fermentation, is essential 
for determining its value to the pig in terms of energy metabolism. Very little is known 
about xylose metabolic utilization in vertebrates but a large majority of dietary 
supplemented D-xylose consistently appears in the urine [82,139,147] and significantly 
decreases the ME available from the diet [81,143,146,157]. For most carbohydrates, 
fermentation is a less efficient means of releasing dietary energy as compared with direct 
absorption and oxidation; however, in the case of xylose, it can be argued that 
fermentation may be more efficient.  
In all species, urinary xylose excretion increases as dietary D-xylose inclusion 
increases [45,81,82,157,174]. Dietary D-xylose supplementation at 0.2% of DM resulted 
in 35% being excreted in the urine [146], while 10% D-xylose inclusion resulted in 37 – 
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45% urinary excretion [81,82], and at 20% dietary D-xylose, 52.6% was excreted in urine 
[82]. The finding that the proportion of xylose excreted in the urine increases with higher 
intake suggests there may be some type of threshold for xylose metabolic capacity and 
that the energy potentially derived from xylose metabolism may change with the amount 
absorbed.  
The detrimental effect of D-xylose on diet ME may be due to more than increased 
urinary xylose excretion. Verstegen et al. [81] compared ME values in pigs fed diets with 
10% D-xylose or 5% D-glucose. Metabolizable energy was significantly lower in xylose 
diets (673.58 vs. 698.85 kcal/d) and the difference was solely due to greater energy 
excreted in the urine (73.63 kcal/d vs 21.03 kcal/d, for xylose and glucose, respectively). 
Surprisingly, the extra urinary energy from the xylose diet was more than could be 
accounted for by the presence of xylose alone. Non-xylose energy in urine was double 
that of control pigs [81]. Similarly, differences in urinary excretion of xylose between 
pigs fed either 10 or 20% D-xylose were not completely reflected in urinary excretion of 
energy [82]. Urinary xylose metabolites, such as threitol, were not measured in these 
experiments but may have contributed to the energetic differences.   
Heat production data determined through indirect calorimetry helps to clarify 
when and how xylose may be altering energy metabolism in the pig. Pigs dosed with 500 
g of D-xylose had increased heat production and the majority of xylose urine excretion 
was on the day of dosing, with only 2 - 6 g excreted on the following day [146]. Yet, the 
increase in heat production persisted until the third day after xylose dosing [146]. The 
authors proposed that this reflected either delayed metabolism of xylose or an increase in 
fermentation. These data provide further evidence of the pig’s capacity to convert xylose 
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into energy, although the efficiency may be limited. The relative contribution of 
fermentation to the energy balance remains unclear. 
Clearly, xylose does not contribute to ME with the same efficiency as glucose 
when provided as a purified monomer at high dietary concentrations (5 - 40%). It has yet 
to be determined if this effect holds for xylose monomers hydrolyzed in vivo from 
arabinoxylans resulting from inclusion of xylanase and supporting enzymes in the diet. 
The concentration of xylose released would depend on dietary NSP composition and 
carbohydrase efficiency, which is not frequently reported. Other than quantifying its 
contribution to ME, experiments in pigs have not examined further metabolic effects of 
increased xylose absorption.  
Few data are available regarding xylose metabolism in pigs, but relevant studies 
in other monogastric species help to clarify the potential metabolic impact of xylose. 
Dietary xylose supplementation in rats increased blood glucose levels over time, but not 
liver glycogen [175,176]. Intravenous infusions of D-xylose solutions (10 - 20 g over 10 
min) in humans also increased blood glucose concentrations and resulted in a drop in 
serum inorganic phosphate concentration [174]. This research seemed to indicate xylose 
conversion to glucose, a phenomenon not supported by current research. However, if 
xylose can be oxidized to CO2 for energy production or metabolized through the pentose 
phosphate pathway, it is possible that glucose may be spared. 
Xylose oxidation to CO2 has been demonstrated in humans; infused D-xylose-1-
14C appeared as expired 14CO2 in humans within 15 min [174]. Expired CO2 was 
maximally labeled 45 min following the end of D-xylose-1-14C infusion; the label was 
detectable for 6 h, and cumulatively represented 15.5% of the administered label [174]. 
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This study was the first to demonstrate metabolism of xylose carbon separate from 
microbial fermentation. 
Similarly, guinea pigs have been shown to oxidize xylose to CO2 [177]. Expired 
CO2 was maximally labeled 75 min after intraperitoneal injection of D-xylose-1-14C, with 
total 14C recovery representing 11.3% of the injected dose. About 50% of the xylose was 
excreted in the urine with the vast majority appearing within 5 h after injection [177]. 
Results from this thorough experiment indicate the ability of multiple tissues to absorb 
xylose. The distribution of 14C retained in tissues was greatest in the muscle followed by 
spleen, pancreas, liver, heart, and was lowest in the kidney. However, when slices of the 
tissues were measured for the oxidation of D-xylose-1-14C to 14CO2, the kidney was the 
most active followed by the liver, pancreas, spleen, heart, diaphragm, and lastly muscle 
[177]. Kidney tissue oxidized 164 times more D-xylose-1-14C than muscle.  
Furthermore, D-xylose-1-14C metabolism was compared between control, intact 
animals and nephrectomized guinea pigs [177]. Control animals oxidized 10.8% of the 
injected dose to 14CO2 in 4 h with 41.3% excreted in urine and 47.9% unrecovered. 
Nephrectomy increased 14CO2 excretion 2 to 3-fold with about 75% of the injected dose 
unrecovered [177]. However, the capacity may have been even greater considering that 
the kidneys significantly contributed to xylose oxidation; therefore, their removal may 
have reduced the overall capacity to oxidize xylose. In sum, these results provide 
evidence for xylose oxidation to CO2 in multiple tissues, with the greatest capacity in the 
kidney. Some absorbed D-xylose may be retained in tissues throughout the body for 
longer than 6 h, and the capacity for greater xylose oxidation to CO2 exists if no other 
means of excretion are available [177].  
  
 
 
 
33 
These data provide convincing evidence that multiple species are capable of 
metabolizing at least some absorbed xylose to CO2 [174,177]. Evidence thus far seems to 
point to critical roles of the liver and kidneys. Severe liver dysfunction had little impact 
in human xylose absorption tests, indicating that hepatic tissue is not significantly 
involved [147]. Furthermore, xylose supplementation to fasted rats did not increase liver 
glycogen concentration compared to fasted controls [178], indicating that the liver cannot 
metabolize xylose to glucose for storage as glycogen.  
Current understanding of metabolic pathways in pigs and other monogastric 
animals support two possible routes for D-xylose metabolism. The first is oxidation by D-
xylose dehydrogenase (EC 1.1.1.175) to D-xylonic acid (Fig. 6) via a D-xylonolactone 
intermediate. D-xylose dehydrogenase has been identified and purified in pig liver [179] 
as well as in monkey kidney, dog liver, and rabbit lens [179,180]. In vitro data from 
guinea pigs supports the presence of pentose dehydrogenase activity in liver extracts 
which is separate and distinct from dehydrogenases for glucose [177]. In liver extracts, 
D-xylose-1-14C was oxidized to D-xylonic acid-1-14C and D-xylonic acid-1-14C injected 
in vivo was also oxidized to 14CO2 [177]. These data support that xylose oxidation to CO2 
can involve conversion to xylonic acid and subsequent decarboxylation [177,179,180].  
A second potential pathway is the reduction of D-xylose by aldose reductase (EC 
1.1.1.21) to D-xylitol (Fig. 7) which is then converted to D-xylulose and can be 
metabolized through the pentose phosphate pathway. Aldose reductase exhibits broad 
substrate specificity, including D-xylose and a variety of sugars [181]; expression of 
aldose reductase genes has been measured in pig lens [182], spleen, lung, ovary, adrenal, 
endometrium, kidney, and liver tissues [182,183]. Xylose metabolism through either of 
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these two potential pathways is possible; however, efficiency of the reactions depends on 
the distribution, abundance, and activity of D-xylose dehydrogenase and aldose reductase 
in pig tissues, something which has not yet been fully described.  
Xylose can also be metabolized to D-threitol, a urinary metabolite (Fig. 8). It has 
been measured in urine following D-xylose consumption by humans [184] and pigs [81]; 
human data seem to indicate a role for the liver. In healthy patients dosed with D-xylose, 
15% of the xylose excreted in the urine was actually recovered as D-threitol within 5 h 
post-dosing; this proportion increased when the collection time was extended to 24 h 
[184]. Delayed excretion is not observed with xylose measured in the urine and seems to 
indicate a delayed conversion to and excretion of threitol. Threitol excretion was 
decreased in patients with cirrhotic liver disease which indicates a substantial portion of 
the xylose to threitol conversion may occur in the liver [184]. Furthermore, similar 
amounts of urinary threitol were noted after both intravenous and oral administration of 
xylose, supporting the hypothesis that the conversion is occurring in the liver as opposed 
to the intestines [184].  
Although specific pathways of xylose metabolism have not yet been clarified, 
results from more recent studies provide information on xylose supplementation effects 
on metabolism of other nutrients and overall physiology. Hepatic expression of enzymes 
and transcription factors involved in glucose and lipid metabolism was measured in 
broiler chickens fed diets containing 0, 5, or 15% D-xylose [142]. The expression of 
phosphoenol pyruvate carboxykinase (PEPCK), a key enzyme in gluconeogenesis, did 
not appear to be affected by xylose supplementation at any time point up to 300 min post 
ingestion [142]. However, in poultry, the kidney is the major organ for gluconeogenesis 
  
 
 
 
35 
[166] and treatment differences may have been observed if kidney samples had been 
analyzed for this enzyme instead. In the fasted state, hepatic pyruvate carboxylase was 
linearly increased by xylose [142]. Because pyruvate carboxylase is a rate limiting 
enzyme for hepatic gluconeogenesis which is active when glycogen stores are depleted, 
such as occurs in starvation, this result corroborates reports that xylose depletes hepatic 
glycogen stores in poultry [141,157]. 
Understanding the effect of xylose on glucose metabolism is integral to 
understanding its contribution to overall energy metabolism. Potential effects must be 
gleaned from studies on other monogastric species as no data are available in pigs. Rats 
have been used as a model to evaluate potential xylose anti-diabetic effects; in one study, 
they were fed meals containing 5 or 10% D-xylose for 14 d [185]. In agreement with the 
attenuated glycemic effects discussed earlier, xylose supplementation decreased fasting 
blood glucose in a dose-dependent manner and decreased hepatic glycogen 
concentrations [185]. In contrast to the data in poultry, hepatic PEPCK protein levels 
were reduced in xylose supplemented rats indicating lower rates of gluconeogenesis. In 
vitro, xylose also increased insulin secretion from pancreatic -cells [185]. These data 
indicate xylose is unlikely to contribute substantially to overall energy balance in pigs; in 
high enough concentrations, xylose may affect postprandial glucose metabolism 
[142,185]. 
Xylose supplementation may also affect lipid metabolism. D-Xylose 
supplementation at 5 and 10% of a high-fat diet reduced weight gain, improved serum 
lipid profiles and reduced hepatic lipid accumulation in obese mice [165]. These effects 
appeared to be influenced by changes in the expression of genes that mediate adipocyte 
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differentiation, lipogenesis, and -oxidation of fatty acids in adipose tissues. Xylose 
supplementation was associated with lower mRNA levels of sterol regulatory element-
binding protein 1C, fatty acid synthase, adipocyte marker, and CCAAT/enhancer-binding 
protein- in visceral adipose tissue of mice [165]. In the liver, xylose supplementation 
decreased protein levels of fatty acid synthase and peroxisome proliferator-activated 
receptor- by at least 40% compared to the high-fat diet control group [165]. These 
results indicate that xylose supplementation may suppress lipogenesis and may give 
insight into mechanisms through which dietary xylose levels greater than 5% reduce 
ADG in pigs and poultry. 
In the muscle, xylose may not be metabolized directly or efficiently for energy 
[177], but it does appear to at least be transported into the muscle cell [177]; and this 
transportation is increased in the presence of insulin [186]. Additionally, xylose may 
influence myocyte glucose transport. High levels of xylose were found to upregulate the 
glucose transport system [187] and generally increase glucose uptake by mouse myotubes 
[185]. Gruzman et al. [187] reported that xylose did not utilize glucose transporters to 
enter myotubes but suggested the presence of a highly specific pentose transport system 
in skeletal muscles. These data corroborate earlier reports of xylose retention in muscle 
[177], yet the transport mechanism and eventual metabolic fate remain unclear. 
While the ambiguity surrounding xylose metabolism is frustrating from a 
nutritional perspective, it is not surprising from an evolutionary perspective. Monogastric 
animals do not have endogenous enzymes capable of degrading xylan to release 
monomeric xylose for absorption in the small intestine; consequently, there was little 
need to develop efficient mechanisms for xylose metabolism. Furthermore, xylose is a 
  
 
 
 
37 
rare carbohydrate in mammalian cells and so far is only found as a link between the 
protein and glycosaminoglycan chains of some proteoglycans and in the Notch receptor 
[134]. The Notch receptor is part of a highly conserved core signaling pathway required 
for various cell fate decisions at multiple stages of development [188]. However, UDP-
xylose, the activated precursor for xylose involvement in these structures, is synthesized 
from UDP-glucose and is not derived from dietary xylose sources [134]. As a result, the 
absence of an efficient or well-conserved pathway for xylose metabolism comes as no 
surprise because there has been no need. In practical terms, it also means that biochemists 
are not likely to find consistent mechanisms of xylose metabolism across species. Nor 
would nutritionists be highly motivated to evaluate the specific effects of xylose 
supplementation or xylose release from enzyme hydrolysis. One consistency regarding 
xylose metabolism is the ability of intestinal microbiota to ferment xylose and 
arabinoxylan. Given the inefficiency of xylose metabolism when absorbed intact by 
enterocytes, a critical comparison with the energy derived from xylose fermentation is 
necessary to determine the most energetically efficient use of dietary xylose. 
Xylose conclusions 
Xylose appears to be poorly utilized by monogastric animals, but xylose 
metabolism to CO2 is possible. Increased dietary concentrations of D-xylose linearly 
decreases ADG, feed intake, and feed efficiency in pigs. Even though xylose disappears 
almost completely from the small intestine, a high proportion of what is absorbed is 
excreted in the urine (35 – 50%), either as xylose or as a metabolite. Of the portion 
retained in the body, only a small percentage is fully oxidized to CO2. This indicates that 
xylose is unlikely to contribute in any significant manner to energy balance in the pig 
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through oxidative pathways. Its energetic contribution through fermentation may be less 
efficient, but quantitatively more important. However, this hypothesis has yet to be 
tested. More specifically, xylose inhibited sucrase activity leading to decreased post-
prandial blood glucose and insulin levels; further, xylose decreases expression of genes 
involved in lipogenesis. Combined, these effects are beneficial to humans, especially for 
those with diabetes, but are negative in growing pigs.     
It is important to consider that only one study has been reported using dietary 
concentrations of D-xylose below 5% in pigs [146]. It has yet to be determined if dietary 
concentrations more relevant to swine nutrition (i.e. 1 - 4% xylose) would exert similar 
effects. It must also be determined if pigs develop increased capacity for xylose 
metabolism as adaptation time to diets supplemented with xylose or xylanase increases. 
Data regarding xylose absorption support the hypothesis that mechanisms exist to handle 
low concentrations of xylose, but those mechanisms may be easily overwhelmed as 
luminal concentrations increase. It is possible that these mechanisms may be up-regulated 
as the pig adapts to higher luminal xylose concentrations. Furthermore, xylose effects on 
nitrogen balance and muscle metabolism have yet to be evaluated. Lastly, there is a need 
for a more comprehensive understanding of the action and hydrolysis products of 
exogenous xylanase in vivo, an understanding of how pig tissues metabolize hydrolyzed 
xylose monomers, and clarity on the contribution of microbial xylose fermentation to 
dietary xylose absorption and the energy value of xylanase supplemented diets.   
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Summary and conclusions 
Mannose and xylose are important components of the NSP fraction of swine diets, 
yet as both intact polysaccharides as individual sugars, their effects on energy 
metabolism in the pig are poorly understood. A more direct evaluation of dietary β-
mannan in swine diets and its effects on immune parameters is required to truly address 
the FIIR hypothesis in pigs. A better understanding of β-mannan effects on the innate 
immune system and maintenance energy requirements of pigs will allow more 
appropriate and efficient β-mannanase application to improve feed utilization in growing 
pigs. In addition to evaluating if, and how, dietary -mannans impact the immune system 
in pigs, it is also important to understand the energetic cost of inducing and maintaining 
an innate immune response. 
Additionally, with improved xylanase efficacy, an increasing proportion of xylose 
will be absorbed in the small intestine. Currently, xylose metabolism is poorly 
understood but understanding its effects in pigs and the energetic value of xylose is 
essential for effective xylanase utilization. As the use of -mannanase and xylanase 
enzymes continues to increase, it is important to evaluate their metabolic impact in order 
to accurately estimate enzyme effects on dietary energy availability to the pig. This 
information will allow nutritionist to improve the accuracy of diet formulations when 
high fiber ingredients and carbohydrase enzymes are utilized. 
Therefore, the overall objective of this dissertation work was to evaluate the 
impact of -mannan and xylose on energy metabolism in the pig. More specifically, the 
objective of Experiment 1 (Chapter 2) was to evaluate the -mannan-induced immune 
response hypothesis in pigs by testing the impacts of -mannanase supplementation and 
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true immune stimulation on maintenance energy requirements. As a follow up, the 
objective of Experiment 2 (Chapter 3) was to evaluate the effects of dietary mannan 
level, -mannanase supplementation, and their interaction on immune parameters, 
growth performance, and feed efficiency in nursery pigs. Finally, the objectives of 
Experiment 3 (Chapter 4) were to evaluate the impact of dietary xylose concentration 
and adaptation time on xylose metabolism and its energy value to the pig.  
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Table 1. Arabinoxylan concentration in feedstuffsa 
Feed ingredient Arabinoxylan concentration, g/kg 
Corn bran 221 
Corn DDGs-reduced oil 143 
Soybean hulls 124 
Barley   84 
Wheat   73 
Corn   47 
Soybean meal   43 
Table 1.1. Arabinoxylan concentration in feedstuffsa 
aAdapted from [12,52,137] 
 
Table 2. β-mannan concentration in typical swine diet ingredientsa 
Feed ingredient β-mannan concentration, g/kg 
Palm kernel meal 367 
Copra meal 250 
Guar meal   87 
Hulled soybean meal   21 
Dehulled soybean meal   13 
Rye       6.1 
Wheat       0.9 
Corn       0.8 
aAdapted from [6] 
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Figure 1. 𝛽-1,4-D-arabinoxylan. 𝛼-1,3 L-Arabinose residues are linked on position O3, 
or O2 and O3 if di-substituted, of a D-xylose unit. 
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A) Mannan 
 
 
 
 
B) Galactomannan
 
 
C) Glucomannan 
 
 
 
D) Galactoglucomannan 
 
 
 
Figure 2. General structures of plant β-mannan. A) A typical mannan polymer of 
repeating β-(1,4)-linked D-mannose units; B) Galactomannan structure consisting of a β-
(1,4)-mannan backbone with α-(1,6)-linked D-galactose residues attached to some 
mannose residues. C) Glucomannan structure consisting of β-(1,4)-linked D-glucose 
substituted within the β-(1,4)-mannan backbone. D) Galactoglucomannan structure 
consisting of the β-(1,4)-linked glucomannan chain with α-(1,6)-linked D-galactose 
residues attached to some mannose residues. Figure adapted from [7]. 
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Figure 3. Arabinoxylan degrading enzymes. Arrows indicate hydrolysis sites of xylan 
degrading enzymes. 
 
 
 
Figure 4. Mannose binding lectin (MBL) structure. The MBL consists of a monomeric 
polypeptide chain with a cysteine-rich N-terminal region, a collagen region, “neck 
region”, and a carbohydrate recognition domain (oval) at the C-terminal. MBL monomers 
then form trimers the trimers form multimers of trimers resulting in a “bouquet-like” 
conformation. Figure adapted from [189]. 
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Figure 5 D-xylose 
 
Figure 6 D-xylonic acid 
 
Figure 7 D-xylitol 
 
Figure 8 D-threitol 
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CHAPTER II 
LIPOPOLYSACCHARIDE IMMUNE STIMULATION BUT NOT -
MANNANASE SUPPLEMENTATION AFFECTS MAINTENANCE ENERGY 
REQUIREMENTS IN YOUNG WEANED PIGS 
 
Modified from a paper published in 2018 by the Journal of Animal Science and 
Biotechnology (In Press) doi: 10.1186/s40104-018-0264-y 
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Abstract 
 Pathogen or diet-induced immune activation can partition energy and nutrients 
away from growth, but clear relationships between immune responses and the direction 
and magnitude of energy partitioning responses have yet to be elucidated. The objectives 
were to determine how β-mannanase supplementation and lipopolysaccharide (LPS) 
immune stimulation affect maintenance energy requirements (MEm) and to characterize 
immune parameters, digestibility, growth performance, and energy balance. In a 
randomized complete block design, 30 young weaned pigs were assigned to either the 
control treatment (CON; basal corn, soybean meal and soybean hulls diet), the enzyme 
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treatment (ENZ; basal diet + 0.056% -mannanase), or the immune system stimulation 
treatment (ISS; basal diet + 0.056% -mannanase, challenged with repeated increasing 
doses of Escherichia coli LPS). The experiment consisted of a 10-d adaptation period, 5-
d digestibility and nitrogen balance measurement, 22 h of heat production (HP) 
measurements, and 12 h of fasting HP measurements in indirect calorimetry chambers. 
The immune challenge consisted of 4 injections of either LPS (ISS) or sterile saline 
(CON and ENZ), one every 48 h beginning on d 10. Blood was collected pre- and post-
challenge for complete blood counts with differential, haptoglobin and mannan binding 
lectin, 12 cytokines, and glucose and insulin concentrations. Beta-mannanase 
supplementation did not affect immune status, nutrient digestibility, growth performance, 
energy balance, or MEm. The ISS treatment induced fever, elevated proinflammatory 
cytokines and decreased leukocyte concentrations (P < 0.05). The ISS treatment did not 
impact nitrogen balance or nutrient digestibility (P > 0.10) but increased total HP (21%) 
and MEm (23%), resulting in decreased lipid deposition (-30%) and average daily gain (-
18%) (P < 0.05). This experiment provides novel data on -mannanase supplementation 
effects on immune parameters and energy balance in pigs and is the first to directly relate 
decreased ADG to increased MEm independent of changes in feed intake in immune 
challenged pigs. Immune stimulation increased energy partitioning to the immune system 
by 23% which limited lipid deposition and weight gain. Understanding energy and 
nutrient partitioning in immune-stressed pigs may provide insight into more effective 
feeding and management strategies. 
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Introduction 
The negative influence of an immune challenge on animal growth is well 
established. Pro-inflammatory cytokines orchestrate an immune response resulting in 
fever, acute phase protein (APP) production, and leukocyte proliferation, each of which 
requires additional energy and amino acids (AA). Therefore, a perceived immune 
challenge can theoretically partition energy and nutrients away from productive processes 
such as muscle growth and negatively impact the efficiency and cost of meat production 
[1]. Innate immune activation occurs when pathogen-associated molecular patterns are 
detected such as the lipid-A component of lipopolysaccharide (LPS) from gram-negative 
bacteria [2]. However, certain dietary components, such as -mannan in soybean, copra, 
and palm kernel meals, mimic carbohydrate structures on pathogen surfaces [3] and have 
previously been shown to activate the innate immune system [4,5], termed a feed-induced 
immune response (FIIR).  
 To inhibit a -mannan derived FIIR, interest in β-mannanase enzyme 
supplementation has increased. It is hypothesized that the hydrolyzed manno-
oligosaccharides can no longer crosslink and stimulate multiple mannose receptors, thus 
reducing immune stimulation and associated energy costs. Research in poultry 
demonstrated that β-mannanase decreased plasma APP concentration and improved 
growth performance and feed efficiency leading to the conclusion that β-mannanase 
supplementation spared energy through prevention of the FIIR [6,7]. In pigs, performance 
responses to β-mannanase are less consistent than in poultry and reports on immune 
responses are limited and effects on energy partitioning have yet to be evaluated. 
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 Nutrient partitioning in pigs during a pathogen challenge has received more 
attention, often utilizing a LPS challenge model [8]. Physiological responses to an LPS 
challenge in pigs have been well characterized. Similar to disease challenges, LPS 
induces anorexia, fever, and nutrient repartitioning leading to decreased growth and 
efficiency [1,2,9]. Fever is an energetically expensive process and its effects on sheep and 
human maintenance energy requirements have been estimated [10]. Immune system 
activation also significantly shifts glucose metabolism and glucose requirements during 
an LPS challenge in pigs have been estimated to be approximately 1.1 g/kg BW0.75/h 
[11]. Yet few studies have addressed comprehensive changes in energy partitioning 
during an immune response and clear relationships between measured immune responses 
and the direction and magnitude of changes in energy partitioning have yet to be 
elucidated.  
 Therefore, the objectives of this experiment were to determine how β-mannanase 
supplementation and innate immune stimulation each affect maintenance energy 
requirements and to characterize changes in immune parameters, nutrient digestibility, 
growth performance, and energy balance. We hypothesized that innate immune 
stimulation would increase maintenance energy requirements by initiating a cytokine-
driven febrile response and inflammatory state, and that β-mannanase supplementation 
would decrease maintenance energy requirements through an energy sparing effect of 
FIIR prevention. 
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Materials and methods 
 All experimental procedures adhered to guidelines for the ethical and humane use 
of animals for research and were reviewed and approved by the University of Manitoba 
Animal Care Committee. 
Animals and experimental design 
Thirty growing barrows ([Yorkshire × Landrace] × Duroc) were acquired from 
the Glenlea Swine Research Unit, University of Manitoba at an average body weight 
(BW) of 9.60 ± 2.00 kg. The experiment was conducted using a randomized complete 
block design. Pigs were blocked by weight and randomly assigned to one of three 
treatments (Table 1). A staggered time course was utilized to accommodate the limited 
number of calorimetry chambers available, whereby 10 blocks of three pigs each (one pig 
per treatment) began the experiment 4 d after the previous block. Day one BW was 
similar among treatments (10.27 ± 0.08 kg). 
Experimental diets, treatments and procedures 
All diets were formulated on the ratio of standardized ileal digestible lysine to 
metabolizable energy (ME) and met or exceeded all specified nutrient requirements of 
growing pigs from 11 to 25 kg [12]. Pigs were fed at 2.5 times their maintenance ME 
requirements [12], once daily at 0800 h and had free access to water at all times. Pigs 
were fed a common pre-trial diet that was corn-soybean meal-based. The experimental 
basal diet (Table 2) was formulated with high soybean meal and soybean hull inclusion 
levels to increase dietary β-mannan concentration.  
Due to the availability of three indirect calorimetry chambers, three experimental 
treatments were evaluated (Table 1). The control treatment (CON) received the basal 
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diet, while the enzyme treatment (ENZ) received CON supplemented with 0.056% β-
mannanase (HemicellTM HT-D, Elanco Animal Health, Guelph, ON, Canada; endo-1,4-β-
mannanase (160 × 106 units/kg) from Paenibacillus alvei). The third treatment was 
challenged with repeated LPS immune system stimulation (ISS) and received the same 
diet as ENZ. This treatment design was determined based on the hypothesis, supported by 
previous research, that β-mannanase would inhibit a FIIR if it occurred in CON [6,7]. In 
this way, the effect of innate immune stimulation by LPS could be evaluated independent 
of a FIIR. 
Upon arrival and during the pre-trial period, pigs were housed individually in 
pens (1.83 × 1.22 m) with plastic-covered expanded metal flooring in a temperature-
controlled room (26 ± 2°C). Daily feed allotment during the pre-trial period was adjusted 
based on BW measured every 4 d. Pigs were maintained on the pre-trial diet for at least 4 
d until initiation of the experiment for their respective block, at which time pigs received 
their assigned treatment diets. The experiment consisted of a 10-d adaptation phase, a 5-d 
total feces and urine collection phase, and 34 h of heat production (HP) measurements.  
At trial initiation (d 1), pigs were individually housed in adjustable metabolism 
crates (1.80 × 0.60 m) with smooth transparent plastic sides and plastic-covered expanded 
metal flooring in a temperature-controlled room (26 ± 2°C). Body weight was measured 
on d 1, 5, 10, 16, daily feed allotment was adjusted accordingly, and pigs were trained to 
consume the entire meal within 1 h of feeding at 0800 h. Orts, if any, were measured to 
determine average daily feed intake (ADFI).  
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Immune challenge 
A low-dose, repeated LPS challenge, following the modified procedures 
described by Rakhshandeh and de Lange [8], was chosen to induce an inflammatory 
response representative of sustained immune system stimulation in the ISS treatment. The 
challenge consisted of four repeated low-dose injections of Escherichia coli LPS serotype 
O55:B5 (Sigma–Aldrich, St. Louis, MO, USA) for pigs on treatment ISS, or a control 
injection of sterile saline for pigs in treatments CON and ENZ. The LPS was dissolved in 
sterile PBS so that an injection of 0.1 mL/kg of BW achieved the desired dosage [13].  
A pilot study with 12 pigs was conducted prior to experiment initiation to discern 
the lowest appropriate initial LPS dose and the subsequent dose increase regimen 
required to limit LPS tolerance development. Results of the pilot study (not reported 
herein) indicated that an initial dose of 20 g LPS/kg of BW with subsequent dose 
increases of 20, 30, and 40% was the regimen that maintained a febrile response (rectal 
temperature ≥ 40°C) at all four challenges while minimizing anorexia and vomiting.  
Pigs were injected intramuscularly at 1000 h on d 10, 12, 14, and 16 with either 
sterile saline or LPS, following the previously described dosing regimen determined from 
the pilot study. Baseline rectal temperature was measured on d 5 and 8 at 1400 h and at 4 
h post-challenge (1400 h) on d 10, 12, and 14. Blood samples were then collected on d 8 
(pre-challenge) and d 10 (post-challenge) via jugular venipuncture into two 10 mL tubes 
for EDTA-whole blood and serum. Whole blood samples were placed on ice pending 
transportation to the laboratory for complete blood count (CBC) analysis with white 
blood cell (WBC) manual differential. Serum was separated by centrifugation (2000 × g 
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for 15 min at 4°C), collected and divided into three subsamples, and stored at -80°C until 
analyzed. 
Digestibility  
On d 10, pigs received 5 g of ferric oxide as an indigestible marker mixed with 
100 g of feed; the remaining allotted feed was offered after the marked feed was 
consumed. Fecal collection commenced when the marker first appeared in the feces. On d 
15, pigs were offered 100 g of marked feed as previously described, and fecal collection 
terminated when the marker appeared in the feces. Feces were weighed and stored at -
20°C until further processing. Total urine collection commenced at 0800 h on d 11 and 
terminated at 0800 h on d 16. Urine was collected once daily into jugs containing 10 mL 
of 6 mol/L HCl. Urine was weighed, thoroughly mixed and subsampled (10% of urine 
weight), strained through glass wool, and stored at -20°C. Urine subsamples were pooled 
per pig throughout the collection period.   
Heat production 
On d 16, within 30 min of consuming their daily feed allotment, pigs were 
transferred to open-circuit indirect calorimetry chambers (1.22 × 0.61 × 0.91 m metallic 
box with a glass door on the front side, plastic-covered expanded metal sheet flooring, 
and a valve at the bottom to collect urine; Columbus Instruments, Columbus, OH, USA) 
for 34 h of calorimetric measurements. Pigs were randomly assigned to chambers to 
reduce the possibility of a chamber bias. The first 2 h of HP (0800 – 1000 h), measured 
prior to pigs receiving the fourth and final challenge of either LPS or saline, were 
designated as acclimation and not included in HP calculations. Total oxygen consumption 
(VO2) and carbon dioxide production (VCO2) were measured every 12 min 
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corresponding to 170 values over 34 h. The first 24 h following feeding was designated 
as the fed state and the last 12 h as the fasting state [14,15]. Urine voided during the fed 
and fasting periods was collected separately and processed as previously described. 
Personnel movement within the room was minimized during HP measurement to avoid 
any disturbance of the pigs. The system was validated using the alcohol combustion 
method described by Aulick et al. [17] and the O2 and CO2 sensors were calibrated prior 
to each block of the experiment. The chambers were air-conditioned to maintain a 
constant temperature (23 ± 1°C). Pig BW on d 16 was similar across all treatments (14.1 
± 0.3 kg). Heat production was measured in only seven of the ten experimental blocks 
because of equipment failure during three blocks; therefore, for HP data, n = 7.  
Analytical methods 
All diet, orts, and fecal samples were dried at 60°C to a constant weight and were 
ground to a particle size of 1 mm. Urine samples were thawed, sieved through cotton 
gauze, and filtered with glass wool. Urine, diet, and fecal samples were analyzed in 
duplicate for nitrogen (N; method 990.03 [17]; TruMac®; LECO Corp., St. Joseph, MI, 
USA). An EDTA sample (9.56% N) was used as the standard for calibration and was 
determined to be 9.55 ± 0.01% N. Crude protein (CP) was calculated as N × 6.25. Diets 
were analyzed for β-mannanase concentration (colorimetric determination, Elanco 
Animal Health, Gaithersburg, MD).  
Diet and fecal samples were analyzed in duplicate for dry matter (DM; method 
930.15), acid hydrolyzed ether extract (EE; method 2003.06), and starch (Total Starch 
Assay Kit, Megazyme International, Wicklow, Ireland, method 996.11) using standard 
methods [17]; and in triplicate for neutral and acid detergent fiber components (NDF [18] 
  
 
 
 
70 
and ADF [19], respectively). Hemicellulose was calculated as the difference between 
NDF and ADF concentrations. Gross energy (GE) was determined using a bomb 
calorimeter (model 6200; Parr Instrument Co., Moline, IL). Benzoic acid (6,318 kcal 
GE/kg; Parr Instrument Co.) was used as the standard for calibration and was determined 
to contain 6,325 ± 6.9 kcal GE/kg. Urine GE was calculated as 192 plus 31 times the 
concentration of urinary N [20] and multiplied by a factor of 0.239 to convert the unit to 
kcal.  
Pre- and post-challenge whole blood samples and blood smears were analyzed for 
CBC performed by Manitoba Veterinary Diagnostic Services (Winnipeg, MB, Canada) 
using Advia 2120i (Siemens Healthcare Diagnostics, Tarrytown, NY, USA) with a 
manual differential. The main response variables of interest were total cell, RBC, and 
WBC (mature and immature neutrophils, eosinophils, basophils, lymphocytes, and 
monocytes) concentrations.  
Serum was divided into three subsamples. One set was analyzed for glucose and 
insulin concentrations by Animal Health Laboratory (University of Guelph, ON, Canada). 
Glucose concentration was determined on an automated Roche Cobas C501 analyzer 
(GLUC3 application, Roche Diagnostics, Indianapolis, IN, USA) and insulin 
concentration was quantified using commercial RIA kits (PI-12K, EMD Millipore, 
Billerica, MA, USA). The second serum subset was analyzed for cytokine concentrations 
(granulocyte macrophage colony-stimulating factor (GM-CSF), tumor necrosis factor 
alpha (TNFα), Interleukin (IL)-one-alpha (IL-1α), IL-1β, IL-one-receptor antagonist 
(IL-1ra), IL-2, IL-4, IL-6, IL-8, IL-10, IL-12, and IL-18) by a commercial multiplex 
assay using laser bead technology (Eve Technologies, Calgary, AB, Canada). The third 
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serum set was analyzed for concentration of APPs haptoglobin and mannose-binding 
lectin A (MBL) using porcine-specific commercial ELISA kits (Immunology Consultants 
Laboratory, Inc., Portland, OR, USA; MyBioSource, Inc., San Diego, CA, USA, 
respectively).  
Calculations 
Dry matter, GE, CP, EE, starch, hemicellulose, NDF, and ADF apparent total tract 
digestibility (ATTD; %) were calculated on a DM basis as [(nutrient intake – nutrient 
output in feces)/nutrient intake] × 100. Digestible energy (DE) content of the diet was 
calculated as GE × GE ATTD. Dietary ME was calculated according to the equation of 
Noblet et al. [21]: ME = DE – [urine GE + (0.4% of DE intake)]. Nitrogen retention (NR) 
was calculated by the difference between N intake and N excreted in the feces and urine, 
and protein deposition (PD) was determined as NR × 6.25.     
Heat production was calculated from respiratory gas exchanges and urinary N 
production according to the equation of Brouwer (1965): HP (kcal) = 3.87 × VO2 
consumed (L) + 1.20 × VCO2 produced (L) – 1.43 × urinary N production (g). Methane 
production was not accounted for, but has been estimated to be very low in growing pigs 
(< 1%, [23]). All HP parameters were normalized to a period of 24 h, expressed as kcal of 
heat produced per kg of BW0.60 [24] and per kg of DM intake (DMI) in order to remove 
known effects of variations in BW and DMI [25,26]. 
Total heat production (HPtotal) was the average HP during the 22 h of post-
challenge, fed state measurement. Total fasting heat production (FHPtotal) was the 
average HP over the 12 h fasted-state. Because the system was not equipped to quantify 
and separate HP due to physical activity, fasting heat production (FHP) was derived from 
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the 10 lowest HP values over the fasted-state, reflecting energy metabolism due to basal 
metabolic rate and not associated with feed consumption, digestion, or physical activity 
[27,28]. The respiratory quotient (RQ) was calculated as VCO2 divided by VO2 during 
the fed (RQfed) and fasting (RQfast) states.  
To best estimate components of HP not attributed to the basal metabolic rate, HP 
values for physical activity and the thermic effect of feeding (TEF) were calculated. 
Activity heat production (AHP) was estimated utilizing fed-state HP data measured over 
10 h post-challenge to represent normal post-feeding daytime behavior. The difference 
between the average HP over this 10 h period (HP10) and the average of the 10 lowest HP 
values over the same time (HPlow; representative of sedentary, resting behavior; [27,28]) 
was designated as AHP. The TEF was calculated as the difference between HP10 and the 
sum of AHP and FHP, so that any HP in excess of basal metabolism and activity was 
partitioned toward TEF. Heat increment (HI) was then calculated as the sum of AHP and 
TEF. Using these data, the efficiency of utilizing ME for maintenance and growth (kmg, 
%) was calculated as (1 – HI / ME intake) × 100 [25,29]. To address the primary research 
question of how an immune challenge and β-mannanase supplementation impact 
maintenance energy requirements, metabolizable energy used for maintenance (MEm) 
was then calculated as FHP × 100/ kmg [25,29].  
Together, dietary energy, N balance, and HP values were utilized to characterize 
energy use and balance in the pig. Retained energy (RE) was calculated by the difference 
of ME intake and the total HP during the 24 h fed-state (both pre- and post-challenge) to 
account for all energy not available for tissue accretion [29]. Energy retained as protein 
(REp) was calculated from N balance assuming a PD (g) energy value of 5.64 kcal/g [30]. 
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Energy retained as lipid (REl) was calculated as the difference between RE and REp [30]. 
Lipid deposition (LD) was then determined from REl assuming an energy content of 9.49 
kcal/g of deposited lipid [22]. Dietary net energy (NE; kcal/kg) was calculated as the sum 
of RE and FHP divided by DMI [21].  
Statistical analyses 
 Data were analyzed as a randomized complete block design with pig as the 
experimental unit. The UNIVARIATE procedure of SAS (Version 9.4, SAS Inst., Cary, 
NC) was used to verify normality and homogeneity of variances. Statistical outliers (> 3 
SD away from the mean) were removed; therefore, one pig from the ISS treatment was 
removed from HP data because of poor feed intake (45% decrease) on the day of HP 
measurement. Immature neutrophil, eosinophil, and basophil CBC data were log 
transformed to achieve a normal distribution.  
The main effects of dietary treatment and block were analyzed using the MIXED 
procedure of SAS. The staggered block experimental design resulted in variations in time 
and body weight among blocks. This variation was expected and resulted in statistical 
detection of block as a significant main effect in most response variables. Therefore, 
block remained in the statistical model, but block P-values are not reported herein. 
Differences among treatments were determined using ANOVA and means were 
separated using the least square means statement and the PDIFF option. Immune and 
rectal temperature data were analyzed as repeated measures and covariance structures 
resulting in the lowest AIC values for each variable were applied. To further evaluate β-
mannanase effects on immune parameters pre-challenge, contrasts comparing CON 
versus ENZ and ISS values were generated using the contrast statement of the MIXED 
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procedure. Differences were considered significant if P was ≤ 0.05 and a trend if P was > 
0.05 and ≤ 0.10. 
 
Results 
Immune response parameters  
Immune system stimulation effects  
Pigs on the ISS treatment exhibited minimal vomiting, diarrhea and signs of 
lethargy and hyperventilation after the first and to a lesser extent, the second LPS 
injection. After the third and fourth challenges, ISS pigs continued to demonstrate signs 
of lethargy and hyperventilation, but vomiting and diarrhea were not observed. No pigs 
died after any injection. The immune stimulation model successfully induced a sustained 
febrile response (rectal temperature ≥ 40°C) in ISS pigs on d 10, 12, and 14 (treatment by 
day interaction P < 0.0001; Fig. 1). Pigs in CON and ENZ treatments maintained normal 
rectal temperatures (38.85°C ± 0.15) throughout the experiment.   
There was a significant interaction between the effects of time (pre- or post-
challenge) and treatment on WBC, mature neutrophil, lymphocyte, and monocyte counts 
and a trend for an interaction on RBC count. In all four variables, treatments had similar 
cell counts at the pre-challenge time point (P ≥ 0.10). Post-challenge, immune 
stimulation by LPS decreased WBC, mature neutrophil, lymphocyte, and monocyte 
counts compared to CON and ENZ (P ≤ 0.05; Fig. 2). There were no differences among 
treatments or time periods for total cell, immature neutrophil, eosinophil, or basophil 
counts (P > 0.10).  
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Glucose, insulin, haptoglobin, and MBL serum concentrations were not affected 
by the interaction of time and treatment (P > 0.10), but concentrations were higher pre-
challenge compared to post-challenge for glucose, haptoglobin, and MBL. 
Lipopolysaccharide challenge increased IL-1β, IL-1ra, IL-6, IL-8, and TNFα 
concentrations post-challenge compared to ISS pre-challenge and both pre- and post-
challenge concentrations in CON and ISS (Fig. 3). All other cytokines were not 
significantly impacted by the interaction or main effects of time and treatment (P > 0.10). 
Interferon-gamma was not detected in any of the samples. Serum GM-CSF 
concentrations were not different (P > 0.10) among CON and ENZ pre-and post-
challenge and ISS pre-challenge, while ISS post-challenge GM-CSF concentration was 
increased compared to the ISS pre-challenge value and CON and ENZ post-challenge 
values (P ≤ 0.015; Fig. 3).  
β-mannanase effects 
 Contrasts comparing immune cell dynamics of pigs fed either the control or β-
mannanase diet prior to the first challenge on d 10 detected no differences in CBC values 
(P ≥ 0.10; Table 3).  Similarly, serum glucose, insulin, MBL, and cytokine concentrations 
(except IL-1α) did not differ with β-mannanase supplementation (P ≥ 0.230; Table 4). 
Serum haptoglobin and IL-1α concentrations were decreased in diets supplemented with 
β-mannanase (P ≤ 0.05; Table 4) 
Pig growth performance, nitrogen balance, and diet digestibility 
 Average initial BW was 10.27 ± 0.15 kg, d 16 average BW was 15.12 ± 0.27 kg, 
and BW did not differ among treatments at either time point (P ≥ 0.471). Average daily 
gain (ADG) over the entire 16-d experiment was not different among treatments (P = 
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0.13; Table 6), but ISS ADG during the immune challenge (d 10-16) was less than CON 
and ENZ gain (P = 0.010; Table 7).  
Immune system simulation numerically decreased ADFI and thus N intake 
compared to CON and ENZ (P = 0.021), resulting in decreased fecal N excretion on a g 
per d basis (P = 0.007). Urine N excretion during the challenge period was similar among 
treatments (P = 0.045) but retained N in the ISS treatment was less than that of CON, 
with ENZ being intermediate (P = 0.045; Table 6). Partitioning of excreted N to either 
the feces or urine was not different among treatment (P = 0.78). When N excretion was 
expressed as a percent of N intake, the previously observed significant treatment effect on 
fecal N excretion was no longer evident (Table 6). There were no differences among 
treatments in ATTD of any analyzed nutrient (P ≥ 0.120; Table 5) and all ATTD 
coefficients were within normal ranges for 10 to 15 kg pigs 
Heat production, maintenance energy requirements, and energy retention 
 Day 16 ME intake was similar among treatments (759.4 ± 37.7 kcal/kg BW0.60/kg 
DMI/d; P = 0.92). Immune system stimulation increased fed state HPtotal compared to 
CON and ENZ (P = 0.040; Table 7). In the fasting state, neither immune stimulation nor 
β-mannanase supplementation affected FHPtotal or FHP compared to control (P ≥ 0.135). 
Treatment did not affect RQ in the fed and fasting states (P ≥ 0.23; Table 7). 
Immune system stimulation increased MEm (kcal/kg BW0.60/kg DMI/d) compared 
to CON or ENZ pigs (P = 0.045), but kmg among treatments did not differ (P = 0.13; 
Table 7). When MEm was expressed as kcal/d, the significant treatment effect was no 
longer detected (P = 0.90). Beta-mannanase supplementation did not change MEm 
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relative to CON whether expressed as kcal/kg BW0.60/kg DMI/d (P = 0.98), kcal/kg 
BW/d (P = 0.72), or kcal/d (P = 0.77). 
Absorbed energy not lost via urine, gases, heat increment, activity and TEF, or 
maintenance, is retained as either protein or lipid. Immune system stimulation decreased 
REl compared to CON and ENZ (P = 0.046) but REp and total RE were not different 
among treatments (P > 0.32) when expressed as kcal/kg BW0.60/kg DMI/d (Table 7). 
When RE was expressed as a proportion of ME intake, similar treatment effects were 
observed for REl and REp, but a significant decrease in total RE was detected due to ISS 
(P = 0.033; Table 7). As less energy was retained as lipid, LD was decreased in the ISS 
treatment compared to CON and ENZ (P = 0.047) while no differences were observed in 
PD (P = 0.15; Table 7). 
Dietary energy values and efficiency 
 The ENZ and ISS treatments tended to decrease diet DE and ME values relative 
to CON (P ≤ 0.052; Table 8). Neither ISS nor β-mannanase supplementation (ENZ 
treatment) affected dietary NE value (P = 0.75) or ME and NE efficiency (P ≥ 0.46).     
   
Discussion 
During an immune challenge, pro-inflammatory cytokines initiate a shift in 
nutrient partitioning away from tissue growth to support activation and maintenance of an 
immune response [1,11,31]. The results of this experiment clearly demonstrate a systemic 
inflammatory response to LPS occurred, verified by increased concentrations of pro-
inflammatory cytokines and elevated body temperature. To our knowledge, these data are 
the first to directly relate decreased ADG to increased MEm independent of changes in 
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feed intake during an immune response. Additionally, this experiment provides novel data 
on -mannanase supplementation effects on immune parameters and energy balance in 
pigs.  
-Mannanase 
As a constituent of hemicellulose, -mannan is not digested by mammalian 
endogenous enzymes [32]. Thus, intact -mannans are available to bind carbohydrate 
recognition domains of pattern recognition receptors on innate immune cells surveying 
the intestinal epithelium for potential pathogens [3,33]. In this way, -mannans are 
hypothesized to be capable of stimulating innate immune cells resulting in a 
nonproductive, energy draining immune response [4–6].  
Typically, only growth and feed efficiency responses have been measured from -
mannanase supplementation and reported in the animal nutrition literature. Reduced feed 
efficiency and ADG have been reported with increasing dietary -mannan concentrations 
[34]. Therefore, there is interest in -mannanase supplementation to alleviate these 
negative effects by enzymatic hydrolysis of -mannan polysaccharides. The FIIR was 
alleviated through -mannanase supplementation in poultry [6,35]; however, -
mannanase supplementation responses in swine have been inconsistent. This experiment 
demonstrated no -mannanase effect on the ATTD of DM, GE, CP, EE, or hemicellulose. 
Growth performance responses are similarly inconsistent with positive results in some 
studies [36–38], but no -mannanase effect in others [39–42]. In this experiment, ENZ 
did not improve ADG, protein, or lipid deposition.  
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Dietary -mannans are proposed to stimulate the innate immune system through 
direct interactions with the carbohydrate binding domains of mannose recognition 
receptors such as the membrane bound mannose receptor and secreted MBL. Therefore, 
serum MBL concentrations were measured to determine if -mannanase supplementation 
decreased circulating MBL, theoretically by removing the substrate for activation and 
synthesis. Serum MBL concentrations were not affected by -mannanase. This may 
indicate that the -mannan concentration in the intestinal lumen was not high enough to 
either interact with MBL, MBL-dietary -mannan interaction was not affected by -
mannanase supplementation, or this interaction is not a mechanism through which -
mannans are sensed by the innate immune system.  
Two significant differences in serum parameters were detected when contrasts 
were applied to compare pre-challenge values between control pigs (no -mannanase, 
CON treatment) and -mannanase supplemented pigs (ENZ and ISS treatments). Beta-
mannanase supplementation decreased serum haptoglobin and IL-1 concentrations. In 
poultry, decreased haptoglobin has been proposed as evidence of immune stress 
alleviation due to -mannanase supplementation [6]. However, this response occurred in 
conjunction with growth performance and feed efficiency improvements which were not 
observed in this study. Beta-mannanase effects on IL-1 concentrations have not been 
previously reported. Interleukin-1-alpha can be involved in inflammation initiation, but 
the relationship between serum concentration and magnitude of immune challenge is not 
as clear as the implication of its counterpart, IL-1 on systemic inflammation [43]. 
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Interleukin-1-beta concentrations were not affected by -mannanase supplementation in 
this study.  
Collectively, decreased serum IL-1 and haptoglobin concentrations are not 
strong enough evidence of an alleviated systemic FIIR when taken in context with the 
lack of all other measured inflammatory-type variables. Importantly, no differences were 
observed in HP, MEm, and growth performance. It is possible that a localized response 
may have occurred at the intestinal level yet went undetected systemically. However, if 
this occurred, whole body nutrient and energy partitioning were still unaffected. The 
hypothesis that -mannanase supplementation would decrease MEm was not supported. 
Pigs fed diets supplemented with  -mannanase had similar WBC counts, cytokine 
concentrations, nutrient digestibility, ADG, N and energy balance, PD, LD, and MEm 
compared to CON pigs.  
Immune stimulation 
 Innate immune stimulation was successfully induced in pigs using sequential, 
increasing doses of E. coli LPS. Elevated rectal temperature, increased pro-inflammatory 
cytokine concentrations, and altered nutrient and energy partitioning are all hallmarks of 
a chronic immune challenge [1] and were observed in ISS pigs in this study. One 
limitation of this study was the number of calorimetry chambers available which limited 
the experiment to a total of three treatments. Due to this limitation, we were unable to 
evaluate the interaction of -mannanase supplementation with LPS immune stimulation. 
Thus, interpretation of ISS effects has been made in comparison to the ENZ treatment. 
However, as discussed above, there were no differences between the CON and ENZ 
treatments in nutrient digestibility, ADG, or N and energy balance. The major finding of 
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this research indicates that the innate immune challenge increased young pig maintenance 
energy requirements by 23.3% which translated into a 18.3% decrease in ADG. 
Unique to this study, decreased ADG could be attributed primarily to increased 
MEm in ISS pigs as opposed to decreased feed intake or effects on nutrient digestibility. 
Anorexia is a well-established response to systemic immune stimulation [2,9,44] induced 
by pro-inflammatory cytokine actions (especially IL-1) in the brain and modulation of 
metabolism and hormone release [45]. In this study, a numerical but not statistically 
significant decrease in ADFI was observed in ISS pigs during the challenge period even 
though IL-1 increased. It is likely that a stronger ADFI decrease was not observed as a 
consequence of challenging the pigs 2 h post-feeding and limit feeding to 2.5 times 
maintenance energy requirements [12]. This feeding level was designed to achieve 
similar ADFI for pigs on all treatments because of the known effect of previous feeding 
level on HP [25]. To further ensure HP results were separated from feed intake and BW 
effects, all energy balance calculations were conducted on a kcal/BW0.60/DMI/d basis. 
Just as feed intake did not influence the observed decrease in ADG of ISS pigs, nutrient 
digestibility was not different across treatments. This is in agreement with other studies 
reporting ATTD during a chronic LPS challenge [46,47].  
Febrile response 
 Before the challenge period, rectal temperatures and blood immune parameters in 
ISS pigs were not different from those on the CON and ENZ treatments. This confirmed 
that prior to the challenge all pigs were in good health and of similar immune status. 
Therefore, any subsequent differences during the challenge were attributed to LPS 
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immune stimulation. Elevated rectal temperatures (> 40°C) post-challenge on d 10, 12, 
and 14 indicated a febrile response in ISS pigs.  
 Fever is energetically expensive with increased caloric requirement estimates 
ranging from 7-15% for each 1°C increase in body temperature [48]. Utilizing the 
average rectal temperature of CON and ENZ pigs and the post-challenge temperature of 
ISS pigs on day 14, an increase of 1.2°C resulted in a 23.3% increase in MEm caloric 
requirements. This value is higher than the previously described range and may indicate 
that the majority, but not all of the increase in maintenance caloric requirement is to 
support the febrile response. The remainder may be partially explained by an increase in 
immune cell glucose requirements [11]. 
Cytokines 
Key pro-inflammatory cytokines include TNF, IL-6, and IL-1 [49] and ISS 
pigs had increased serum concentrations of all three after the first LPS challenge. Pro-
inflammatory cytokines shift metabolism away from anabolic processes toward a more 
catabolic state to generate AAs and energy necessary to support fever, increase immune 
cell proliferation, and APP synthesis [50,51]. In this study, the pro-inflammatory 
cytokine profile of ISS pigs clearly shifted metabolism toward a lipolytic state and this 
resulted in significantly less energy retained as lipid and decreased lipid deposition 
compared to non-immunologically challenged pigs.  
Complete blood count 
 Immune stimulation decreased WBC counts, specifically neutrophils, 
lymphocytes, and monocytes. This is similar to other instances of leukopenia observed 
due to LPS administration [11,52]. However, WBC distribution drastically changed 
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following LPS administration and circulating concentrations are dependent upon the time 
of sampling relative to immune challenge [52,53]. Thus, variable responses in WBC 
counts have been reported due to LPS immune stimulation. Rakhshandeh and de Lang 
observed 1.6 times greater WBC in one study [8], but in a second, WBC count decreased 
by 9% [54]. At the time of sampling in this study, leukocyte extravasation into the LPS 
injection site and into immunologically important tissues likely explains the observed 
leukopenia.    
Acute phase proteins 
 In addition to increased pro-inflammatory cytokine production and leukocyte 
migration that occur during infection, the acute phase response typically includes 
increased APP synthesis by the liver. However, in this study, ISS APP concentrations did 
not differ compared to CON. This was an unexpected result because LPS has been 
demonstrated to increase APPs such as haptoglobin [8,46] and C-reactive protein [55] in 
pigs. A less responsive APP, MBL has been demonstrated to attenuate LPS-induced pro-
inflammatory cytokine production [56] and inhibit T-lymphocyte activation [57]. 
However, in this study it did not appear that LPS induced greater MBL or haptoglobin 
production. 
Although a MBL response was not necessarily expected, a haptoglobin response 
was. Haptoglobin is a primary APP in pigs and is synthesized in the liver when activated 
by IL-6 and to a lesser extent IL-1 [58], both of which were significantly elevated in ISS 
pigs post-challenge. Similar to our results, Koopmans et al. [55] discussed unpublished 
data which showed no LPS effect on haptoglobin concentrations even though there were 
clear increases in plasma cortisol, TNF, IL-6, and C-reactive protein over a 24-h period 
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after LPS challenge. One possible explanation for a lack of haptoglobin response could 
be time related. Serum samples in this study were collected 4 h after the first challenge 
and haptoglobin may be a better indicator of chronic inflammation [59].  
Nitrogen balance  
 Disease is associated with decreased growth performance and changes in nutrient 
partitioning. Often, N metabolism is affected because of increasing AA requirements for 
immune cell proliferation and APP synthesis [51]. In this study, only numerical decreases 
in protein deposition were measured in ISS pigs compared to CON and ENZ. If protein 
catabolism had increased to provide AAs for APPs, an increase in urinary N would have 
been expected because APPs have a distinctly different AA profile than skeletal muscle 
[50,60]. However, due to the high dietary CP concentration, it is possible that these 
excessive dietary amino acids may have provided the additional amino acids required for 
APP synthesis and prevented the typically observed increase in skeletal muscle protein 
catabolism. 
Energy balance 
 Disease is well known to be detrimental to pig efficiency and productivity. A 
considerable amount of research has focused on products to mitigate the drop in 
performance [13,61] or prevent initial disease onset [62]. Yet few studies have evaluated 
the energetic cost of an immune challenge in order to generate more effective dietary 
interventions. In this study, total HP increased by 21.1% in ISS pigs compared to the 
ENZ treatment.  
Campos et al. [46] also evaluated HP components during an immune response and 
reported significant decreases in ADFI leading to decreased TEF compared to baseline 
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values. In this study DMI did not differ, potential feed intake effects on TEF were 
removed by interpreting the data after normalizing to a constant feed intake, and TEF 
values were not affected by ISS. Therefore, both experiments indicate that a chronic 
inflammatory response did not increase HP through increased TEF. This is supported by 
the lack of treatment differences in diet digestibility and further supports our supposition 
that the impact of immune stimulation on energy balance in this study is not through 
influences on diet digestion or nutrient uptake.  
However, it is clear that energy partitioning between maintenance and growth was 
affected by ISS. A 23.3% increase in MEm was detected due to ISS. As caloric 
requirements for maintenance increased to support the immune system, less dietary 
energy was retained for growth. This manifested as less REl resulting in a 30.2% decrease 
in lipid deposition. 
Previous studies across all species have related increased caloric requirements 
with fever [48,63], but few have directly related a chronic immune challenge with 
increased MEm. In vitro studies with isolated mitochondria from rats stimulated with 
TNF or IL-1 showed up to 30% increases in respiration rate [64]. Demas et al. [63] 
reported that mice injected with a mild antigen had limited immune activation that 
resulted in significantly more O2 consumption than control mice injected with saline. 
Interleukin-six infusions in humans increased resting metabolic rates by 25% [65].  
In pigs, the direct relationship between immune stimulation and increased energy 
requirements has not previously been demonstrated. Some studies reported that immune 
system stimulation did not impact growth, efficiency, or energy balance measurements 
[66,67] However, Moon et al. [66] reported fibroblast formation at the injection site 
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which encapsulated the immunogen and prevented systemic delivery. Williams et al. [67] 
used the comparative slaughter technique and reported no differences in the energetic 
costs of maintenance, PD, and LD between pigs raised in environments encouraging high 
or low chronic immune activation.  
Conversely, Labussière et al. [68] and Campos et al. [46] reported decreased HP 
in pigs during inflammatory challenges. Labussière et al. [68] administered a single 
injection of complete Freund’s adjuvant to young weaned pigs but did not measured HP 
until the day after challenge and only re-entered the calorimetry chamber after visual 
recovery [68]; and this likely biased the response. Campos et al. [46] reported a 14% 
decrease in total HP (kcal/BW0.60/d) in response to a repeated LPS challenge in growing 
pigs even though typical inflammatory-type and febrile responses were observed. 
Decreased HP was mainly attributed to lower TEF which reflected the effect of feed 
intake depression on HP. According to the relationship reported by Labussière et al. [25], 
lower ADFI should have decreased MEm by 24 kcal/BW0.60/d. Because this drop in MEm 
did not occur, the authors reasoned that the immune stimulation did in fact increase MEm 
relative to baseline [46]. This supports our experimental model of limit feeding to 
encourage similar feed intake and to evaluate energy balance on a kcal/BW0.60/DMI/d 
basis. Feed intake clearly influences and can bias HP results and interpretations. 
Interpretation of our results in context with the previously discussed reports 
suggests that an inflammatory response does increase MEm relative to healthy control 
animals, but in some experiments this response may be masked by decreased HP related 
to decreased feed intake. This may mean that during an immune response the total caloric 
requirement may not drastically change because of decreased feed intake, but how those 
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calories are partitioned does change; and this results in growth and feed efficiency 
depressions commonly observed during disease challenges.  
These results supported our hypothesis that energy partitioning shifts to allocate 
more energy for initiation and maintenance of immune functions and less toward nutrient 
deposition. Other research would support changes in N metabolism [46,67,69] whereas 
our data suggest that less energy was allocated for LD. Both result in decreased ADG and 
efficiency losses in pork production, yet these effects are generally given little 
consideration in commercial swine feeding practices.  
 
Conclusions 
This experiment provides novel data on -mannanase supplementation effects on 
immune parameters and energy balance in pigs. Beta-mannanase supplementation did not 
affect immune status, nutrient digestibility, growth performance, energy balance, or MEm 
in young pigs fed a corn, soybean meal, and soybean hulls-based diet. More research is 
needed to determine how -mannanase functions in pigs and in which environments and 
diets it might be effective. These novel data directly relate decreased ADG to increased 
MEm independent of changes in feed intake in immune challenged pigs. An innate 
immune challenge increased proinflammatory cytokine concentrations which induced a 
febrile response and elevated HP and MEm by 23.3%. Increased energy partitioning 
toward the immune response limited LD by 30.2% leading to a 18.3% decrease in ADG 
during the immune challenge. These data expand upon the available literature to describe 
the magnitude of increase in MEm in immune challenged pigs relative to healthy control 
animals. Understanding the extent to which energy requirements and nutrient deposition 
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change in pigs experiencing sustained immune stress may help develop more effective 
feeding strategies for health challenged herds and encourage appreciation for the 
economic benefits of maintaining high health populations. 
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Table 1. Summary of experimental treatments  
 Experimental treatment 
 
CON1 ENZ2 ISS3 
Diet Control Control + β-mannanase Control + β-mannanase 
β-mannanase inclusion No Yes Yes 
Challenge treatment Saline Saline E. coli LPS 
1Control treatment (CON) = pigs fed basal diet with no LPS (Escherichia coli serotype O55:B5) 
injection 
2Enzyme treatment (ENZ) = pigs fed enzyme diet (0.056% β-mannanase) with no LPS injection 
3Immune system stimulation treatment (ISS) = pigs fed enzyme diet (0.056% β-mannanase) with 
LPS injection 
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Table 2. Experimental diet ingredient and analyzed nutrient composition (as-fed basis)   
Item Control diet Enzyme diet 
Ingredient, % of diet   
Corn 47.33 47.27 
Soybean meal,  
(dehulled, solvent extracted) 
38.40 38.40 
Soybean hulls 10.00 10.00 
Soybean oil   1.85   1.85 
Limestone   1.04   1.04 
Monocalcium phosphate   0.60   0.60 
Vitamin premix1   0.33   0.33 
Trace mineral premix2   0.20   0.20 
Salt   0.25   0.25 
Hemicell HT-D3   0.00   0.06 
Calculated composition, % of diet   
SID Lys 1.18 1.18 
SID Met 0.32 0.32 
SID Thr 0.75 0.75 
SID Trp 0.26 0.26 
SID Cys + Met 0.62 0.62 
β-mannan5   1.33   1.33 
Analyzed composition, % of diet   
DM 86.75 87.17 
GE, Mcal/kg   4.03   4.00 
CP 22.28 21.83 
EE4   4.02   3.97 
Starch 29.34 30.89 
NDF 12.17 11.83 
ADF   6.97   6.79 
Endo-1,4-β-mannanase6, U/kg 
Below detectable 
limit 
150,000 
1Provided per kilogram of complete diet: 6,614 IU of vitamin A; 827 IU of vitamin D; 26 IU of vitamin 
E; 2.6 mg of vitamin K; 29.8 mg of niacin; 16.5 mg of pantothenic acid; 5.0 mg of riboflavin; 0.023 
mg of vitamin B12. 
2Provided per kilogram of complete diet: Zn, 165 mg as ZnSO4; Fe, 165 mg as FeSO4; Mn, 39 mg as 
MnSO4; Cu, 17 mg as CuSO4; I, 0.3 mg as Ca(IO3)2; and Se, 0.3 mg as Na2SeO3. 
3HemicellTM HT-D, Elanco Animal Health, Guelph, ON, Canada; endo-1,4-β-mannanase (160 × 106 
units/kg) from Paenibacillus alvei 
4Acid hydrolyzed ether extract 
5β-mannan concentration was calculated using values reported in Shastak et al. [70] 
6endo-1,4-β-mannanase activity. One U = the amount of enzyme which generates 0.72 micrograms of 
reducing sugars per minute from a mannose-containing substrate at pH 7.0 and temperature of 40°C. 
  
 
 
 
97 
 
Table 3. Complete blood count values in young weaned pigs fed a diet with or without -
mannanase1,2 
1Blood was collected on d 8 of the experiment 6 h post-feeding, prior to the immune challenge 
beginning on d 10. 
2n = 10 pigs per treatment 
3Control diet was a corn, soybean mean, and soy hulls based diet containing 1.33% β-mannans 
and did not contain β-mannanase enzyme. Pigs on the control (CON) treatment were fed the 
control diet and estimates are representative of the CON treatment only.  
4Enzyme diet was the control diet supplemented with 0.056% β-mannanase (HemicellTM HT-D, 
Elanco Animal Health, Guelph, ON, Canada; endo-1,4-β-mannanase (160 × 106 units/kg) from 
Paenibacillus alvei). Pigs on the enzyme (ENZ) and immune system stimulation (ISS) treatments 
were fed the enzyme diet. Estimates are representative of the ENZ and ISS treatments prior to 
immune stimulation.  
5Basophils (Baso); eosinophils (Eos); immature neutrophils (Bands); lymphocytes (Lymph); 
mature neutrophils (Neut); monocytes (Mono); white blood cells (WBC) 
Treatment 
Control diet3  -mannanase diet4  
Contrast 
P-value 
Estimate SEM 
 
Estimate SEM  
Cell type count 
(cells x109/L)5 
       
     Total cells 468.6 34.9  432.4 23.8  0.405 
     WBC 24.50 1.43  21.51 0.98  0.104 
          Neut 6.47 0.94  6.83 0.64  0.758 
          Bands 0.200 0.050  0.266 0.034  0.504 
          Eos 0.202 0.099  0.300 0.068  0.599 
          Baso 0.048 0.061  0.100 0.042  0.451 
          Lymph 15.35 1.46  12.46 1.00  0.124 
          Mono 0.727 0.181  0.709 0.123  0.934 
     RBC 7.44 0.14  7.55 0.09  0.547 
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Table 4. Effect of -mannanase on pig serum glucose, insulin, acute phase protein, and cytokine 
concentrations1,2 
1Blood was collected on d 8 of the experiment 6 h post-feeding, prior to the immune challenge 
beginning on d 10. 
2n = 10 pigs per treatment 
3Control diet was a corn, soybean mean, and soy hulls based diet containing 1.33% β-mannans 
and did not contain β-mannanase enzyme. Pigs on the control (CON) treatment were fed the 
control diet and estimates are representative of the CON treatment only.  
4Enzyme diet was the control diet supplemented with 0.056% β-mannanase (HemicellTM HT-D, 
Elanco Animal Health, Guelph, ON, Canada; endo-1,4-β-mannanase (160 × 106 units/kg) from 
Paenibacillus alvei). Pigs on the enzyme (ENZ) and immune system stimulation (ISS) treatments 
were fed the enzyme diet. Estimates are representative of the ENZ and ISS treatments prior to 
immune stimulation.  
5Mannose binding lectin A (MBL) 
6Granulocyte-macrophage colony-stimulating factor (GM-CSF); interleukin-1α (IL-1α); 
interleukin-1 (IL-1); interleukin-1 receptor antagonist (IL-1ra); interleukin-2 (IL-2); 
interleukin-4 (IL-4); interleukin-6 (IL-6); interleukin-8 (IL-8); interleukin-10 (IL-10); 
interleukin-12 (IL-12); interleukin-18 (IL-18); tumor necrosis factor alpha (TNFα) 
Treatment 
Control diet3  Enzyme diet4  Contrast 
P-value Estimate SEM  Estimate SEM  
Glucose, mmol/L 7.70 0.46  7.41 0.25  0.585 
Insulin, pmol/L 88.92 10.99  83.35 6.06  0.664 
Insulin:Glucose 11.56 1.21  11.08 0.67  0.734 
Acute phase protein, mg/mL         
     Haptoglobin 1.57 0.22  1.02 0.14  0.050 
     MBL5 125.4 8.6  117.5 5.2  0.445 
Cytokine, pg/mL6         
     GM-CSF 17.01 13.01  14.56 7.85  0.874 
     IL-1 35.01 6.81  7.50 4.27  0.004 
     IL-1 1064 598  1138 361  0.917 
     IL-1ra 428.6 257.5  673.7 161.5  0.435 
     IL-2 328.4 157.6  228.8 95.0  0.596 
     IL-4 995.5 545.6  711.6 329.0  0.662 
     IL-6 190.2 61.5  98.72 38.59  0.230 
     IL-8 263.1 95.4  402.2 57.5  0.230 
     IL-10 499.4 159.1  332.9 95.9  0.383 
     IL-12 1570 173  1730 104  0.439 
     IL-18 1994 546  1380 329  0.350 
     TNF 24.29 39.90  52.30 25.02  0.563 
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Table 5. Apparent total tract digestibility (ATTD) in pigs on the control, enzyme, or immune 
system stimulation treatment1   
Item CON2 ENZ3 ISS4 SEM 
Treatment 
P-value 
ATTD5, % 
     
     DM 88.05 87.36 87.66 0.33 0.356 
     GE 87.35 86.73 86.86 0.33 0.418 
     CP 87.59 86.47 86.77 0.44 0.212 
     EE6 70.41 69.62 66.85 1.18 0.122 
     Starch 99.41 99.50 99.56 0.10 0.565 
     NDF 68.81 66.11 70.23 1.55 0.178 
     ADF 71.65 68.04 74.13 2.26 0.175 
     Hemicellulose7 65.00 63.51 64.99 0.92 0.429 
1n = 10 pigs per treatment 
2Control treatment (CON) = pigs fed basal diet (0.0% β-mannanase) with saline injection 
3Enzyme treatment (ENZ) = pigs fed enzyme diet (0.056% β-mannanase) with saline injection 
4Immune system stimulation treatment (ISS) = pigs fed enzyme diet (0.056% β-mannanase) with 
LPS (Escherichia coli serotype O55:B5) injection 
5ATTD, % = [(nutrient intake (kg) – fecal nutrient output (kg)) / nutrient intake (kg)] × 100 
6Acid hydrolyzed ether extract 
7Hemicellulose = NDF - ADF 
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Table 6. Growth performance and nitrogen balance in pigs on control, enzyme, or immune 
system stimulation treatment1   
Item CON2 ENZ3 ISS4 SEM 
Treatment 
P-value 
Body Weight, kg 
     
     d 0 10.23 10.21 10.38 0.15 0.651 
     d 16 15.25 15.26 14.86 0.27 0.471 
ADG d 1-16, g/d 313.9 316.0 279.7 13.6 0.128 
Nitrogen (N) balance, g/d 
     
     Intake 21.02a 20.93a 17.38b 0.95 0.021 
     Excreted 6.21 7.08 6.24 0.45 0.318 
          in feces 2.62a 2.83a 2.27b 0.11 0.007 
          in urine 3.59 4.25 3.97 0.47 0.624 
     Retained 14.81a 13.85ab 11.14b 0.99 0.045 
% of excreted N in feces 41.31 41.21 38.42 3.29 0.778 
% of excreted N in urine 58.69 58.79 61.58 3.29 0.778 
Nitrogen balance, % of 
intake      
     Excreted in feces 12.41 13.54 13.23 0.44 0.212 
     Excreted in urine 17.38 21.40 24.56 4.14 0.495 
a,bWithin a row, treatment means without a common superscript differ, P < 0.05. 
1n = 10 pigs per treatment 
2Control treatment (CON) = pigs fed basal diet (0.0% β-mannanase) with saline injection 
3Enzyme treatment (ENZ) = pigs fed enzyme diet (0.056% β-mannanase) with saline injection 
4Immune system stimulation treatment (ISS) = pigs fed enzyme diet (0.056% β-mannanase) with 
LPS (Escherichia coli serotype O55:B5) injection
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Table 7. Effect of treatment on energy balance, respiratory quotient, maintenance energy 
requirements, and nutrient deposition1 
  Treatment  
P-value 
Item CON2 ENZ3 ISS4 SEM  
d 16 BW, kg 14.37 14.19 13.77 0.26  0.313 
d 16 DMI, kg 0.51 0.51 0.46 0.03  0.348 
Energy, kcal/kg BW0.60/kg DMI/d 
    
 
 
     ME intake 771.3 755.9 751.1 37.7  0.924 
     Heat production5     
 
 
          HPtotal 278.8b 274.9b 333.0a 14.9  0.040 
          FHPtotal 287.8 276.0 324.3 17.1  0.178 
          FHP 207.8 206.6 243.3 12.9  0.135 
     Retained energy6 
    
 
 
          As protein 197.5 173.6 191.0 18.3  0.627 
          As lipid 291.4a 302.9a 227.7b 19.2  0.046 
          Total 488.9 476.5 418.7 32.0  0.318 
     kmg, % 87.07 86.44 83.01 1.34  0.130 
     Estimated MEm 239.0b 239.5b 295.5a 15.3  0.045 
Retained energy, % of ME intake 
    
 
 
          As protein 25.68 23.15 24.99 1.27  0.354 
          As lipid 37.77a 40.07a 29.81b 2.02  0.013 
          Total 63.44a 63.22a 54.80b 2.18  0.033 
Respiratory quotient 
    
 
 
     Fed state 0.92 0.90 0.88 0.01  0.225 
     Fasting state 0.74 0.73 0.73 0.01  0.381 
Nutrient deposition7, g/d 
    
 
 
     As protein 87.74 78.55 69.80 5.86  0.150 
     As lipid 76.22a 79.43a 55.45b 6.21  0.047 
ADG d 10-16, g/d 447.1a 404.8a 330.7b 21.3  0.010 
a,bWithin a row, treatment means without a common superscript differ, P < 0.05. 
1n = 7 pigs per treatment (CON and ENZ) and 6 pigs per treatment (ISS) 
2Control treatment (CON) = pigs fed basal diet (0.0% β-mannanase) with saline injection 
3Enzyme treatment (ENZ) = pigs fed enzyme diet (0.056% β-mannanase) with saline injection 
4Immune system stimulation treatment (ISS) = pigs fed enzyme diet (0.056% β-mannanase) with LPS 
(Escherichia coli serotype O55:B5) injection 
5Heat production (HP) = (3.87 × O2 consumption (L) + 1.20 × CO2 production (L) – 1.43 × urinary 
N)/BW0.60 (kg) [22]; Total HP (HPtotal)= avg. HP over 22 h fed state, post- challenge; Total fasting HP 
(FHPtotal) = avg. HP over 12 h fasted state; Fasting HP (FHP) = avg. of 10 lowest HP values over the 12 h 
fasted state [27,28]; HP10 = avg. HP over 10 h post-challenge (1000 h – 2000 h), fed state; HPlow = avg. of 
10 lowest HP values over 10 h  post-challenge (1000 h – 2000 h), fed state;  Activity HP (AHP) = HP10 - 
HPlow; Thermic effect of feeding (TEF) = HP10 - AHP – FHP; Heat increment (HI) = AHP + TEF; ME 
efficiency for maintenance and growth (kmg) = (1 – HI) × 100 [25]; ME used for maintenance (MEm) = 
FHP × 100/kmg [25] 
6Retained energy (RE) = ME intake – total fed-state HP, pre-and post-challenge [29]; RE as protein (REp) 
= [PD (g) × 5.66 (kcal/g)]/ BW0.60/DMI [30]; RE as lipid (REl) = RE - REp [30] 
7Protein deposition (PD) nitrogen retention (g) × 6.25; Lipid deposition = REl (kcal) / 9.49 (kcal/g) [30] 
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Table 8. Dietary energy values and efficiency in pigs on control, enzyme, or immune system 
stimulation treatment1 
  Treatment  Treatment 
P-value Item CON
2 ENZ3 ISS4 SEM  
Dietary energy value5, Mcal/kg DM     
 
 
     GE 4.65 4.59 4.59 
 
 
 
     DE 4.07 3.99 4.00 0.02  0.051 
     ME 3.96 3.86 3.89 0.03  0.052 
     NE 3.29 3.30 3.11 0.19  0.748 
ME/DE efficiency, % 97.31 96.92 97.35 0.37  0.457 
NE/ME efficiency, % 83.09 85.31 80.03 4.42  0.701 
1n = 7 pigs per treatment (CON and ENZ) and 6 pigs per treatment (ISS) 
2Control treatment (CON) = pigs fed basal diet (0.0% β-mannanase) with saline injection 
3Enzyme treatment (ENZ) = pigs fed enzyme diet (0.056% β-mannanase) with saline injection 
4Immune system stimulation treatment (ISS) = pigs fed enzyme diet (0.056% β-mannanase) with 
LPS (Escherichia coli serotype O55:B5) injection 
5Gross energy (GE) analyzed via bomb calorimetry; digestible energy (DE) = GE apparent total 
tract digestibility coefficient × diet GE; metabolizable energy (ME) = DE – (urinary energy + 
0.4% of DE intake); net energy (NE) = (retained energy + fasting heat production)/DMI. 
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Figure 1. Effect of treatment on young weaned pig (n = 10 per treatment) rectal temperature 
(C). Control treatment (CON) = pigs fed basal diet (0.0% β-mannanase) with saline injection. 
Enzyme treatment (ENZ) = pigs fed enzyme diet (0.056% β-mannanase) with saline injection. 
Immune system stimulation treatment (ISS) = pigs fed enzyme diet (0.056% β-mannanase) with 
LPS (Escherichia coli serotype O55:B5) injection. The arrows indicate days on which either a 
saline (CON and ENZ) or LPS (ISS) injection were administered at 1000 h. Rectal temperatures 
were measured 4 h post-challenge. Data points on d 5 and 8 represent average baseline pre-
challenge temperature, and d 10, 12, and 14 represent post-challenge temperatures. Treatment by 
day interaction P < 0.0001; day P < 0.0001; treatment P < 0.0001; block P = 0.0015. 
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Figure 2. Effect of treatment on complete blood count before (d 8) and after (d 10) challenge. 
Serum was collected at 1400 h each day (4 h post- challenge). Control treatment (CON) = pigs 
fed basal diet (0.0% β-mannanase) with saline injection. Enzyme treatment (ENZ) = pigs fed 
enzyme diet (0.056% β-mannanase) with saline injection. Immune system stimulation treatment 
(ISS) = pigs fed enzyme diet (0.056% β-mannanase) with LPS (Escherichia coli serotype 
O55:B5) injection. n=10 per treatment. a,bWithin a graph, bars without a common superscript 
differ, P < 0.05. 
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Figure 3. Effect of treatment on serum cytokine concentrations before (d 8) and after (d 10) 
challenge. Serum was collected at 1400 h each day (4 h post- challenge). Control treatment 
(CON) = pigs fed basal diet (0.0% β-mannanase) with saline injection. Enzyme treatment (ENZ) 
= pigs fed enzyme diet (0.056% β-mannanase) with saline injection. Immune system stimulation 
treatment (ISS) = pigs fed enzyme diet (0.056% β-mannanase) with LPS (Escherichia coli 
serotype O55:B5) injection. n=10 per treatment. a,bWithin a graph, bars without a common 
superscript differ, P < 0.05. 
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CHAPTER III 
BETA-MANNANASE SUPPLEMENTATION EFFECTS ON NURSERY PIG 
GROWTH PERFORMANCE AND SERUM ACUTE PHASE PROTEIN 
CONCENTRATIONS 
 
Modified from a paper submitted to the Journal of Animal Science 
 
N. F. Huntley*, S. A. Gould*, J. F. Patience* 
*Department of Animal Science, Iowa State University, Ames, 50011, USA 
 
Abstract 
 Dietary -mannans resemble carbohydrate structures on pathogen surfaces that 
may activate the innate immune system. Beta-mannanase supplementation has been 
proposed to prevent potential immune stimulation and spare energy for growth. The 
objective of this experiment was to evaluate the effects of dietary mannan level, -
mannanase supplementation, and their interaction on growth performance, feed 
efficiency, and serum acute phase protein (APP) concentrations in nursery pigs. Pigs (n = 
480, 10 pigs per pen) were blocked by initial BW and pens (n = 12 per treatment) were 
randomly assigned to 1 of 4 treatments in a 2  2 factorial arrangement for a 28-d 
experiment with 3 phases. Two levels of dietary mannan were achieved by replacing part 
of the corn and soybean meal in the low mannan diet (0.4% -mannan) with copra meal 
for a high mannan diet (2.8% -mannan). Each diet was fed with and without 0.05% 
endo-1,4--mannanase (Hemicell HT 1.5, Elanco Animal Health). Serum was collected 
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(1 pig/pen) for haptoglobin and C-reactive protein (CRP) analysis prior to treatment 
initiation (d 0) and on d 28. Data were analyzed as a 2 x 2 factorial design with main 
effects of mannan level and -mannanase supplementation. There were no significant 
interactions between mannan level and -mannanase supplementation overall (d 0 to 28; 
P = 0.852) or within each phase (P ≥ 0.106). Overall, high mannan diets decreased ADG 
(0.37 vs. 0.38 kg/d; P = 0.027) and ADFI (0.52 vs. 0.54 kg/d; P = 0.024) compared to 
low mannan diets. There were no significant -mannanase effects on growth performance 
or feed efficiency (P > 0.10). Serum APP concentrations were similar among treatments 
at baseline. At d 28 haptoglobin concentrations were lower (P ≤ 0.0001) and CRP 
concentrations were greater (P ≤ 0.0001) compared to baseline values, but neither was 
affected by mannan level or -mannanase supplementation (P ≥ 0.160). Beta-mannanase 
supplementation tended to increase serum CRP in the high mannan diet (290.64 g/ml) 
compared to the low diet (243.49 g/ml; P = 0.0791) with no differences compared to 
when the enzyme was not supplemented (avg. = 273.91 g/ml). In conclusion, dietary -
mannan concentrations as high as 2.8% did not induce a systemic innate immune 
response in nursery pigs. The levels of -mannan found in practical, commercial-type 
swine diets are not likely to induce an immune response and supplementation of -
mannanase for this purpose is not warranted. 
 
Introduction 
 Certain dietary carbohydrate components, such as β-mannans, have been 
hypothesized to induce innate immune system activation by mimicking bacterial cell wall 
structures [1–3]. Beta-mannans are found in feed ingredients such as soybean meal 
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(SBM), palm kernel meal, and copra meal in varying concentrations [4]. If feed-induced 
immune stimulation occurs it may decrease dietary energy partitioning toward productive 
processes such as growth [5], and exogenous β-mannanase enzymes have been developed 
to theoretically inhibit this innate immune stimulation. In poultry, β-mannanase 
supplementation decreased serum acute phase proteins (APP), thus ameliorating systemic 
inflammatory stress in broilers [6]. However, this response has yet to be demonstrated in 
pigs. 
Beta-mannanase supplementation responses in pigs have been variable [7–10]. 
Previous research in our laboratory evaluated β-mannanase supplementation in a corn, 
SBM, and soy hulls-based diet and found no effects on diet digestibility, nitrogen 
balance, maintenance energy requirements, or systemic innate immune response variables 
[5]. Thus, the results did not support the hypothesis that β-mannanase supplementation 
ameliorates an innate immune response induced by soybean β-mannans at a concentration 
of 1.3% of the diet. It is possible, however, that this concentration was too low to either 
effectively stimulate a systemic inflammatory response or to be able to measure the 
effects of β-mannanase supplementation. To test this hypothesis, the objectives of this 
study were to evaluate the impact and interactions of dietary β-mannan concentration and 
β-mannanase supplementation on serum APP, as indicators of systemic immune 
activation, and on growth performance in nursery pigs. 
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Materials and methods 
 All experimental procedures adhered to guidelines for the ethical and humane use 
of animals for research and were approved by the Iowa State University Institutional 
Animal Care and Use Committee (IACUC #5-16-8263-S). 
Animals, housing, and experimental design 
 A total of 480 weanling pigs (6.6 ± 0.4 kg BW; Genetiporc 6.0 × Genetiporc F25, 
PIC, Inc., Hendersonville, TN) were purchased and transported to the Iowa State 
University Swine Nutrition farm. Upon arrival, pigs were individually weighed, ear-
tagged, and vaccinated for porcine reproductive and respiratory syndrome virus, and 
Escherichia coli. Pigs were blocked by initial weight and pens were randomly assigned to 
1 of 4 dietary treatments. There were 10 pigs per pen and 12 pens per treatment. Sexes 
were not separated but there were the same number of barrows and gilts per treatment 
within each block.  
Diets and feeding 
 Pens (1.2 m × 2.4 m) had a four-space self-feeder and 2 nipple waterers to provide 
ad libitum access to feed and water. Pigs were fed a common diet for 7 d post weaning; 
the experimental diets were then fed in 3 phases over 28 d. Phases 1 and 2 each were 
offered for 7 d each and phase 3 for 14 d. Diets were formulated to meet or exceed NRC 
(2012) nutrient recommendations and were formulated to provide equal ME:SID lysine 
concentrations. Treatments were arranged as a 2 × 2 factorial of dietary -mannan level 
(low or high) and -mannanase supplementation (positive or negative). Two levels of 
dietary mannan were achieved by replacing a proportion of the corn and soybean meal in 
the low mannan diet (0.4% -mannan; Table 1) with copra meal for a high mannan diet 
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(2.8% -mannan; Table 2). Diet -mannan concentration was calculated based on 
ingredient -mannan concentrations [12–14]. Beta-mannanase (Hemicell HT-1.5, Elanco 
Animal Health, Greenfield, IN; endo-1,4-β-mannanase (EC 3.2.1.78; 160 x 106 units/kg) 
from Bacillus lentus) was supplemented at 0.05% of the diet. One β-mannanase unit of 
activity is defined as the amount of enzyme that generates 0.72 g of reducing sugars per 
min from a mannose-containing substrate at pH 7.0 and 40C.  
Sample collection 
Pig BW and feed intake were measured on d 0, 7, 14, 21, and 28 of the 
experiment to calculate ADG, ADFI, and G:F for each phase. On d 0 (baseline) and d 28 
serum was collected from 1 barrow per pen (the same pig at each time point) via jugular 
venipuncture. Blood was allowed to clot, and serum was separated by centrifugation 
(2000 × g for 15 min at 4°C), collected and divided into two subsamples, and stored at -
80°C until analysis. Diet subsamples were collected during mixing. 
Analytical methods 
Diets were ground to 1 mm particle size and analyzed in duplicate for DM 
(method 930.15) and acid-hydrolyzed ether extract (aEE; method 2003.06) using 
standard methods [15]; and in triplicate for NDF [16] and ADF [17]. Diets were analyzed 
in duplicate for nitrogen (N; method 990.03 [15]; TruMac; LECO Corp., St. Joseph, MI). 
An EDTA sample (9.56% N) was used as the standard for calibration and was determined 
to contain 9.55 ± 0.01% N. Crude protein was calculated as N  6.25. Gross energy was 
determined in duplicate using an isoperibol bomb calorimeter (model 6200; Parr 
Instrument Co., Moline, IL). Benzoic acid (6318 kcal GE/kg; Parr Instrument Co.) was 
used as the standard for calibration and was determined to contain 6316 ± 0.9 kcal 
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GE/kg. Diets were analyzed in duplicate for β-mannanase concentration (colorimetric 
determination, Elanco Animal Health, Gaithersburg, MD).  
Serum subsamples were analyzed in duplicate for haptoglobin and C-reactive 
protein (CRP) using porcine specific commercially available kits according to the 
manufacturer’s instructions (Immunology Consultants Laboratory, Inc., Portland, OR). 
The intra- and inter-assay coefficients of variation for haptoglobin and CRP were 4.9 and 
16.0%, and 3.6 and 9.9%, respectively.  
Statistical analysis 
Data were analyzed as a 2 × 2 factorial in a randomized complete block design to 
test the main effects and interaction of dietary mannan level and -mannanase 
supplementation. Data were analyzed with pen as the experimental unit and block as a 
random variable using the MIXED procedure of SAS (SAS Institute Inc., Cary, NC). 
Differences among treatments were determined using ANOVA and means were separated 
using the least square means statement and the PDIFF option. Serum APP data were log 
transformed and analyzed as repeated measures with compound symmetry covariance 
structure. Differences were considered significant if P was ≤ 0.05 and a tendency if P was 
> 0.05 and ≤ 0.10. 
 
Results 
Growth performance 
There were no significant interactions between mannan level and -mannanase 
supplementation overall (d 0 to 28) or within each phase (Table 6). Pig BW did not differ 
among treatments on d 0, 7, or 14, but pigs fed the low mannan diets, independent of -
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mannanase inclusion, tended to weigh more on d 21 and 28 (Table 6). This tendency for 
BW differences during phase 3 was driven by increased ADG in the low mannan 
treatments during d 15 – 21 (P = 0.015; Table 6). During this time, feed intake was also 
greater (P = 0.007) for pigs fed low mannan diets, corresponding to no differences in G:F 
(P = 0.834; Table 6).  
Overall (d 0 – 28), pigs fed low mannan diets had greater ADG and ADFI 
compared to pigs fed high mannan diets (P ≤ 0.027) and feed efficiency did not differ (P 
= 0.653; Table 6). Beta-mannanase inclusion did not impact BW or growth performance 
throughout the entire experiment or within each phase (P ≥ 0.106; Table 6). 
Acute phase proteins 
 Serum APP concentrations were similar among treatments at baseline (P ≥ 0.20). 
On d 28, haptoglobin concentrations were lower (P ≤ 0.0001; Fig. 1) and CRP 
concentrations were greater (P ≤ 0.0001; Fig. 2) compared to baseline values, but neither 
were affected by mannan level or -mannanase supplementation (P ≥ 0.160). Beta-
mannanase supplementation tended to increase serum CRP in the high mannan diet 
(290.64  20.10 g/ml) compared to the low mannan diet (243.49  20.10 g/ml) with no 
differences compared to when the enzyme was not supplemented (avg. = 273.91  20.10 
g/ml; P = 0.0791). 
 
Discussion 
 This experiment evaluated the interaction of dietary -mannan level and -
mannanase supplementation on nursery pig growth performance and serum acute phase 
protein concentrations and tested the hypotheses that dietary -mannans induce an innate 
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immune response in nursery pigs and that -mannanase supplementation alleviates this 
response [6,18]. Understanding if, or how, this response occurs in pigs is important 
because a perceived immune challenge can partition energy and nutrients away from 
productive processes such as muscle growth and negatively impact the efficiency and 
cost of meat production [5,19,20]. In the face of a true pathogen challenge, this is a 
desirable response to maintain animal health and survival. However, β-mannan in 
soybean, copra, and palm kernel meals resemble carbohydrate structures on pathogen 
surfaces [21] and may induce an unproductive and undesirable innate immune response, 
termed a feed-induced immune response (FIIR).  
 Beta-mannans are components of hemicellulose in the plant cell wall and are 
linear polysaccharides comprised of repeating β-(1,4)-linked D-mannose units with 
galactose and/or glucose substitutions [22]. Specifically, galactomannans (α-(1,6)-linked 
D-galactose residues attached to mannose residues within the β-(1,4)-mannan backbone) 
are the type of mannans in the endosperm of legume plant seeds such as soybeans [22]. 
As a constituent of hemicellulose, β-mannans are not digested by mammalian 
endogenous enzymes. Thus, intact β-mannans may be available to bind carbohydrate 
recognition domains of pattern recognition receptors on innate immune cells surveying 
the intestinal epithelium for potential pathogens [1,23,24]. It is hypothesized that in this 
way, β-mannan may be capable of stimulating innate immune cells resulting in a 
nonproductive, energy-draining, inflammatory immune response [2,3,6]. One component 
of innate immune activation is the acute phase response, which is characterized by 
dramatic changes in the concentration of APP, such as haptoglobin and CRP.  
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 The initial FIIR descriptions were in poultry and reported increased macrophage 
and lymphocyte proliferation [25] and plasma APP concentrations [6] due to increasing 
dietary SBM inclusion. This response was then attenuated by the addition of -
mannanase and was supported by improvements in feed efficiency [6,25]. It was 
hypothesized that the hydrolyzed manno-oligosaccharides no longer retained the degree 
of polymerization necessary to stimulate and cross-link multiple mannose receptors, thus 
reducing innate immune stimulation.  
 However, there is a paucity of data regarding immune responses of pigs when 
dietary -mannan and -mannanase are supplemented, and a -mannan-derived FIIR has 
yet to be demonstrated. This study provides novel data on the interaction of dietary β-
mannan level and β-mannanase enzyme supplementation on nursery pig serum APP 
concentrations, as a measure of systemic immune stress. If an immune response to β-
mannan had occurred, both CRP and haptoglobin concentrations would have been 
expected to increase substantially [26]. The main effect of dietary mannan level did not 
impact concentrations of either APP, indicating that an acute phase response was not 
detected in pigs fed the high mannan diet. The changes in APP concentrations from 
baseline to d 28 were likely due to time, age of the pig, or other environmental factors 
that equally affected each treatment.  
 Similarly, there was no interaction between the effects of mannan level and -
mannanase supplementation on serum ACP concentrations. Had an innate immune 
response occurred in either or both diets, it would have been expected that -mannanase 
supplementation would prevent immune stimulation and decrease serum haptoglobin and 
CRP, and this response would have been exaggerated in the high-mannan diets due to the 
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greater amount of substrate for the enzyme. Thus, it was concluded that dietary -mannan 
concentrations as high as 2.8% did not induce a systemic innate immune response in 
nursery pigs. However, because diets with different -mannan concentrations were 
achieved by replacing corn and SBM with copra meal, a specific ingredient effect, 
separate from a -mannan nutrient effect, cannot be ruled out. 
 The results of this experiment corroborate data from Huntley et al. [5] which 
indicated that -mannanase supplementation did not impact nursery pig serum 
proinflammatory cytokines, haptoglobin, or mannose-binding lectin concentrations. 
Furthermore, there were no differences in maintenance energy requirements between 
control and -mannanase supplemented pigs, supporting the conclusion that -mannanase 
did not prevent an energy-draining immune response. It is possible that a localized 
response may have occurred at the level of the intestines but was not detected 
systemically. However, if this did occur, the response did not impact energy partitioning 
or decrease growth or feed efficiency. Interpreted together, the data from Huntley et al. 
[5] and the current study indicate that the levels of -mannan found in practical, 
commercial-type swine diets are not likely to induce a FIIR and supplementation of -
mannanase for this purpose is not warranted.    
 While -mannan did not induce an innate immune response, increasing its 
inclusion in nursery diets certainly decreased ADFI and ADG in line with responses 
expected from feeding higher fiber diets [27]. Inclusion of high-fiber co-products in 
commercial swine diets is continually increasing and carbohydrase enzymes have been 
developed to reduce the detrimental effects of fiber on nutrient and energy digestibility, 
as well as improve growth and feed efficiency. For this purpose, -mannanase has had 
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variable effects when supplemented in swine diets, and results seem to depend on pig 
age, diet ingredient composition, and enzyme inclusion level.  
 In this experiment, -mannanase supplementation did not affect growth 
performance or feed efficiency in either the high or low mannan diets. Similarly, other 
studies have reported no -mannanase effects on growth performance and feed efficiency 
[7,10,28], or nutrient and energy digestibility [5,28,29]. Yet, others have reported 
improvements in these measurements due to -mannanase supplementation [8–10] and 
data from Kim et al. [30] indicate that -mannanase supplementation effectively 
improved DM, GE, and -mannan digestibility as well as growth performance and feed 
efficiency, regardless of the amount of -mannan in the diet. More research is needed to 
better understand the circumstances in which -mannanase supplementation is effective. 
Furthermore, data from this experiment and others do not support the hypothesis that -
mannanase prevents a -mannan-induced immune response.   
 
Conclusions 
In conclusion, the high mannan diet decreased ADFI and thus, decreased ADG by 
2.7% compared to the low mannan diet with no apparent effect on serum haptoglobin or 
CRP concentrations. This experiment provides immune data previously lacking in pig 
growth trials assessing -mannanase efficacy. Beta-mannanase supplementation had no 
impact on growth performance and did not affect haptoglobin or CRP concentrations 
differently in high compared to low mannan diets. Thus, the data do not support the 
hypothesis that the level of -mannan found in practical swine diets induces an innate 
immune response or that -mannanase supplementation may prevent such a response. 
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Table 1. Ingredient composition (as-fed basis) of the low mannan diets for phases 1 - 31 
Ingredient, % Phase 1 Phase 2 Phase 3 
Corn 51.69 51.04 49.75 
Reduced-oil corn DDGS 10.00 12.50 15.00 
Fish meal 5.00 4.00 3.00 
Soybean meal 25.00 25.00 25.00 
Soybean oil 4.20 3.50 3.20 
Limestone 1.10 1.15 1.20 
Monocalcium phosphate 0.60 0.55 0.55 
L-Lysine-HCl 0.50 0.43 0.45 
DL-Methionine 0.08 0.06 0.10 
L-Threonine 0.15 0.15 0.11 
L-Tryptophan 0.05 0.04 0.04 
L-Valine 0.05 0.00 0.00 
Vitamin premix2 0.25 0.25 0.25 
Trace mineral premix3 0.20 0.20 0.20 
Denagard4 0.18 0.18 0.00 
Aureomycin5 0.40 0.40 0.00 
Mecadox 2.56 0.00 0.00 0.20 
Salt 0.50 0.50 0.50 
Choline chloride, 60% 0.05 0.05 0.05 
Titanium dioxide 0.00 0.00 0.40 
For the enzyme positive diet, -mannanase (Hemicell HT 1.5, Elanco Animal Health, 
Greenfield, IN; endo-1,4-β-D-mannanase from Bacillus lentus with not less than 237 
million units per kg of product) was included at 0.05% at the expense of corn.  
1Phase 1 = d 0 – 7; Phase 2 = d 8 – 14; Phase 3 = d 15 - 28 
2Provided 6,614 IU vitamin A, 827 IU vitamin D, 26 IU vitamin E, 2.6 mg vitamin K, 
29.8 mg niacin, 16.5 mg pantothenic acid, 5.0 mg riboflavin, and 0.023 mg vitamin B12 
per kg of diet.  
3Provided 165 mg Zn (zinc sulfate), 165 mg Fe (iron sulfate), 39 mg Mn (manganese 
sulfate), 17 mg Cu (copper sulfate), 0.3 mg I (calcium iodate), and 0.3 mg Se (sodium 
selenite) per kg of diet.  
4Denagard 10 (tiamulin, 0.22 g per kg), Elanco Animal Health, Greenfield, IN 
5Aureomycin (chlortetracycline (0.44 g per kg diet), Zoetis Inc., Kalamazoo, MI 
6Mecadox 2.5 (carbadox), Phibro Animal Health Corp., Ridgefield Park, NJ 
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Table 2. Ingredient composition (as-fed basis) of the high mannan diets for phases 1 - 31 
Ingredient, % Phase 1 Phase 2 Phase 3 
Corn 45.79 45.30 44.23 
Reduced-oil corn DDGS 10.00 12.50 15.00 
Fish meal 5.00 4.00 3.00 
Soybean meal 20.00 20.00 20.00 
Copra meal 10.00 10.00 10.00 
Soybean oil 4.80 4.10 3.70 
Limestone 1.20 1.15 1.10 
Monocalcium phosphate 0.70 0.55 0.50 
L-Lysine-HCl 0.60 0.55 0.57 
DL-Methionine 0.07 0.07 0.09 
L-Threonine 0.17 0.15 0.15 
L-Tryptophan 0.06 0.05 0.06 
L-Valine 0.03 0.00 0.00 
Vitamin premix2 0.25 0.25 0.25 
Trace mineral premix3 0.20 0.20 0.20 
Denagard4 0.18 0.18 0.00 
Aureomycin5 0.40 0.40 0.00 
Mecadox 2.56 0.00 0.00 0.20 
Salt 0.50 0.50 0.50 
Choline chloride, 60% 0.05 0.05 0.05 
Titanium dioxide 0.00 0.00 0.40 
For the enzyme positive diet, -mannanase (Hemicell HT 1.5, Elanco Animal Health, 
Greenfield, IN; endo-1,4-β-D-mannanase from Bacillus lentus with not less than 237 
million units per kg of product) was included at 0.05% at the expense of corn.  
1Phase 1 = d 0 – 7; Phase 2 = d 8 – 14; Phase 3 = d 15 - 28 
2Provided 6,614 IU vitamin A, 827 IU vitamin D, 26 IU vitamin E, 2.6 mg vitamin K, 
29.8 mg niacin, 16.5 mg pantothenic acid, 5.0 mg riboflavin, and 0.023 mg vitamin B12 
per kg of diet.  
3 Provided 165 mg Zn (zinc sulfate), 165 mg Fe (iron sulfate), 39 mg Mn (manganese 
sulfate), 17 mg Cu (copper sulfate), 0.3 mg I (calcium iodate), and 0.3 mg Se (sodium 
selenite) per kg of diet.  
4Denagard 10 (tiamulin, 0.22 g per kg), Elanco Animal Health, Greenfield, IN 
5Aureomycin (chlortetracycline (0.44 g per kg diet), Zoetis Inc., Kalamazoo, MI 
6Mecadox 2.5 (carbadox), Phibro Animal Health Corp., Ridgefield Park, NJ 
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Table 3. Phase 1 diet formulated and analyzed energy and nutrient composition (as-fed 
basis) 
 Low mannan diet High mannan diet 
 - enzyme + enzyme - enzyme + enzyme 
Formulated composition     
     ME, Mcal/kg 3.46 3.46 3.46 3.46 
     SID amino acid, %     
          Lys 1.38 1.38 1.37 1.37 
          Met 0.42 0.42 0.40 0.40 
          Total sulfur AA 0.74 0.74 0.74 0.74 
          Thr 0.83 0.83 0.81 0.81 
          Trp 0.26 0.26 0.26 0.26 
     Ca, % 0.81 0.81 0.85 0.85 
     STTD P, % 0.41 0.41 0.44 0.44 
Analyzed composition     
     DM, % 90.43 89.99 90.93 90.91 
     GE, Mcal/kg 4.16 4.16 4.32 4.33 
     CP, % 22.70 22.15 21.77 20.85 
     aEE1, % 7.62 7.41 8.78 8.37 
     NDF, % 9.21 8.88 12.90 13.01 
     ADF, % 3.58 3.47 5.04 5.89 
     -mannanase2, 3, U/kg 
< detection 
limit 
345,000 
< detection 
limit 
355,000 
1Acid-hydrolyzed ether extract (aEE) 
2Endo-1,4-β-mannanase (EC 3.2.1.78); 1 U = the amount of enzyme which generates 
0.72 g of reducing sugars per min from a mannose-containing substrate at pH 7.0 and 
40C 
3The limit of detection for feed samples was 45,000 U/kg 
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Table 4. Phase 2 diet formulated and analyzed energy and nutrient composition (as-fed 
basis) 
 Low mannan diet High mannan diet 
 - enzyme + enzyme - enzyme + enzyme 
Formulated composition     
     ME, Mcal/kg 3.42 3.42 3.42 3.42 
     SID amino acid, %     
          Lys 1.30 1.30 1.30 1.30 
          Met 0.40 0.40 0.40 0.40 
          Total sulfur AA 0.71 0.71 0.71 0.71 
          Thr 0.82 0.82 0.79 0.79 
          Trp 0.25 0.25 0.24 0.24 
     Ca, % 0.78 0.78 0.77 0.77 
     STTD P, % 0.39 0.39 0.40 0.40 
Analyzed composition     
     DM, % 89.50 89.79 90.82 90.88 
     GE, Mcal/kg 4.10 4.11 4.23 4.24 
     CP, % 21.52 21.88 21.06 20.57 
     aEE1, % 6.61 7.19 8.59 8.53 
     NDF, % 9.62 9.91 13.89 14.43 
     ADF, % 3.04 3.19 4.92 4.92 
     -mannanase2,3, U/kg 
< detection 
limit 
304,000 
< detection 
limit 
316,000 
1Acid-hydrolyzed ether extract (aEE) 
2Endo-1,4-β-mannanase (EC 3.2.1.78); 1 U = the amount of enzyme which generates 
0.72 g of reducing sugars per min from a mannose-containing substrate at pH 7.0 and 
40C 
3The limit of detection for feed samples was 45,000 U/kg 
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Table 5. Phase 3 diet formulated and analyzed energy and nutrient composition (as-fed 
basis) 
 Low mannan diet High mannan diet 
 - enzyme + enzyme - enzyme + enzyme 
Formulated composition     
     ME, Mcal/kg 3.39 3.39 3.39 3.39 
     SID amino acid, %     
          Lys 1.28 1.28 1.28 1.28 
          Met 0.43 0.43 0.41 0.41 
          Total sulfur AA 0.72 0.72 0.70 0.70 
          Thr 0.78 0.78 0.78 0.78 
          Trp 0.25 0.25 0.25 0.25 
     Ca, % 0.75 0.75 0.70 0.70 
     STTD P, % 0.38 0.38 0.38 0.38 
Analyzed composition     
     DM, % 90.60 90.35 90.94 91.15 
     GE, Mcal/kg 4.17 4.15 4.27 4.27 
     CP, % 21.60 21.61 21.72 21.11 
     aEE1, % 6.98 6.99 8.16 8.47 
     NDF, % 10.38 10.83 14.87 15.00 
     ADF, % 3.27 3.39 5.70 5.80 
     -mannanase2,3, U/kg 
< detection limit 327,000 
< detection 
limit 
365,000 
1Acid-hydrolyzed ether extract (aEE) 
2Endo-1,4-β-mannanase (EC 3.2.1.78); 1 U = the amount of enzyme which generates 
0.72 g of reducing sugars per min from a mannose-containing substrate at pH 7.0 and 
40C 
3The limit of detection for feed samples was 45,000 U/kg 
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Table 6. Effects of dietary mannan level and -mannanase supplementation on nursery pig 
BW, growth rate, feed intake, and efficiency1 
 Mannan level1  
Enzyme 
inclusion2 
 SEM P-value 
 High Low  - +   ME Mannan Enzyme 
Overall           
  d 0 BW, kg 6.64 6.65  6.64 6.65  0.36 0.583 0.736 0.790 
  d 28 BW 17.05 17.43  17.14 17.33  0.67 0.954 0.051 0.317 
  ADG, kg  0.37 0.38  0.37 0.38  0.01 0.852 0.027 0.354 
  ADFI, kg  0.52 0.54  0.53 0.53  0.02 0.922 0.024 0.922 
  G:F  0.71 0.71  0.70 0.71  0.01 1.000 0.653 0.106 
d 0 - 7           
  ADG, kg  0.11 0.12  0.12 0.12  0.01 0.364 0.221 0.629 
  ADFI, kg  0.17 0.18  0.17 0.17  0.01 0.576 0.100 0.779 
  G:F  0.69 0.71  0.69 0.71  0.02 0.357 0.427 0.570 
d 8 - 14           
  initial BW 7.44 7.53  7.47 7.50  0.38 0.396 0.202 0.680 
  ADG, kg  0.34 0.34  0.34 0.34  0.01 0.169 0.586 0.952 
  ADFI, kg  0.40 0.41  0.41 0.40  0.02 0.106 0.181 0.699 
  G:F  0.84 0.83  0.83 0.84  0.01 0.789 0.164 0.383 
d 15 - 21           
  initial BW 9.79 9.90  9.84 9.86  0.46 0.203 0.254 0.859 
  ADG, kg  0.50 0.53  0.51 0.52  0.01 0.935 0.015 0.463 
  ADFI, kg  0.67 0.70  0.68 0.68  0.02 0.528 0.007 0.795 
  G:F  0.75 0.76  0.75 0.76  0.01 0.645 0.834 0.706 
d 22 - 28           
  initial BW 13.33 13.61  13.41 13.53  0.56 0.328 0.058 0.429 
  ADG, kg  0.53 0.55  0.53 0.54  0.02 0.267 0.111 0.267 
  ADFI, kg  0.87 0.89  0.87 0.88  0.03 0.168 0.198 0.687 
  G:F  0.61 0.61  0.61 0.62  0.01 1.000 0.603 0.351 
1n=12 pens per treatment with 10 pigs per pen 
2Two levels of dietary mannan were achieved by replacing a proportion of the corn and 
soybean meal in the low mannan diet (0.4% -mannan) with copra meal for a high mannan 
diet (2.8% -mannan) 
3For the enzyme positive diet, -mannanase (Hemicell HT 1.5, Elanco Animal Health, 
Greenfield, IN; endo-1,4-β-D-mannanase from Bacillus lentus with not less than 237 million 
units per kg of product) was included at 0.05%
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Figure 1. Effects of dietary mannan level and -mannanase supplementation on nursery 
pig serum haptoglobin concentration (𝜇g/ml) at baseline (d 0) and after 28 d on the 
experimental diet. Two levels of dietary mannan were achieved by replacing a proportion 
of the corn and soybean meal in the low mannan diet (0.4% -mannan) with copra meal 
for a high mannan diet (2.8% -mannan). For the enzyme positive diet, -mannanase 
(Hemicell HT 1.5, Elanco Animal Health, Greenfield, IN; endo-1,4-β-D-mannanase from 
Bacillus lentus with not less than 237 million units per kg of product) was included at 
0.05%. The main effect of time (baseline or d 28) was significant (P < 0.0001) but time 
did not have any significant interactions with the effects of mannan, enzyme, or the 
combination of the 2 (P ≥ 0.437). Dietary mannan level, -mannanase supplementation, 
or the interaction of the two effects did not significantly impact serum haptoglobin 
concentrations (P ≥ 0.160).  
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Figure 2. Effects of dietary mannan level and -mannanase supplementation on nursery 
pig serum C-reactive protein concentration (𝜇g/ml) at baseline (d 0) and after 28 d on the 
experimental diet. Two levels of dietary mannan were achieved by replacing a proportion 
of the corn and soybean meal in the low mannan diet (0.4% -mannan) with copra meal 
for a high mannan diet (2.8% -mannan). For the enzyme positive diet, -mannanase 
(Hemicell HT 1.5, Elanco Animal Health, Greenfield, IN; endo-1,4-β-D-mannanase from 
Bacillus lentus with not less than 237 million units per kg of product) was included at 
0.05%. The main effect of time (baseline or d 28) was significant (P < 0.0001) but time 
did not have any significant interactions with the effects of mannan, enzyme, or the 
combination of the two (P ≥ 0.332). Neither dietary mannan level nor -mannanase 
supplementation significantly impacted serum C-reactive protein concentrations (P ≥ 
0.201). The interaction of mannan level and enzyme inclusion tended to affect C-reactive 
protein concentrations (P = 0.079).  
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CHAPTER IV 
XYLOSE METABOLISM IN THE PIG  
 
Modified from a paper submitted to PLOS ONE 
 
N. F. Huntley, and J. F. Patience* 
*Department of Animal Science, Iowa State University, Ames, 50011, USA 
 
Abstract 
It is important to understand if, and to what extent, the pig can utilize xylose as an 
energy source if xylanase releases free xylose in the small intestine. The experimental 
objectives were to determine the effects of industry-relevant dietary xylose 
concentrations and adaptation time on xylose retention efficiency and metabolism, diet 
digestibility and energy value, nitrogen balance, and hindgut fermentation. Forty-eight 
pigs were housed in metabolism crates and randomly assigned to one of four treatments 
with increasing D-xylose levels (n=12/treatment) in 2 replications of a 22-d experiment 
with 3 collection periods. The control diet was xylose-free (0%), to which either 2, 4, or 
8% D-xylose was added. Adaptation effects were assessed during three fecal and urine 
collection periods: d 5-7, 12-14, and 19-21. On d 22, pigs from the 0 and 8% treatments 
were euthanized; cecal and colon digesta were collected. Dietary xylose did not affect the 
total tract digestibility of dry matter, gross energy, or crude protein; digesta short chain 
fatty acids concentrations and molar proportions, and cecal pH were not different 
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(P>0.10). This experiment utilized a targeted metabolomics approach to characterize and 
quantify urine xylose and metabolite excretion. Xylose retention decreased from 60% to 
47% to 41% when pigs were fed diets containing 2, 4, or 8% xylose, respectively. A 
comprehensive pathway for xylose metabolism was proposed and D-threitol was 
confirmed as the major urinary metabolite of xylose. In conclusion, pigs can metabolize 
xylose, but with considerably lower efficiency than glucose, and can adapt with time to 
utilize xylose more efficiently.  
 
Introduction 
Xylose is a primary component of arabinoxylan in the hemicellulose fraction of 
carbohydrates in swine diets. Xylose is a potential energy source within the fiber 
structure of arabinoxylan, which is unavailable to the pig as a monosaccharide but can 
contribute some energy through fermentation. Xylanase hydrolyzes the -linked xylose 
backbone of arabinoxylan and releases a mixture of oligosaccharides, disaccharides, and 
monomeric pentose sugars [1–3] such as xylose. Free xylose can be absorbed by the 
small intestine and thus could potentially contribute energy to the pig; yet little 
information is available on xylose metabolism in pigs and mammals in general [4]. It is 
important to understand the energy available from xylose because nutritionists formulate 
diets to precisely balance the concentrations of energy and nutrients. Therefore, to 
effectively utilize xylanase to improve pig performance and efficiency when fed high 
fiber diets, we must understand how xylanase supplementation impacts dietary energy 
availability through the release of free xylose.  
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Most research on xylose metabolism in pigs has been conducted utilizing diets 
with xylose concentrations ranging from 5 - 40% [4]. However, typical growing pig diets 
will contain only 3 - 5% xylose as arabinoxylan, and not all of this would be released as 
free xylose in the small intestine. Additionally, most studies have allowed only 4 - 7 d of 
adaptation to treatment diets, so it is yet to be determined if pigs develop increased 
capacity for xylose metabolism as the length of exposure increases. Therefore, the 
objectives of this experiment were to determine the effects of industry-relevant dietary 
xylose concentrations and adaptation time on xylose retention efficiency and metabolism, 
diet digestibility and energy value, nitrogen (N) balance, and hindgut fermentation, and to 
identify urinary metabolites and propose a metabolic pathway of xylose using a targeted 
metabolomics approach. 
 
Materials and methods 
  All experimental procedures adhered to guidelines for the ethical and humane use 
of animals for research and were approved by the Iowa State University Institutional 
Animal Care and Use Committee (2-17-8452-S). 
Animals, housing, and experimental design 
  The experiment was conducted at the Iowa State University Swine Nutrition 
Farm (Ames, IA) using 48 crossbred gilts (Genetiporc 6.0 × Genetiporc F25, PIC, Inc., 
Hendersonville, TN) with an initial body weight (BW) of 28.3  1.5 kg in two 
replications using 24 pigs each. 
Prior to the experiment, pigs were housed individually for 4 d in pens (1.8  1.9 
m) with slatted concrete floors for adaptation to individual housing and to the basal diet 
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and feeding schedule. At the start of the trial, pigs were randomly allotted to one of four 
dietary treatments and were individually housed in metabolism crates (0.7   1.5 m) for 
the 22-d experiment. The metabolism crates allowed for separate collection of feces and 
urine and were equipped with a slatted floor, feeder, and nipple waterer that was attached 
to a modified water container to allow accurate measurement of water intake. Pigs were 
weighed on d 0 and 22. On the last day of the experiment (d 22) a total of 24 pigs, 12 
from each replication (six each from the 0% and 8% treatments), were euthanized for 
tissue collection via captive bolt stunning and exsanguination.  
Diets and feeding 
 Four dietary treatments with increasing levels of D-xylose were evaluated (Table 
1). The basal control diet was xylose-free (0%) and the following three treatments 
consisted of either 2%, 4%, or 8% D-xylose (DuPont Nutrition & Health, Copenhagen, 
Denmark) added to the basal diet at the expense of corn starch. All diets were formulated 
to meet or exceed NRC [5] (2012) requirements for growing pigs (Table 2) and were 
manufactured in mash form. The same batch of feed was used for both replications. 
During diet mixing, representative diet samples were obtained by homogenizing 10 
subsamples; these were stored at -20C for future analysis. Titanium dioxide (TiO2) was 
included in the diet as an indigestible marker to determine nutrient digestibility. Four 
days prior to initiation of the experiment, all pigs were offered the 0% diet. On d 0, pigs 
were transitioned to their assigned dietary treatments at 4% of the average initial BW. 
The daily feed allotment was split into two daily feedings at 0800 and 1600 h. Any orts 
remaining after 1 h were collected and weighed. Pigs in both replicates received the same 
amount of feed. Pigs had ad libitum access to water throughout the entire trial. 
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Sample collection 
The effect of adaptation time was assessed by utilizing three fecal and urine 
collection periods throughout the 22 d experiment. Collection periods 1 (d 5-7; C1), 2 (d 
12-14; C2) and 3 (d 19-21; C3) allowed pigs to adapted to the treatment diets for 4, 11, 
and 18 d prior to each collection, respectively.  
Each collection period lasted 72 h and total urine and fresh fecal grab samples 
were collected at 0830 and 1630 h each day. Fecal samples were compiled and 
homogenized within each collection period and immediately stored at -20°C. Urine was 
collected quantitatively into 4-liter bottles containing 6 M-HCl to ensure that the pH was 
maintained below 2.0 to minimize nitrogen (N) volatilization. Total urine output was 
weighed and stored at -20°C. After each collection period was completed, urine was 
thawed, homogenized, strained through glass wool, subsampled, and again stored -20°C 
for later analysis. Urine specific gravity was measured by weighing a subsample of 500  
1 ml. 
Water intake was also measured during each collection period. A 12-liter plastic 
container was modified to attach to the nipple waterers already installed in the 
metabolism crates. The containers were placed on top of each crate to allow water to be 
gravity-fed into each waterer. The containers were emptied at the beginning of each 
collection period and the volume of water added throughout the collection period was 
recorded. At the end of the 72-h period the volume of water remaining was recorded to 
calculate water disappearance. Correspondingly, at the beginning of each collection 
period, trays were placed underneath the front of each crate to collect and measure the 
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volume of wasted water. Water intake was then calculated by subtracting water waste 
from water disappearance during each collection period.  
On d 22, 24 total pigs (12 pigs from the 0% treatment and 12 pigs from the 8% 
treatment) were euthanized 60  3 min after feeding. The abdomen of the carcass was 
opened and, to minimize digesta movement, the gastrointestinal tract was clamped at the 
stomach/duodenum sphincter, the ileum/cecum junction, the cecum/large intestine 
junction, and at the rectum. The intestines were then removed from just below the 
stomach to near the anus. Digesta pH was measured at the cecum and mid-colon, and 
digesta from both sections was collected, and immediately frozen. Digesta samples were 
stored on dry ice for transportation to the lab and stored at -20°C until analysis. 
Analytical methods and calculations 
All diet, orts, and fecal samples were dried at 60°C to a constant weight and were 
ground to a particle size of 1 mm. Urine subsamples were thawed, mixed, and filtered 
through Whatman 41 filter paper (GE Healthcare Life Sciences, Chicago, IL, USA) prior 
to analysis. Urine, diet, and fecal samples were analyzed in duplicate for N (method 
990.03 [6]; TruMac; LECO Corp., St. Joseph, MI, USA). Standard calibration was 
performed using EDTA (9.56% N) which was determined to contain 9.55 ± 0.01% N. 
Crude protein (CP) was calculated as N 6.25. 
Diet and fecal samples were analyzed in duplicate for dry matter (DM; method 
930.15), TiO2 and gross energy (GE). Titanium dioxide was determine according to the 
colorimetric method of Leone (1973) [7]. For urine energy determination, 3 ml of urine 
was added to 0.5 g of dried cellulose (SolkaFloc, International Fiber Corporation, North 
Tonawanda, NY, USA), subsequently dried at 50C for 72 h, and urine plus cellulose 
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dried samples were analyzed in duplicate for GE. Gross energy was determined using a 
bomb calorimeter (model 6200; Parr Instrument Co., Moline, IL). Benzoic acid (6,318 
kcal/kg; Parr Instrument Co.) was used as the standard for calibration and was determined 
to contain 6,315 ± 6.9 kcal/kg. Urinary energy was calculated from the difference of 
energy determined in cellulose and the energy determined in the samples containing both 
urine and cellulose.  
Apparent total tract digestibility (ATTD) of dry matter, GE, and CP were 
calculated according to the equation of Oresanya et al. [8], as 100 – {100 × 
[concentration (g) of TiO2 in diet × concentration (g) of DM, GE, or CP in 
feces]/[concentration (g) of TiO2 in feces × concentration (g) of DM, GE, or CP in diet]}.  
Diets and a representative portion of the fecal and colon digesta samples (n = 24) 
were also analyzed for D-xylose concentration using a commercially available kit 
(Megazyme, Wicklow, Ireland). To prepare diet samples, they were ground to 0.5 mm 
particle size and acid hydrolyzed according to manufacturer’s instructions. Fecal and 
colon digesta samples used for D-xylose analysis were lyophilized, ground to 0.5 mm 
particle size, and clarified according to manufacturer’s instructions. In all fecal and colon 
digesta samples, the xylose concentration was determined to be < 1% (average = 0.24%), 
which agrees with previous literature that free xylose is nearly completely absorbed in the 
small intestine [9]. Therefore, the ATTD of xylose was not measured. Diets were also 
analyzed in duplicate for acid hydrolyzed ether extract (aEE; method 2003.06) and in 
triplicate for neutral and acid detergent fiber components (NDF [10] and ADF [11], 
respectively). The analyzed nutrient composition of the diets is presented in Table 2. 
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Quantitative metabolomics analysis was completed for all urine samples using 
tandem GC/MS. Filtered urine samples were vortexed, 10 l was transferred to a 2-ml 
glass vial, and 50 l of ribitol (1 mg/ml in HPLC grade water) was added to each sample 
as an internal standard. The samples were then concentrated to complete dryness in a 
SpeedVac concentrator (Savant, Thermo Fisher Scientific Inc., Waltham, MA). The dried 
samples were treated with methoxamine (20 mg/ml methoxamine HCl in dry pyridine) 
followed by sonication at ambient temperature for 30 min and incubation at 60C for 60 
min. The samples were then derivatized with the addition of N,O-bis(trimethylsilyl)-
trifluoroacetamide with 1% trimethylchlorosilane and incubated at 60C for 30 min.  
Analysis was performed on an Agilent 19091s-433 GC/MS system equipped with 
a HP-5ms chromatographic column (30 m  250 m  0.25 m; Santa Clara, CA). The 
injection temperature set to 280C and the injected volume was 1 l with a 1:10 split. The 
helium flow rate was 1 ml/min. The column temperature was initially set at 90C for 2 
min and then increased to 320C at a rate of 15C/min where it was held for 3 minutes. 
Mass spectral analysis was performed in the scan-total ion monitoring mode after 
electron ionization. The MS quadrupole temperature was set to 150C and the ion source 
temperature was set to 230C. The mass data were collected in the range from m/z 40 to 
m/z 800. The acceleration voltage was turned on after a solvent delay of 7 min. 
The AMDIS software (National Institute of Standards and Technology (NIST), 
Gaithersburg, MD) was used for peak quantification. A hydrocarbon ladder was used for 
retention index calculation and standards of D-threitol (Sigma-Aldrich, Saint Louis, MO), 
D-xylose, D-erythritol, xylitol, D-xylulose, and D-xylonic acid (Supelco, Bellefonte, PA) 
were used for compound identification. Additional compounds were identified using 
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NIST14 Mass Spectral Library (version 2.2) based on mass spectral matching. The 
integrated peak areas of multiple derivative peaks belonging to the same compound were 
summed and considered as a single compound. Concentrations of identified compounds 
were calculated using the ratio of the peak area of each compound to the internal 
standard; and D-xylose, D-threitol, D-erythritol, xylitol, D-xylulose, and D-xylonic acid 
were quantified based on a standard curve regression. 
Urine GE (kcal/l) contributed from xylose, threitol, xylitol, xylonic acid, and 
xylulose were calculated as the concentration of the compound (g/l)  GE of the 
compound (kcal/g). Urine GE contributed by N-containing compounds was estimated by 
applying an assumption that all urinary N was in the form of urea and was calculated as 
the urine N concentration (g/l)  2.52 (kcal/g, the GE of urea). Urine GE not allocated to 
xylose, metabolites, or N-containing compounds was calculated as urine GE (kcal/l) – 
[urine GE from xylose + threitol + xylitol + xylonic acid + xylulose + N-containing 
compounds (kcal/l)]. 
Digesta samples from the cecum and colon were analyzed for short chain fatty 
acid (SCFA) concentrations. One gram of sample was diluted with 2.5 ml ddH2O and 
mixed with 0.2 ml of 25% metaphosphoric acid and 0.1 ml of isocaproic acid (48.3 mM; 
Sigma-Aldrich, Saint Louis, MO) as an internal standard. A standard curve was generated 
using five concentrations of acetate, propionate, butyrate, valerate, isobutyrate, and 
isovalerate (Sigma-Aldrich, Saint Louis, MO). The internal standard (0.1 ml) was added 
to each set of standards. Samples and standards were centrifuged, and the supernatant 
was transferred to a glass vial for analysis. Gas chromatography (3800 Varian GC, 
Agilent Technologies, Santa Clara, CA) was performed using a 15 m  0.25 mm  0.25 
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μm fused silica capillary column (Supelco, Bellefonte, PA) with flame ionization 
detection. Helium was used as the carrier gas at the flow rate of 1 ml/min. The injector 
temperature was 250°C and the oven temperature held at 143°C until increasing to 200°C 
for 6 min. Concentrations of acetate, propionate, butyrate, valerate, isobutyrate, and 
isovalerate were calculated using the ratio of the peak area of each compound to the 
internal standard and standard curve regression. Molar proportions of SCFA were 
calculated as the individual SCFA concentration (mM) / total SCFA concentration (mM). 
Statistical analyses 
Data were analyzed as a three by four factorial design with pig as the 
experimental unit. The UNIVARIATE procedure of the Statistical Analysis Systems 
package version 9.4 (SAS Institute, Cary, NC, USA) was used to verify normality of 
residuals and homogeneity of variances and statistical outliers (> 3 standard deviations 
away from the mean) were removed. Water intake, urine output, and digesta SCFA molar 
proportions data were log transformed, and SCFA concentration data were reciprocal 
transformed to achieve a normal distribution. The statistical models for all SCFA data 
were fit with separate variances for each of the two treatments.  
The fixed effects of dietary treatment (Trt), collection period (Col), and their 
interaction (Trt  Col), and the random effect of replication were analyzed using the 
MIXED procedure of SAS. Data were analyzed as repeated measures with pig as the 
subject and an unstructured covariance structure was applied. For data collected only at 
one time period (i.e. growth performance and cecal and colon pH and SCFA), the fixed 
effect of dietary treatment was analyzed with replication as a random effect.  
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Differences due to dietary treatment, collection period, and their interaction were 
determined using ANOVA and means were separated using the least square means 
statement and the PDIFF option. Linear and quadratic polynomial contrasts were used to 
determine the response to dietary xylose concentration. Differences were considered 
significant if P was ≤ 0.05 and a trend if P was > 0.05 and ≤ 0.10.  
Urine metabolomics data were analyzed as grams of compound excreted per day 
to account for differences in urine volume. Multivariate analysis of log-transformed and 
range-scaled data was performed using MetaboAnalyst 4.0 [12] including repeated 
measures two-way ANOVA for the effects of dietary treatment and collection period, 
heat map generation, and the impact of dietary xylose concentration on metabolic 
pathways and metabolite set enrichment. 
 
Results 
Growth performance and water balance  
All pigs remained healthy throughout the entire trial. Initial BW and d 22 BW did 
not differ (Trt P  0.6659; Table 3) and pigs on all dietary treatments had similar average 
daily gain (ADG) and feed efficiency (Trt P  0.1653; Table 3). Water intake increased 
in a linear fashion as dietary xylose concentration increased; in turn, this resulted in a 
linear increase in urine output (Table 4; Trt P < 0.01). However, urine specific gravity did 
not differ among treatments (Table 4). A tendency for differences among dietary 
treatments (P = 0.0656) and a significant collection period effect (P = 0.0087) were 
detected for urine specific gravity, but these were likely due to the very small standard 
error of the mean (SEM; 0.01). In any event, this magnitude of differences would not be 
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biologically relevant. Collection period significantly impacted water balance as well as 
water waste, with pigs wasting less water during C2 and C3 compared to C1 (P = 0.0001; 
Table 4) 
Diet digestibility and energy value and nitrogen balance 
The ATTD of DM, GE, and CP did not differ among treatments (Trt P  0.4074; 
Table 5), but the ATTD was significantly impacted by collection period (Col P  
0.0014). There were significant interactions between treatment and collection period for 
DM and GE ATTD (Trt  Col P  0.0003) and a trend for interaction for CP ATTD (Trt 
 Col P = 0.0858; Table 5). Small differences in GE ATTD resulted in a tendency for an 
interaction of treatment and collection period on diet digestible energy (DE, Mcal/kg; 
Table 5). Dietary treatment affected diet DE with pigs on the 2% xylose treatment having 
lower DE value compared to all other treatments (3.56 Mcal/kg vs. an average of 3.61 
Mcal/kg; Trt P = 0.0004). However, the SEM for all digestibility variables was relatively 
low ( 0.50) which likely resulted in detection of the interaction. 
Urine N (%) decreased linearly with increasing dietary xylose concentration (Trt 
P = 0.009, linear P = 0.009; Table 5) but increased across collection periods as pigs had 
longer adaptation time to the diets (Col P < 0.0001). There tended to be an interaction 
between treatment and collection period for urine N with concentrations increasing across 
collection periods for all treatments, but to a lower magnitude in the 8% xylose treatment 
(Table 5). Nitrogen balance (retained N and the percent of N excreted in the urine or 
feces) was not affected by dietary treatment (Trt P  0.5738; Table 5). As pigs had longer 
adaptation time, the proportion of N excreted in the feces increased (Col P < 0.0001) 
while the proportion excreted in the urine decreased (Col P < 0.0001). 
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 Urine energy concentration (kcal/l) linearly increased with increasing dietary 
xylose concentration (Trt P < 0.0001, linear P < 0.0001) and increased across collection 
periods as pigs had longer adaptation time to the treatment diets (Col P < 0.0001). This 
resulted in a significant treatment by collection period interaction for diet metabolizable 
energy (ME, Mcal/kg) value (Table 4.5). 
Digesta short chain fatty acids 
 Short chain fatty acid concentrations (mM) and molar proportions in the cecum 
and colon did not differ between the 0 and 8% treatments (Trt P  0.2534; Table 6). The 
pH of the cecal digesta did not differ (Trt P = 0.3845) but colon digesta in pigs fed 8% 
xylose had a lower pH (Trt P = 0.0249; Table 6).  
Urine metabolomics 
 Figure 1 displays the distribution patterns of compounds identified in urine from 
pigs fed increasing dietary xylose concentrations and among three collection periods 
representing increasing adaptation time to treatment diets. The Euclidean distance 
measure and the unweighted paired group average linkage technique for hierarchical 
clustering were applied. In total, 22 compounds were identified in the urine samples and 
20 were determined to be differentially excreted due to dietary treatment, collection 
period, or their interaction (adjusted P < 0.05; Fig. 1). All compounds were impacted by 
collection period, except glutaric acid and malic acid which were significantly affected 
only by treatment. Erythrono-1,4-lactone was only affected by the main effect of 
collection period. In general, increasing dietary xylose concentration increased the 
excretion of metabolites in the urine with the exceptions of malic acid, glutaric acid, 
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pseudouridine, citric acid, and p-cresol glucuronide for which excretion decreased (Trt 
adjusted P < 0.05). 
Xylose metabolic pathway 
Metabolomic analysis was used to identify metabolic pathways impacted by 
xylose consumption and determine metabolite set enrichment. According to the pathway 
enrichment analysis, the pentose and glucuronate interconversions pathway was the most 
significantly impacted (Trt P < 0.001) and contained the largest proportion of identified 
compounds (4/22) that were enriched in the pathway. Based on this analysis, a review of 
the literature on xylose metabolism in pigs [13–24] and other mammals [25–35] where 
data specifically in pigs were not available, and validation using KEGG metabolic 
pathways [36] and BRENDA comprehensive enzyme database [37], a pathway for the 
metabolism of xylose is proposed (Fig. 2). Clustering results (Fig. 1) and interpretation of 
the xylose metabolic pathway (Fig. 2) were used to determine that the most plausible 
direct metabolites of dietary xylose were considered to be D-threitol, xylitol, D-xylulose, 
and D-xylonic acid, in addition to xylose excreted in the urine unchanged. The excretion 
of all other identified compounds in the urine significantly affected by dietary xylose 
concentration were considered to have been indirectly affected as opposed to directly 
converted from dietary xylose. 
Xylose metabolite excretion 
The excretion of xylose and its metabolites are presented in Table 7. Xylose was 
the most abundant compound identified in urine from pigs on the 2, 4, and 8% xylose 
treatments. Xylose excretion increased as xylose consumption increased (Trt P < 0.0001, 
linear P < 0.0001, quadratic P < 0.0001). In the 0 and 2% xylose treatments, xylose 
  
 
 
 
142 
excretion was similar across collection periods, but in the 4 and 8% treatments, excretion 
was decreased in C2 and C3 compared to C1 (Col P < 0.0001). In the 4% treatment, 
xylose excretion was not different between C2 and C3 but in the 8% treatment, xylose 
excretion was greater in C3 compared to C2, but still less than C1 (Trt  Col P < 0.0001; 
Table 7). In pigs fed xylose-containing diets, the percent of consumed xylose excreted in 
the urine increased as dietary xylose concentration increased (Trt P < 0.0001, linear P < 
0.0001; Table 8) but this proportion decreased after the first collection period (Col P < 
0.0001). In the 8% treatment, the proportion was greater in C3 compared to C2 (Trt  Col 
P = 0.0026, Table 8). 
Threitol was the major metabolite of xylose. Urinary excretion of threitol 
increased as xylose consumption increased (Trt P < 0.0001, linear P < 0.0001, quadratic 
P < 0.0001) and, similar to xylose, a treatment by collection period interaction was 
observed (Trt  Col P = 0.0008; Table 7). In pigs fed the xylose-containing diets, the 
percent of consumed xylose excreted in the urine as threitol increased as dietary xylose 
concentration increased (Trt P < 0.0001, linear P < 0.0001, Table 8). This proportion 
differed across all collection periods with C1 > C3 > C2 (Col P < 0.0001). 
Xylitol, xylonic acid, and xylulose were minor metabolites of dietary xylose. 
Urinary excretion of these metabolites also increased as xylose consumption increased 
(Trt P < 0.0001, linear P < 0.0001) and significant treatment by collection period 
interactions were detected (Trt  Col P  0.0021; Table 7). The proportion of consumed 
xylose excreted as either xylitol, xylonic acid, or xylulose was also impacted by the 
interaction (Trt  Col P = 0.0133; Table 8), but in no instance did it exceed 1.1% of 
xylose intake.  
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Allocation of urine GE 
Because urine GE was found to significantly increase as dietary xylose 
concentration increased, it was of interest to determine where the excess urinary energy 
was coming from. The allocation of urine GE to xylose and its derivatives is presented in 
Fig. 3; values are averaged across collection period. Xylose contributed a large portion of 
the excess urine energy; the remainder was explained by its metabolite threitol, and to a 
lesser extent xylitol, xylonic acid, and xylulose. In the 4 and 8% treatments the amount of 
urine GE coming from N-containing compounds was lower than the control treatment 
(Trt P  0.0088; Fig. 3). Once the differences in energy coming from xylose, its 
metabolites, and N-containing compounds were accounted for, the remaining 
unassociated GE was similar among the 0, 2, and 4% treatments, but was lower in the 8% 
treatment (Trt P = 0.0420; Fig. 3). The underlying reason for this difference has yet to be 
determined. 
 
Discussion 
Growing pigs are commonly being fed diets with increasing dietary fiber levels. 
To help mitigate the negative effects of fiber on growth performance and feed efficiency, 
exogenous carbohydrases that break down the fiber structure are often supplemented 
[38,39]. Of the fiber that is found in cereal grains and co-products, a large proportion is 
hemicellulose and of this, a large fraction is arabinoxylan [40–42], which in turn is 
primarily composed of the pentose sugars xylose and arabinose. Xylanase releases a 
portion of the xylose from the xylan backbone [1–3]. This free xylose can then be 
absorbed in the small intestine [9,43–46] and potentially contribute energy to the pig. 
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However, previous research indicates that free xylose is poorly utilized [4], so it is 
unknown whether xylose would contribute more energy when absorbed as a 
monosaccharide  or through fermentation of arabinoxylan in the hindgut. 
Energy is the most expensive component of swine diets [47], so nutritionists 
formulate diets to precisely balance the concentrations of available energy and nutrients. 
Therefore, to effectively utilize xylanase to improve the efficiency of pig production, the 
amount of energy contributed by free xylose must be quantified. While the efficiency and 
extent of the release of free xylose by xylanase has yet to be determined, the 
concentration of xylose available for absorption is unlikely to be greater than 4% of diet 
DM [4]. To our knowledge, only one previous study in pigs has been reported using 
dietary D-xylose concentrations below 5% [44], and the pig’s ability to adapt and 
improve its utilization of xylose has yet to be evaluated. To accomplish the experimental 
objectives and to begin to address the question “what is the energy value of xylose for 
pigs?”, this experiment utilized four diets starting with a xylose-free control diet (0%) to 
which either 2, 4, or 8% xylose was added. Samples were collected in three separate 
periods over 22 d to evaluate the effects of adaptation time. 
Water balance 
 Water balance was clearly impacted by xylose consumption in this study. 
Increasing xylose consumption increased water intake and urine output which agrees with 
previously reported xylose effects in pigs [9]. We hypothesize that more water was 
excreted in the urine to balance osmolarity as increasing amounts of xylose and other 
metabolites were excreted. This hypothesis is supported by the constancy of the specific 
gravity of urine across all treatments, even though the quantity of solutes excreted per 
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day increased. As adaptation time increased, pigs excreted less xylose in the urine, and 
water intake and urine output were lower, accordingly. It would be interesting in future 
studies evaluating xylanase efficacy to measure water consumption and relate this to 
xylose release. 
Digestibility, fermentation, and diet energy value 
 Contrary to the results of previous studies [9,43], dietary xylose concentration did 
not affect total tract digestibility of DM, GE, or CP in biologically relevant ways. Among 
all treatments and throughout the entire trial, the ATTD of DM ranged from 87.6 – 89.1% 
and diet DE was found to be slightly lower in the 2% treatment compared to the other 
three treatments. Based on previous research [9,43,44] and analysis of a subset of the 
colon digesta and fecal samples from pigs on this experiment, dietary xylose was 
assumed to be completely absorbed by the terminal ileum. Because possible microbial 
fermentation of xylose in the small intestine [9,44] was not evaluated, one potential 
drawback of this assumption is an overestimation of retained xylose. However, there is 
empirical evidence that xylose is readily absorbed in the duodenum and proximal 
jejunum in rats [48,49]. This suggests that the concentration of any unabsorbed xylose 
would likely be very low in the terminal ileum where microbial populations are more 
abundant. 
 The SCFA results from this experiment are consistent with the hypothesis that 
xylose was almost completely absorbed in the small intestine. Concentrations and molar 
proportions of SCFA did not differ between the 0 and 8% treatments, indicating that the 
nutrient composition of substrates fermented  in the cecum and colon were similar [50]. 
In accordance, the pH of cecal digesta did not differ. Because no differences were 
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detected in SCFA concentrations in either the cecum or colon, an explanation for a lower 
pH in the colon of pigs fed 8% xylose is not directly apparent. 
 Urine energy concentration linearly increased with increasing dietary xylose 
concentration, and diet ME decreased with xylose inclusion. Across all collection 
periods, the 8% treatment consistently provided the lowest diet ME. Although xylose did 
decrease the ME value of the diet, the relative differences of the 2 and 4% xylose diets 
compared to the control diet are quite low. For the 2% treatment across C1 – 3, the ME 
values were 98%, 97%, and 96% the value of the control diet and for the 4% treatment, 
the values were 98%, 98%, and 97%, respectively. The 8% xylose diets had the lowest 
relative ME value at 94%, 95%, and 93% of the control diet during C1 – 3, respectively. 
Unlike previous studies using dietary xylose concentrations of 10% [43] or 18.7 and 
37.4% [51], dietary xylose inclusion did not impact ADG or feed efficiency in pigs on 
this experiment. This result may be partially explained by the relatively small differences 
in diet ME value among treatments.  
Xylose metabolism 
 Dietary xylose, adaptation time to the diets (i.e. the effect of collection period), 
and their interaction significantly impacted the profile of compounds excreted in the urine 
of pigs. Many of the identified compounds are related to general energy metabolism (ex. 
malate and citrate), amino acid metabolism (ex. glutaric acid), or are derivatives of 
microbial metabolism (ex. p-cresol glucuronide and hippuric acid) [52]. The excretion of 
these compounds was impacted by dietary xylose concentration and indicates that 
metabolic pathways beyond those directly related to xylose were affected.  
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Interestingly, sucrose excretion was found to increase with increasing dietary 
xylose concentrations. Although total urinary sucrose excretion was low (0.03 – 0.12 
g/d), it is uncommon for sucrose to be found in the urine of healthy animals. If sucrose is 
not hydrolyzed by sucrase at the intestinal brush border, it can be absorbed intact and is 
usually excreted as such in the urine [53,54]. The fact that urinary sucrose excretion 
increased due to xylose consumption, even though all diets contained the same amount of 
sucrose, may support the conclusions of previous studies that xylose inhibits intestinal 
sucrase activity [55] and reduces the post-prandial glycemic effect of sucrose-containing 
meals [56,57].  
 By far, xylose was the most concentrated compound identified in the urine of pigs 
fed xylose-containing diets. A small amount of xylose was excreted in the urine of the 
control pigs (0.61 g/d) which is comparable to basal xylose urinary excretion previously 
reported [44]. As expected, as dietary xylose concentration increased, urinary xylose 
excretion increased from 6.3 to 40.1 g/d. Adaptation was evident in the 4 and 8% 
treatments because xylose excretion was significantly lower in C2 and C3 compared to 
C1. However, in the 8% treatment, xylose excretion was greater in C3 compared to C2.  
To be able to compare xylose utilization efficiency on an equivalent basis across all 
treatments, the proportion of consumed xylose that was excreted in the urine was 
calculated (Table 8). As xylose consumption increased, the percent excreted in the urine 
as D-xylose increased from 27.6 to 39.2 to 43.9% in the 2, 4, and 8% xylose treatments, 
respectively. This was the first indication that the efficiency of xylose utilization 
decreases proportionally as dietary xylose concentration increases. These value are 
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comparable to previous studies in pigs which reported that 35 – 53% of absorbed xylose 
is excreted in the urine [9,43,44]. 
 Previous research has also shown that xylose can be metabolized to other 
compounds. Radioisotope studies in mammals demonstrated that xylose can be oxidized 
to xylonic acid [25], CO2 [25,58], and be converted to threitol [26,43]. Authors of 
previous studies have proposed metabolic pathways for some conversions; however, they 
have generally only been speculated upon for individual reactions [28] or short 
conversion pathways [25,26]. We have proposed a more comprehensive metabolic 
pathway to help explain the conversion of xylose to urinary metabolites identified in this 
study. Metabolic connections with the pentose phosphate pathway (PPP) were shown due 
to the common assumption that xylose, being a 5-carbon sugar, would be metabolized 
within the PPP. The connections to the PPP are also likely the means through which 
xylose can eventually be fully oxidized to CO2 and contribute energy to the pig. The 
proposed pathway was interpreted in conjunction with the cluster analysis of 
metabolomics data, that indicate which compounds were most similarly influenced by 
dietary treatment. As discussed below, research in pigs confirms the presence of the 
enzymes, mostly in the liver and kidneys, which can convert D-xylose into either D-
xylonic acid or xylitol.  
 D-xylose is oxidized to D-xylonic acid by NADP+-linked D-xylose 
dehydrogenase (EC 1.1.1.179) with D-xylonolactone formed as an intermediate. This 
enzyme and metabolic conversion has been confirmed in pig liver [13,14,17] with lower 
activity in the kidney and lens, and even lower activity in the spleen, brain, heart and 
muscle [18]. The same pathway was demonstrated in guinea pigs using intraperitoneal 
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injections of D-xylose-1-14C [25]. The same study then demonstrated that D-xylonic acid-
1-14C was metabolized much faster than D-xylose and a greater proportion was converted 
to 14CO2. This may indicate that D-xylose dehydrogenase could be a rate-limiting step for 
xylose metabolism. In our study, D-xylonic acid was excreted in the urine at low levels 
(< 0.6 g/d) but its excretion increased with increasing xylose consumption. 
 D-xylonic acid can then be converted to D-erythrulose by L-gulonate 3-
dehydrogenase (EC 1.1.1.45); this enzyme activity has been confirmed in pig kidney[19]. 
D-erythrulose can then be reduced by D-erythrulose reductase (EC 1.1.1.162) to D-
threitol, the most abundant xylose metabolite identified in the urine in our study. This 
enzyme (also known as D-threitol:NADP+ oxidoreductase) has not been reported 
specifically in the pig; however, it has been confirmed in the mouse kidney and liver [32] 
and cattle liver [29,30], with the highest enzyme activity reported in the kidney. If not 
converted to D-threitol, D-erythrulose can also be phosphorylated to D-erythrulose-4P, 
which links to the PPP. 
  In this study, D-threitol excretion increased with increasing xylose consumption - 
up to 16 g/d in the 8% treatment during C1. If D-threitol is assumed to be a metabolite of 
dietary xylose, urinary D-threitol represented 11, 13, or 15% of consumed xylose when 
the 2, 4, or 8% diet was fed, respectively. The identification of D-threitol as the major 
urine xylose metabolite corroborates previous studies in pigs [43] and humans [26] which 
both reported that 10-11% of ingested xylose was excreted as threitol. Pitkänen [26] 
specified that in the first 5 h after ingestion only 4% of the oral xylose dose was excreted 
as threitol; when the collection was extended to 24 h, the proportion increased to 10.6%. 
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 In the literature, the ME value of diets is consistently reduced by xylose inclusion 
[4,9], but it is likely that in addition to excreted xylose, threitol also significantly 
accounts for the reduction in ME. This was apparent in our study and likely was an 
unidentified causative factor in the studies by Verstegen et al. [43] and Schutte et al. [9]. 
Furthermore, threitol likely explains the unidentified compound in guinea pig urine that 
contained 18% of an intraperitoneal injection of D-xylose-1-14C [25]. 
 D-xylose can also be oxidized to xylitol via aldose/aldehyde reductase (EC 
1.1.1.21). This conversion has been confirmed in the cortex of pig kidney [20,59], but the 
reaction seems to occur at a slow rate [20]. The enzyme has also been identified in the 
lens and skeletal muscle of pigs [21]. Xylitol was the second most abundantly excreted 
metabolite of xylose, but at most, only 0.41 g/d were excreted. In all xylose-containing 
treatments, xylitol excretion was the greatest during C3, potentially indicating a slow 
metabolic upregulation of aldose/aldehyde reductase as pigs adapted to the diets. Xylitol 
was also identified as a metabolite in humans infused with D-xylose-1-14C, but 
represented < 0.1% of the recovered 14C [58]. 
 Xylitol can be converted to either the D- or L-isomer of xylulose. In this study, D-
xylulose excretion was found to increase with increasing xylose consumption. Xylitol 
dehydrogenase (EC 1.1.1.14) oxidizes xylitol to D-xylulose and this enzyme is 
distributed in many mammalian tissues of which, the liver is the main organ [15]. Finally, 
in the liver and kidneys, D-xylulose can be phosphorylated by xylulokinase (EC 2.7.1.17) 
to D-xylulose-5P[27], an intermediate in the PPP. Xylitol, D-xylulose, and D-xylonic 
acid were determined to be minor metabolites of dietary xylose, and together represented 
0.58 – 1.03% of consumed xylose. 
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 Taking into account xylose that was either excreted in the urine directly or 
excreted as threitol or a minor metabolite, the proportion of consumed xylose that was 
retained in the body ranged from 27 – 63%. Increased dietary xylose concentration 
decreased the retention efficiency across all collection periods. However, a larger 
proportion of xylose was retained during C2 and C3, i.e. after pigs had been adapted to 
the treatment diets for at least 11 d. This indicates that pigs are able to adapt 
metabolically to utilize xylose more efficiently. Further research is necessary to 
determine how this occurs, which mechanisms may be up or down regulated, and the 
final metabolic fate of retained xylose in pigs. 
 Dietary xylose concentration clearly impacts its retention efficiency. This is a 
consistent finding across studies in pigs and other species, as reviewed earlier this year by 
Huntley and Patience [4]. Considering these data in the context of commercial pig 
production, it is unlikely that exogenous xylanase supplementation would release free D-
xylose in the small intestine at concentrations > 4% of the total diet DM. Based on the 
results of this experiment, only about 50 – 63% of the xylose released would be retained 
and could potentially contribute energy to the pig through oxidation. Experiments must 
still be conducted to directly compare the net energetic value of xylose through metabolic 
oxidation verses fermentation. To speculate, based on the xylose retention efficiency 
measured in pigs fed 4% xylose in this study (51%), and using the metabolic energy 
efficiencies of xylose reported by Yule and Fuller [44] and reported energetic efficiencies 
of fiber fermentation in the pig [60–62], it is estimated that xylose would provide 
approximately 15% less energy if absorbed in the small intestine vs. through 
fermentation.  
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 Further research is needed to determine how much free xylose is released from 
arabinoxylan in the small intestine of pigs due to xylanase supplementation. Furthermore, 
it would be valuable to examine the liver and kidney for enzymes that may be 
differentially expressed and regulated in pigs consuming xylose. This will help determine 
how adaptation to xylose-containing diets occurs, and how other metabolic processes 
may be affected. Understanding potential effects on other metabolic processes may also 
help to explain the decreased proportion of urine GE not associated with xylose, its 
metabolites, or N-containing compounds in pigs fed 8% xylose diets. 
 
Conclusions 
 In conclusion, pigs can metabolize xylose, but with considerably lower efficiency 
than glucose. Furthermore, pigs can adapt over time to utilize xylose more efficiently. 
Xylose retention decreased from 60% to 47% to 41% when pigs were fed diets containing 
2, 4, or 8% xylose, respectively. Thus, increasing dietary xylose concentration decreases 
diet ME. A comprehensive pathway for xylose metabolism in the pig is proposed and D-
threitol was confirmed as the major urinary metabolite of xylose. Xylitol, D-xylonic acid, 
and D-xylulose were identified as minor metabolites.  
 This experiment provides novel data regarding xylose metabolism when fed at 
relevant concentrations for typical swine diets. To fully understand these data in the 
context of practical swine nutrition, further research is needed to determine how much 
free xylose is released from arabinoxylan with xylanase supplementation. Because of the 
importance and cost of energy in swine diets, assigning an energy release value to 
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xylanase is of great interest. These data indicate that xylose’s energy contribution to the 
pig will depend on the amount of xylose released and the length of adaptation to the diet.  
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Table 1. Diet ingredient composition (as-fed) 
 
Dietary treatment, % xylose inclusion 
Item, % 0 2 4 8 
Corn starch 57.00 55.00 53.00 49.00 
Sucrose 8.60 8.60 8.60 8.60 
Cellulose 9.00 9.00 9.00 9.00 
Casein 5.50 5.50 5.50 5.50 
Bovine plasma 5.00 5.00 5.00 5.00 
Fish meal 4.50 4.50 4.50 4.50 
Skim milk powder 3.00 3.00 3.00 3.00 
Whey powder 3.00 3.00 3.00 3.00 
Soybean oil 1.00 1.00 1.00 1.00 
D-Xylose1 0.00 2.00 4.00 8.00 
Limestone 0.90 0.90 0.90 0.90 
Monocalcium phosphate 0.35 0.35 0.35 0.35 
Choline chloride 0.05 0.05 0.05 0.05 
Potassium carbonate 0.50 0.50 0.50 0.50 
Magnesium oxide 0.07 0.07 0.07 0.07 
L-Lysine HCl 0.05 0.05 0.05 0.05 
DL-Methionine 0.10 0.10 0.10 0.10 
L-Threonine 0.03 0.03 0.03 0.03 
Vitamin premix2 0.25 0.25 0.25 0.25 
Trace mineral premix3 0.20 0.20 0.20 0.20 
Salt 0.50 0.50 0.50 0.50 
Titanium dioxide 0.40 0.40 0.40 0.40 
1DuPont Nutrition & Health, Copenhagen, Denmark 
2Provided 6,614 IU vitamin A, 827 IU vitamin D, 26 IU vitamin E, 2.6 mg vitamin K, 
29.8 mg niacin, 16.5 mg pantothenic acid, 5.0 mg riboflavin, and 0.023 mg vitamin B12 
per kg of diet. 
3Provided 165 mg Zn (zinc sulfate), 165 mg Fe (iron sulfate), 39 mg Mn (manganese 
sulfate), 17 mg Cu (copper sulfate), 0.3 mg I (calcium iodate), and 0.3 mg Se (sodium 
selenite) per kg of diet. 
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Table 2. Formulated and analyzed diet energy and nutrient composition (as-fed) 
 
Dietary treatment, % xylose inclusion 
Item 0 2 4 8 
Formulated composition     
     SID amino acid, %     
          Lys 1.02 1.02 1.02 1.02 
          Met 0.36 0.36 0.36 0.36 
          Total sulfur AA 0.56 0.56 0.56 0.56 
          Thr 0.61 0.61 0.61 0.61 
          Trp 0.18 0.18 0.18 0.18 
     Ca, % 0.66 0.66 0.66 0.66 
     STTD P, % 0.33 0.33 0.33 0.33 
Analyzed composition     
     DM, % 94.02 94.90 95.26 95.58 
     GE, Mcal/kg 3.92 3.91 3.95 3.96 
     CP, % 14.05 14.03 14.07 14.03 
     aEE, % 1.62 1.57 1.76 1.52 
     NDF, % 10.31 10.40 10.49 10.56 
    ADF, % 7.62 7.71 7.62 8.00 
    Xylose, % 0.00 1.99 4.02 8.02 
Pigs (n = 12/treatment) were housed individually in metabolism crates and fed diets 
containing either 0, 2, 4, or 8% D-xylose at 4% of BW and fecal samples were collected 
during 3 different periods representing increasing adaptation time to treatment diets. 
SID, standardized ileal digestible; AA, amino acids; STTD, standardized total tract 
digestible; GE, gross energy; CP, crude protein; aEE, acid hydrolyzed diethyl ether 
extract; NDF, neutral detergent fiber; ADF, acid detergent fiber. 
 
 
Table 3. Effect of dietary xylose concentration on pig growth performance 
 
Dietary treatment, % xylose inclusion 
  
Item 0 2 4 8 SEM P-value 
BW, kg       
     d 0 28.18 28.27 28.38 28.20 0.46 0.9895 
     d 22 40.90 40.23 40.75 40.28 0.46 0.6659 
ADG, g/d 606 570 589 576 20 0.1653 
Gain: feed 0.53 0.50 0.52 0.51 0.02 0.1660 
Pigs (n = 12/treatment) were housed individually in metabolism crates and fed diets 
containing either 0, 2, 4, or 8% D-xylose at 4% of BW for 22 d. 
BW, body weight; ADG, average daily gain 
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Table 4. Effect of dietary xylose concentration and collection period on water balance 
 
Dietary treatment, % xylose inclusion 
  
Collection period 
  
T×C1 
Item 0 2 4 8 SEM P-value d 5-7 d 12-14 d 19-21 SEM P-value P-value 
Water waste, ml/d 853 796 1024 1265 321 0.3633 1404x 712y 837y 294 0.0001 0.4096 
Water intake‡, ml/d 2447b 2532b 2762ab 3017a 222 0.0424 3025x 2551y 2493y 176 <0.0001 0.4352 
Urine output‡, ml/d 984c 1159bc 1286ab 1566a 129 0.0032 1465x 1196y 1085z 74 <0.0001 0.7898 
Urine specific gravity 1.034 1.031 1.025 1.029 0.009 0.0656 1.029xy 1.028y 1.032x 0.009 0.0087 0.2528 
Pigs (n = 12/treatment) were housed individually in metabolism crates and fed diets containing either 0, 2, 4, or 8% D-xylose at 4% of 
BW. Water intake and urine output were measured during 3 different collection periods representing increasing adaptation time to 
treatment diets. 
a-cTreatment means without a common superscript differ (P   0.05) 
x-zCollection period means without a common superscript differ (P   0.05) 
1Dietary treatment × collection period interaction (T×C) 
‡Treatment linear contrast is significant at P < 0.01 
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Table 5. Effect of dietary xylose concentration and collection period on diet digestibility and energy value and on nitrogen balance 
Collection 
period, d 
5 - 7 12 - 14 19 - 21 
 
 
Dietary 
treatment, % 
xylose inclusion 
0 2 4 8 0 2 4 8 0 2 4 8 
Pooled 
SEM 
T×C1 
P-value 
ATTD, %               
     DM† 87.82de 88.49abcd 88.39abcde 88.12bcde 88.14cde 89.10a 88.89ab 88.58abcd 88.70abc 87.56e 88.80abc 88.06cde 0.30 0.0003 
     GE† 88.98ef 89.45bce 89.43abcef 89.33bcef 89.39ce 90.18a 90.05ab 89.69abce 90.00abd 88.62f 90.01abc 89.19cdef 0.29 <0.0001 
     CP† 90.86 91.16 91.29 90.74 91.96 92.18 91.78 91.64 92.62 91.95 92.57 91.59 0.50 0.0858 
Urine GE*‡†, 
kcal/l 
171 212 220 289 213 241 273 312 224 249 300 328 17 0.5803 
Diet energy value, Mcal/kg, as-fed 
     DE*#† 3.56 3.54 3.61 3.59 3.61 3.58 3.63 3.63 3.63 3.57 3.66 3.62 0.02 0.0857 
     ME*‡† 3.30bc 3.24de 3.23e 3.11g 3.33b 328bc 3.27cde 3.17f 3.37a 3.24e 3.28cd 3.14fg 0.02 0.0116 
Urine N*‡†, % 0.28 0.31 0.20 0.21 0.43 0.39 0.33 0.29 0.50 0.44 0.41 0.34 0.03 0.0962 
Nitrogen balance 
     Retained, % 
of intake 
76.70 75.08 78.72 75.98 76.32 75.97 76.03 75.90 76.25 75.85 75.69 73.19 1.62 0.1497 
     N in feces†, % 
of excreted N 
59.98 63.08 58.52 61.03 65.30 66.25 64.86 66.02 67.97 66.12 69.22 69.18 2.03 0.2949 
     N in urine†, % 
of excreted N 
40.02 36.92 41.48 38.97 34.70 33.75 35.14 33.98 32.03 33.88 30.78 30.82 2.03 0.2949 
Pigs (n = 12/treatment) were housed individually in metabolism crates and fed diets containing either 0, 2, 4, or 8% D-xylose at 4% of BW. Feces 
and urine were collected during 3 different periods representing increasing adaptation time to treatment diets. 
ATTD, apparent total tract digestibility; GE, gross energy; CP, crude protein; ME, metabolizable energy; N, nitrogen 
a-fWithin a row, means without a common superscript differ (P  0.05) 
1Dietary treatment × collection period interaction (T×C) 
*Treatment is significant at P < 0.01 
#Treatment linear contrast is significant at P < 0.05 
‡Treatment linear contrast is significant at P < 0.01 
†Collection period is significant at P < 0.01 
1
6
1
 
  
 
 
 
162 
Table 6. Effect of dietary xylose inclusion on cecum and colon digesta pH and SCFA 
concentration and molar proportions 
 
Dietary treatment, % xylose inclusion 
 
  0 SEM 8 SEM P-value 
Digesta pH 
     
     Cecum 6.64 0.11 6.54 0.11 0.3845 
     Colon 6.52 0.10 6.17 0.10 0.0249 
Cecal digesta SCFA concentration, mmol/g      
     Acetate 22.55 1.76 22.55 1.11 0.8394 
     Propionate 8.82 0.70 8.90 0.62 0.9281 
     Butyrate 2.13 0.16 2.46 0.29 0.4230 
     Valerate 0.87 0.06 0.91 0.09 0.7377 
     Isobutyrate 0.68 0.04 0.68 0.04 0.8756 
     Isovalerate 1.14 0.09 1.10 0.05 0.6613 
     Total 36.20 2.42 37.03 1.62 0.5341 
Cecal digesta SCFA molar proportion, %      
     Acetate 61.97 1.78 62.02 1.40 0.9819 
     Propionate 24.41 1.24 23.97 1.18 0.7782 
     Butyrate 6.00 0.65 6.59 0.78 0.4075 
     Valerate 2.43 0.12 2.51 0.24 0.9100 
     Isobutyrate 1.96 0.16 1.89 0.15 0.7435 
     Isovalerate 3.23 0.27 3.02 0.14 0.4632 
Colon digesta SCFA concentration, mmol/g      
     Acetate 22.20 2.09 22.12 2.19 0.9731 
     Propionate 8.39 0.73 8.91 0.79 0.7775 
     Butyrate 3.65 0.41 3.60 0.34 0.9181 
     Valerate 1.00 0.11 1.01 0.11 0.8466 
     Isobutyrate 0.72 0.06 0.64 0.06 0.3509 
     Isovalerate 1.38 0.09 1.22 0.09 0.2534 
     Total 37.34 1.97 37.51 2.11 0.9474 
Colon digesta SCFA molar proportion, % 
     
     Acetate 59.06 2.73 58.55 2.97 0.8741 
     Propionate 22.57 1.68 23.90 2.07 0.6321 
     Butyrate 9.85 1.34 9.62 1.18 0.9392 
     Valerate 2.70 0.29 2.73 0.31 0.9706 
     Isobutyrate 2.04 0.23 1.80 0.24 0.4379 
     Isovalerate 3.79 0.33 3.40 0.40 0.4664 
Pigs (n = 12/treatment) were housed individually in metabolism crates and fed diets 
containing either 0 or 8% D-xylose at 4% of BW for 22 d. 
SCFA, short chain fatty acids 
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Table 7. Effect of dietary xylose concentration and collection period on urine xylose and metabolite excretion 
Collection period, d 5 - 7 12 - 14 19 - 21 
 
 
Dietary treatment, % 
xylose inclusion 
0 2 4 8 0 2 4 8 0 2 4 8 
Pooled 
SEM 
T×C1 
P-value 
Urinary excretion, g/d               
     Xylose*‡† 0.51g 7.04f 21.59d 50.06a 0.49g 6.01f 16.25e 31.53c 0.83g 5.73f 16.06e 38.58b 1.28 < 0.0001 
     Threitol*‡† 0.12f 2.73e 6.53d 15.96a 0.08f 2.36e 5.61d 10.95c 0.27f 2.46e 6.01d 13.46b 0.45 0.0008 
     Xylitol*‡† 0.01f 0.07e 0.16cd 0.27b 0.01f 0.06ef 0.14d 0.23b 0.04ef 0.05ef 0.21bc 0.41a 0.02 0.0021 
     Xylulose*‡ 0.02e 0.08d 0.12c 0.20a 0.02e 0.08d 0.13c 0.17b 0.02e 0.07d 0.13c 0.21a 0.007 0.0021 
     Xylonic acid‡† 0.000cd 0.001cd 0.009cd 0.059a 0.000d 0.001de 0.009c 0.033b 0.000d 0.001d 0.008ce 0.035b 0.003 < 0.0001 
Pigs (n = 12/treatment) were housed individually in metabolism crates and fed diets containing either 0, 2, 4, or 8% D-xylose at 4% of 
BW. Urine was collected during 3 different periods representing increasing adaptation time to treatment diets. 
a-gWithin a row, means without a common superscript differ (P  0.05) 
1Dietary treatment × collection period interaction (T×C) 
*Treatment is significant at P < 0.01 
‡Treatment linear contrast is significant at P < 0.01 
†Collection period is significant at P < 0.01 
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Table 8. Effect of dietary xylose concentration and collection period on urine energy concentration and urine sugar concentration and 
excretion 
Collection period, d 5 - 7 12 - 14 19 - 21 
 
 
Dietary treatment, % 
xylose inclusion 
2 4 8 2 4 8 2 4 8 
Pooled 
SEM 
T×C1 
P-value 
Consumed xylose excreted 
in urine, % 
           
     As xylose*‡† 31.09cd 47.17b 54.87a 26.53de 35.50c 34.56c 25.32e 35.08c 42.29b 2.34 0.0026 
     As threitol*‡† 12.05 14.27 17.49 10.40 12.26 12.00 10.88 13.13 14.75 0.71 0.1037 
     As xylitol, xylulose, or 
xylonic acid*# 
0.94abc 0.89abc 0.80cd 0.92abc 0.90bc 0.73d 0.86abcd 1.03a 0.98ab 0.06 0.0180 
Retained xylose*‡†, % 55.92bc 37.67d 26.84e 62.15ab 51.35c 52.77c 62.94a 50.77c 42.01d 2.85 0.0063 
a-eWithin a row, means without a common superscript differ (P   0.05) 
1Dietary treatment × collection period interaction (T×C) 
*Treatment is significant at P < 0.01 
‡Treatment linear contrast is significant at P < 0.01 
†Collection period is significant at P < 0.01 
#Collection period is significant at P < 0.05 
Pigs (n = 12/treatment) were housed individually in metabolism crates and fed diets containing either 0, 2, 4, or 8% D-xylose at 4% of 
BW. Urine was collected during 3 different periods representing increasing adaptation time to treatment diets. 
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Figure 1. Two-way heat map visualization and hierarchical clustering of urine metabolite 
distribution. Pigs (n = 12/treatment) were fed diets containing either 0, 2, 4, or 8% D-
xylose and 3 different collection periods were utilized to represent increasing adaptation 
time to treatment diets. The rows display the metabolites and the columns represent 
individual samples. Relative urinary metabolite excretion (g/d, log transformed) is 
represented in the heat map by colors, which correspond to the magnitude of difference 
when compared with the average value for the metabolite. Only metabolites significantly 
(adjusted P  0.05) impacted by treatment (% dietary xylose inclusion; 0, 2, 4, or 8%), 
collection period (1 = d 5-7, 2 = d 12-14, 3 = d 19-21), or their interaction are displayed. 
Significance was determined using two-way ANOVA. 
  
 
 
 
166 
 
Figure 2. Proposed xylose metabolic pathway. Dietary D-xylose concentration (0, 2, 4, 
or 8%) linearly increased the urinary excretion of the compounds in bold font (P < 
0.0001). Non-bolded compounds were not detected in urine samples. The color of the 
block arrow indicates average excretion amount of the compound in pigs from the 8% 
xylose treatment; red: 40 g/d, orange: 13 g/d, yellow: 0.3 g/d, white: < 0.2 g/d. Solid 
connecting arrows represent reactions confirmed in mammals and dashed connecting 
lines represent presumed reactions based on reactions occurring in microorganisms. 
Highlighted enzymes: 1) D-xylose 1-dehydrogenase (1.1.1.179), 2) L-gulonate 3-
dehydrogenase (1.1.1.45), 3) D-erythrulose reductase (1.1.1.162), 4) aldose/aldehyde 
reductase (1.1.1.21), 5) L-xylulose reductase (1.1.1.10), 6) xylitol dehydrogenase 
(1.1.1.14), 7) xylulokinase (2.7.1.17), and 8) D-ribose dehydrogenase (1.1.1.115). The 
boxes indicate KEGG metabolic pathway classifications [36].
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Figure 3. Allocation of urine gross energy (GE) from xylose, metabolites, and nitrogen 
(N)-containing compounds. Pigs (n = 12/treatment) were fed diets containing either 0, 2, 
4, or 8% D-xylose. The presented values are treatment averages across 3 different 
collection periods. The effect of treatment was significant for all variables (P  0.042). 
Dietary xylose concentration linearly impacted each variable (linear contrast P  0.012) 
except the unassociated fraction. Increasing dietary xylose concentration increased the 
urine GE (kcal/l) contributed from xylose (SEM = 4.16), threitol (SEM = 2.05), and the 
combination of all lesser metabolites (xylitol, xylonic acid, and xylulose; SEM = 0.08), 
but decreased the GE contributed from N-containing compounds (SEM = 4.07). The 
amount of urine GE unexplained by the xylose, its metabolites, or N-containing 
compounds (SEM = 10.83) was not different among the 0, 2, and 4% treatments (P  
0.416) but was lower in the 8% treatment (P = 0.042).  
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CHAPTER V 
INTEGRATIVE SUMMARY 
 
General discussion  
Feed ingredient economics are pushing pork producers to increase the use of 
higher-fiber coproducts while maintaining high production and efficiency goals. To do 
this, nutritionists must have a comprehensive understanding of fiber utilization in the pig. 
Xylose and mannose are two of the primary carbohydrates of grain and legume fiber; yet, 
their direct and indirect influences on swine energy metabolism are poorly understood. 
As -mannanase and xylanase enzymes use continues to increase, it is important to 
evaluate their metabolic impact to accurately estimate enzyme effects on dietary energy 
availability. This information will allow nutritionists to improve the accuracy of diet 
formulations when high-fiber ingredients and carbohydrase enzymes are utilized. 
Therefore, the overall objective of this dissertation work was to evaluate the impacts of 
-mannan and xylose on energy metabolism in the pig.  
-Mannanase can be added to swine diets with the objective of inhibiting a -
mannan-induced immune response. This hypothesis was developed from and supported 
by experiments in broilers which reported that -mannanase supplementation alleviated a 
soybean-meal derived immune response and spared that energy for growth [1]. However, 
prior to our experiments, only growth trials had been published regarding the effect of -
mannanase in swine [2–5]; as such, evidence supporting this dietary -mannan-induced 
immune response and amelioration due to -mannanase supplementation was lacking.  
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Therefore, the objective of Experiment 1 (Chapter 2) was to evaluate the -
mannan-induced immune response hypothesis in pigs by testing -mannanase 
supplementation influence of on maintenance energy requirements and to characterize 
systemic immune response and nutrient partitioning effects. The data from this 
experiment did not support the hypothesis that β-mannanase supplementation ameliorates 
an innate immune response induced by soybean β-mannans at a concentration of 1.3%. It 
is possible, however, that this concentration was too low to either effectively generate a 
systemic inflammatory response or to be able to measure β-mannanase supplementation 
effects. Therefore, Experiment 2 (Chapter 3) was a follow-up trial to evaluate the impact 
and interactions of dietary β-mannan concentration and β-mannanase supplementation on 
serum acute phase proteins, as indicators of systemic immune activation, and on growth 
performance in nursery pigs. This experiment provided immune data previously lacking 
in pig growth trials assessing -mannanase efficacy and confirmed the conclusions from 
the initial experiment.  
In order to truly understand what immune stimulation would look like in the 
context of Experiment 1, a positive control treatment using LPS was included. 
Importantly, this treatment allowed us to evaluate the impact of an innate immune 
challenge on maintenance energy requirements. Prior to this experiment, few studies had 
addressed comprehensive changes in energy partitioning during an immune response. 
Innate immune challenge elevated pigs’ maintenance energy requirements by 23.3% and 
this shift in energy partitioning toward the immune response limited lipid deposition by 
30.2%, leading to an 18.3% decrease in ADG during the immune challenge.  
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It is important to understand that in the face of a true pathogen challenge, 
increased maintenance energy requirement compounds the issue of decreased feed – and 
thus energy - intake typically observed during disease outbreaks. This means that during 
health challenges, energy available for growth is likely even more restricted than 
previously thought. The results of this research are most valuable when interpreted in 
context with the findings of other Iowa State researchers that immune stimulation 
increases glucose requirement [6], and pathogen challenges increase the lysine:energy 
requirement [7] in addition to decreasing the digestibility of specific amino acids [8]. 
Clearly, immune responses drastically affect energy and nutrient requirements and 
nutritional strategies could be implemented to alleviate resource competition and improve 
animal health and productivity during health challenges. 
The use of exogenous carbohydrases to improve fiber utilization in swine diets 
presents multiple issues for nutritionists to consider, such as poor response consistency 
and appropriate enzyme application (ex.  -mannanase). Furthermore, understanding how 
enzyme hydrolysis products contribute to energy availability and affect overall 
metabolism adds additional complexity. As interest in xylanase supplementation 
continues to increase, an improved understanding of xylose metabolism in the pig and its 
energetic value is essential for effective xylanase utilization. Based on older experiments 
that utilized pigs fed unrealistically high dietary concentrations [9–11], it was commonly 
assumed that pigs cannot effectively catabolize xylose for energy. It is possible that these 
high xylose concentrations overwhelmed the pig’s metabolic capacity and led to incorrect 
conclusions. Therefore, Experiment 3 (Chapter 4) evaluated more industry-relevant 
dietary xylose concentrations and tested for possible adaptation mechanisms. It was 
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found that the pig can utilize xylose but does so less efficiently as more xylose is 
consumed; only 40 – 60% of consumed xylose was retained. Furthermore, pigs can adapt 
over time to improve xylose utilization efficiently. By applying metabolomic approaches, 
urinary metabolites of xylose were identified and quantified. This information facilitated 
construction of a comprehensive pathway for xylose metabolism in the pig. 
Overall, this dissertation improved our understanding of how -mannanase and 
xylanase may impact energy metabolism in the pig. This research also furthered the 
understanding of how immune activation can repartition energy and increase maintenance 
energy requirements. Understanding the extent to which energy requirements and nutrient 
deposition change in pigs experiencing sustained immune stress may help develop more 
effective feeding strategies for health-challenged herds and encourage appreciation for 
the economic benefits of maintaining high-health populations. Furthermore, this research 
was the first to address xylose metabolism in pigs using industry-relevant dietary 
concentrations and will substantially further the scientific community’s understanding of 
xylose metabolism in mammals, in addition to helping swine nutritionists determine the 
energetic value of fiber in pig diets.  
Recommendations for future research 
Future directions to expand upon this work include evaluating xylose effects on 
overall energy metabolism and regulation mechanisms by measuring differential gene 
expression and protein abundance in key metabolic tissues, such as the liver and kidney 
[12,13]. This approach would also be of interest in the muscle, which may be able to 
utilize or accumulate xylose [13–15], and the intestinal mucosa, to potentially identify 
mechanisms of absorption [16]. Such data would further inform how xylose is 
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metabolized and potentially provide more empirical evidence to support the proposed 
xylose metabolic pathway. Additionally, there is a need for more comprehensive 
understanding of xylanase vivo mode of action and hydrolysis products. Specifically, 
quantifying the xylanase release efficiency of free xylose in the small intestine would 
provide clearer context in which to interpret the results of Experiment 3. With a greater 
understanding of the nutritional and metabolic influences of dietary carbohydrates and 
carbohydrases, we can improve the productivity and efficiency of pork production. 
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